[
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    5284,
                    5913
                ],
                "answer": "WHEREAS, pursuant to this Agreement, Merger Subsidiary has agreed to commence, and Parent has agreed to cause Merger Subsidiary to commence, a tender offer (as it may be extended and amended from time to time pursuant to this Agreement, the \u201cOffer\u201d) to purchase any (subject to the Minimum Tender Condition) and all of the shares of common stock, $0.067751 par value per share, of the Company (\u201cCompany Common Stock\u201d), issued and outstanding, at a price per share of $22.00 (the \u201cOffer Price\u201d), net to the holder of such share, in cash, without interest, on the terms and subject to the conditions set forth in this Agreement;   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    86031,
                    86699
                ],
                "answer": "(a)         Conversion of Shares. Each Share outstanding immediately prior to the Effective Time, other than Shares irrevocably accepted for purchase by Merger Subsidiary in the Offer, any Excluded Shares and any Appraisal Shares, shall be canceled and converted into the right to receive the Offer Price in cash, without interest (the \u201cMerger Consideration\u201d). As of the Effective Time, all such Shares shall no longer be outstanding and shall automatically be canceled and retired and shall cease to exist, and each share shall thereafter represent only the right to receive the Merger Consideration to be paid in accordance with Section 2.05(b), without interest.   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    348970,
                    349290
                ],
                "answer": "there shall have been validly tendered in the Offer and not validly withdrawn that number of Shares that (together with any Shares owned by Parent and its Affiliates) represent at least a majority of the Shares outstanding as of the consummation of the Offer at the Offer Expiration Time (the \u201cMinimum Tender Condition\u201d)"
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    348255,
                    348939
                ],
                "answer": "Conditions of the Offer   Notwithstanding any other term of the Offer or this Agreement and in addition to (and not in limitation of) Merger Subsidiary\u2019s right to extend and amend the Offer pursuant to the provisions of the Agreement, Parent shall not be required to accept for payment or, subject to any applicable rules and regulations of the SEC, including Rule 14e-l(c) under the 1934 Act (relating to Parent\u2019s obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the Offer), to pay for any Shares validly tendered and not validly withdrawn in the Offer, unless, immediately prior to the then applicable Offer Expiration Time:  \n\n\n\n\n\n\n\n\n"
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    352036,
                    352281
                ],
                "answer": "(e)         the Company shall have performed or complied with, in all material respects, each covenant, agreement and obligation required by the Merger Agreement to be performed or complied with by it on or prior to the Offer Expiration Time;   "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    129468,
                    129516
                ],
                "answer": "Section 4.10.     Absence of Certain Changes.   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    130228,
                    130513
                ],
                "answer": "(b)               From the Company Balance Sheet Date until the date hereof, there has not been any event, occurrence, development of a state of circumstances or facts that has had or would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.   "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    36602,
                    41924
                ],
                "answer": ". \u201cMaterial Adverse Effect\u201d means an event, occurrence, development, circumstance, change or effect that has a material adverse effect on the condition (financial or otherwise), business, assets or results of operations of the Company and its Subsidiaries, taken as a whole, excluding any effect resulting from (i)  changes in the financial, securities, credit, debt, banking or other capital markets or conditions (including changes therein) or foreign or domestic economic, financial, regulatory, legislative, political or social conditions (including changes therein), (ii) changes or conditions generally affecting the industry in which the Company and its Subsidiaries operate or to the industries to which the Company and its Subsidiaries sell their products and services, including changes in interest and exchange rates or commodity pricing, in the United States or any other jurisdiction in which the Company or its Subsidiaries operate, (iii) geopolitical conditions, the occurrence, escalation, outbreak or worsening of hostilities, acts of war (whether or not declared), tariffs, trade wars, transportation delays (including work stoppages or port closures), cyber-attacks, acts of armed hostility, sabotage, civil unrest, protests and public demonstrations, insurrection, domestic or international terrorism or national or international calamity or other occurrences of instability, (iv) any (1) plagues, pandemics (including SARS-CoV-2 or COVID-19 (collectively, \u201cCOVID-19\u201d)) or any escalation or worsening or subsequent waves thereof, epidemics or other outbreaks of diseases or public health events, or (2) hurricane, tornado, tsunami, flood, volcanic eruption, earthquake, nuclear incident, weather conditions or other natural or man-made disaster or other force majeure event, (v) any quarantine, \u201cshelter in place,\u201d \u201cstay at home,\u201d workforce reduction, social distancing, shut down, closure, sequester, safety or similar laws, directives, restrictions, guidelines, responses or recommendations of or promulgated by any Governmental Authority, including the Centers for Disease Control and Prevention and the World Health Organization, or other reasonable actions taken, in each case, in connection with or in response to COVID-19 and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease outbreaks (all of the foregoing, \u201cCOVID-19 Measures\u201d), (vi) changes or prospective changes in Applicable Law, Tax or GAAP or authoritative interpretation or enforcement thereof on or after the date hereof, (vii) any failure, in and of itself, of the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, guidance, estimates or predictions in respect of revenues, earnings or other financial or operating metrics or other matters before, on or after the date hereof, or changes or prospective changes in the market price or trading volume of the securities of such Person or the credit rating of the Company (whether made by the Company or third parties) (it being understood that the underlying facts giving rise or contributing to such failure or change may be taken into account in determining whether there has been a Material Adverse Effect if such facts are not otherwise excluded under this definition), (viii) any seasonal fluctuations materially consistent with historical seasonal fluctuations affecting the business of the Company and its Subsidiaries, (ix) the identity of, or any facts or circumstances relating to Parent, Merger Subsidiary or their respective Affiliates, (x) the negotiation, announcement, pendency or consummation of the Transactions, including any loss or change in relationship with any supplier, vendor, reseller, customer, distributor, lender, employee, investor, venture partner or other business partner of the Company or its Subsidiaries (other than for the purpose of any representation or warranty in respect of a Material Contract with any such counterparty contained in Section 4.04), (xi) any litigation, suit, action or proceeding in respect of this Agreement or the other Transaction Documents (or the transactions contemplated hereby or thereby), or the Offer Documents (including breach of fiduciary duty and disclosure claims), and (xii) (1) any action taken by the Company or any of its Subsidiaries at the written request, or with the written consent, of Parent or Merger Subsidiary or (2) compliance by the Company or any of its Subsidiaries with the express terms of, or the taking by the Company or any of its Subsidiaries of any action expressly required by, this Agreement (including Section 8.07(h)), or the failure by the Company or any of its Subsidiaries to take any action expressly prohibited by this Agreement (other than the obligations to operate in the ordinary course or restrictions on taking certain actions pursuant to Section 6.01); except, in the case of clauses (ii) through (vi), to the extent having a materially disproportionate effect on the Company and its Subsidiaries, taken as a whole, relative to other participants in the industry in which the Company and its Subsidiaries operate (in which case the incremental materially disproportionate impact or impacts may be taken into account in determining whether there has been a Material Adverse Effect).   \n\n\n"
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    30599,
                    30877
                ],
                "answer": "\u201cknowledge\u201d of any Person that is not an individual means the actual knowledge of such Person\u2019s executive officers; provided, however, that \u201cknowledge\u201d of the Company means the actual knowledge of the individuals listed in Section 1.01(a) of the Company Disclosure Letter.   \n\n\n"
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    215723,
                    215769
                ],
                "answer": "Section 6.03.     Go-Shop; No Solicitation.   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    224238,
                    226137
                ],
                "answer": "(d)                Notwithstanding anything to the contrary in Section 6.03, if at any time prior to the Acceptance Time, the Company or any of its Representatives has received a written Acquisition Proposal from any Third Party (including any Excluded Party, at any time) that the Company Board determines after consultation with its financial advisor and outside legal counsel, is, could lead to, result in or constitute a Superior Proposal, then the Company and its Subsidiaries, directly or indirectly through its and their Representatives, may (i) engage or participate in negotiations or discussions with such Third Party and its Representatives and (ii) furnish to such Third Party or its Representatives non-public information relating to the Company or any of its Subsidiaries pursuant to an Acceptable Confidentiality Agreement; provided, that, (A) prior to or substantially concurrently with the time it is made available to such Third Party, the Company shall make available to Parent any material non-public information relating to the Company or its Subsidiaries that is made available to such Third Party and that was not previously made available to Parent or its Representatives and (B) the Company shall not provide to any such Person any non-public information of or relating to Parent, Merger Subsidiary or any of their respective Affiliates or Representatives. Notwithstanding anything in this Agreement to the contrary and notwithstanding the occurrence of the No-Shop Period Start Date, from and after the Cut Off Date, the Company may continue to engage in the activities described in Section 6.03(a) with respect to any Excluded Party, including with respect to any amended proposal or offer submitted by an Excluded Party following the Cut Off Date, and the restrictions in Section 6.03(b) and Section 6.03(c) will not apply with respect thereto, until the Cut Off Date.   "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    232356,
                    233140
                ],
                "answer": "\u201cSuperior Proposal\u201d means a bona fide written Acquisition Proposal for at least a majority of the outstanding Shares or at least a majority of the consolidated assets of the Company and its Subsidiaries that was not solicited in material breach by the Company of the first sentence of Section 6.03(b) or the first sentence of Section 6.03(c) and that the Company Board determines in good faith, after consultation with its financial advisor and outside legal counsel, and taking into account all relevant terms and conditions of such Acquisition Proposal, is more favorable to the Company\u2019s stockholders from a financial point of view than the Merger (taking into account any irrevocable written proposal by Parent to amend the terms of this Agreement pursuant to Section 6.03(h)).   "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    301451,
                    301581
                ],
                "answer": "Section 10.01. Termination. This Agreement may be terminated and the Transactions may be abandoned at any time only as follows:   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    304672,
                    305121
                ],
                "answer": "(d)               by the Company, if:   (i)             at any time prior to the Acceptance Time, the Company Board authorizes the Company to enter into a definitive agreement concerning a Superior Proposal pursuant to Section 6.03(h) and the Company contemporaneously enters into such definitive agreement concerning such Superior Proposal; provided, that the Company pays the Company Termination Fee payable pursuant to Section 11.05(a)(ii);   \n\n\n"
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    318396,
                    318421
                ],
                "answer": "Section 11.05. Expenses. "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    318609,
                    318647
                ],
                "answer": "(a)               Termination Fees.   "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    319132,
                    319151
                ],
                "answer": "(iii)           If "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    319520,
                    319549
                ],
                "answer": "this Agreement is terminated "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    319843,
                    320207
                ],
                "answer": "(C) within nine (9) months after such termination, the Company enters into a definitive agreement with respect to an Acquisition Proposal and, at any time thereafter, consummates such Acquisition Proposal, then the Company shall pay to Parent the Company Termination Fee by wire transfer of same-day funds on the date of consummation of such Acquisition Proposal. "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    201533,
                    202909
                ],
                "answer": "Section 6.01.     Conduct of the Company. Except for matters set forth in Section 6.01 of the Company Disclosure Letter, as contemplated by this Agreement (including any actions taken by the Company or any of its Subsidiaries pursuant to Section 8.07(h)), as required by Applicable Law or Contract, due to factors excluded from the definition of Material Adverse Effect, or with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed, and shall be deemed to be given if, within five (5) Business Days after the Company has provided to Parent a written request for consent, Parent has not rejected such request in writing), from and after the date hereof until the earlier of the Effective Time or the date this Agreement is terminated, as applicable, (I) the Company shall, and shall cause each of its Subsidiaries to, conduct its business in the ordinary course (except for any actions taken reasonably and in good faith in response to COVID-19 or COVID-19 Measures) and use its reasonable best efforts to (x) preserve intact its present business organization, (y) keep available the services of its directors, officers and key employees and (z) maintain existing relationships with its material suppliers and others having material business relationships with it, and, without limiting the generality of the foregoing, "
            },
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    313784,
                    314311
                ],
                "answer": "References to \u201cordinary course\u201d or \u201cordinary course of business\u201d refers to the ordinary course of business of the Company and the Subsidiaries of the Company, taken as a whole, materially consistent with past practice, and, except with respect to Section 6.01(II), reasonable actions or omissions taken or to be taken by the Company in good faith from time to time in response to changing economic and other conditions, circumstances or events relating to or arising from COVID-19 or COVID-19 Measures and the results thereof. "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Magic AcquireCo, Inc.\" and Target \"The Michaels Companies, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/The Michaels Companies, Inc._Apollo Global Management, LLC.txt",
                "span": [
                    340568,
                    341722
                ],
                "answer": "Section 11.14. Specific Performance. The parties hereto agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy would occur in the event that the parties hereto do not perform their obligations under the provisions of this Agreement (including failing to take such actions as are required of them hereunder to consummate the Merger and the other Transactions) in accordance with its specified terms or otherwise breach such provisions. The parties acknowledge and agree that, subject to the last sentence of this Section 11.14, the parties shall be entitled to an injunction or injunctions, specific performance or other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in the courts described in Section 11.09 without proof of damages or otherwise, this being in addition to any other remedy to which they are entitled under this Agreement at law or in equity, and the right of specific enforcement is an integral part of the Transactions and without that right, neither the Company nor Parent would have entered into this Agreement. "
            }
        ],
        "file_set": [
            "The Michaels Companies, Inc._Apollo Global Management, LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    297458,
                    297791
                ],
                "answer": "8.2 Conditions to Obligations of Parent, Holding and Merger Sub. The obligations of Parent, Holding and Merger Sub to consummate the Merger are further subject to the satisfaction, at or prior to the Effective Time, of the following conditions (which may be waived, in whole or in part, to the extent permitted by Law, by Parent):   "
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    298780,
                    299017
                ],
                "answer": "(b) Performance of Obligations of the Company. The Company shall have performed in all material respects all obligations (subject to Section 7.2(d)) required to be performed by it under this Agreement at or prior to the Closing Date. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    132485,
                    132521
                ],
                "answer": "5.10 Absence of Certain Changes. \n\n\n"
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    132899,
                    133357
                ],
                "answer": "(b) Since July 31, 2019, and through the Original Signing Date, there has not been any event, change, development, circumstance, fact or effect materially adverse to the financial condition, assets, liabilities (contingent or otherwise), business operations or results of operations of the Company and its Subsidiaries (taken as a whole) that, individually or in the aggregate, has had, or would reasonably be expected to have, a Material Adverse Effect. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    40215,
                    40530
                ],
                "answer": "\u201cKnowledge\u201d or any similar phrase means (a) with respect to the Company, the knowledge of the individuals set forth in Section 1.1 of the Company Disclosure Letter, and (b) with respect to Parent, Holding and Merger Sub, the knowledge of the individuals set forth in Section 1.1 of the Parent Disclosure Letter. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    53879,
                    54295
                ],
                "answer": "\u201cRepresentative\u201d means, with respect to any Person, any director, principal, partner, manager, member (if such Person is a member-managed limited liability company or similar entity), employee (including any officer), consultant, investment banker, financial advisor, legal counsel, attorneys-in-fact, accountant or other authorized advisor or agent of such person, in each case acting in their capacity as such. \n\n\n"
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    224484,
                    226964
                ],
                "answer": "7.3 Acquisition Proposals; Change of Recommendation. \n\n\n(a) No Solicitation. At all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to Article IX and the Effective Time, except as expressly permitted by this Section 7.3, the Company shall, and shall cause its Subsidiaries and the Company\u2019s directors, executive officers, or controlled Affiliates, and shall instruct its other Representatives to, immediately cease any discussions or negotiations with any Person conducted heretofore with respect to an Acquisition Proposal or proposal that would reasonably be expected to lead to an Acquisition Proposal, terminate access to any physical or electronic dataroom relating to the Company for any such Acquisition Proposal and request the prompt return or destruction of any confidential information provided to any third party in connection with an Acquisition Proposal made in the twelve (12) months prior to the date of this Agreement (other than in respect of Parent and the Original Merger Agreement). From and after the date of this Agreement, the Company and its Subsidiaries and the Company\u2019s executive officers and directors shall use their reasonable best efforts to enforce any confidentiality provisions or provisions of similar effect to which the Company or any of its Subsidiaries is a party in connection with an Acquisition Proposal or of which the Company or any of its Subsidiaries is a beneficiary in connection with an Acquisition Proposal. Without prejudice to the foregoing sentences, at all times during the period commencing with the execution and delivery of this Agreement and continuing until the earlier to occur of the termination of this Agreement pursuant to Article IX and the Effective Time, except as expressly permitted by this Section 7.3, the Company shall not, and shall cause its Subsidiaries and its and their respective directors, executive officers or controlled Affiliates, and shall instruct any other Representatives and other employees not to, directly or indirectly: \n\n\n(i) initiate, solicit, cause, propose or knowingly encourage, assist or facilitate any inquiry, proposal or offer with respect to, or the making, submission or announcement of any Acquisition Proposal or any inquiry, proposal or request for information that would reasonably be expected to lead to, or result in, an Acquisition Proposal;   "
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    232042,
                    232298
                ],
                "answer": "The Company acknowledges and agrees that any action, that if taken by the Company would be a breach of this Section 7.3, is taken by a Representative of the Company, such action shall be deemed to constitute a breach of this Section 7.3 by the Company. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    14257,
                    15627
                ],
                "answer": "\u201cAcquisition Proposal\u201d means any (a) proposal, offer, inquiry or indication of interest (whether in writing or otherwise) relating to a merger, joint venture, partnership, consolidation, dissolution, liquidation, tender offer, recapitalization, reorganization, spin-off, share exchange, asset purchase, extraordinary dividend, business combination or similar transaction involving the Company or any of its Subsidiaries or (b) direct or indirect acquisition (whether by tender offer, share purchase, share exchange or other manner) in a single transaction or a series of related transactions by any Person or group (as defined under Section 13 of the Exchange Act), or any proposal, offer, inquiry or indication of interest with respect to any such direct or indirect acquisition, which, in each case of (a) or (b), if consummated would result in any Person or group (as defined under Section 13 of the Exchange Act) becoming the beneficial owner of, directly or indirectly, in one or a series of related transactions, fifteen percent (15%) or more (i) measured by either voting power or value, of the Shares and other equity and voting interests in the Company (or any class thereof) or (ii) of the revenue, net income, EBITDA or assets of the Company and its Subsidiaries (taken as a whole), in each case, other than the transactions contemplated by this Agreement.   "
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    56585,
                    57627
                ],
                "answer": "\u201cSuperior Proposal\u201d means an unsolicited, bona fide written Acquisition Proposal (with all references to fifteen percent (15%) in the definition of Acquisition Proposal deemed to reference eighty and 1/10th percent (80.1%)) that the Company Board has determined in good faith (after consultation with a financial advisor (of nationally recognized reputation) and outside legal counsel), taking into account all financial, legal, regulatory and other aspects of such Acquisition Proposal and this Agreement, (a) to be reasonably likely to be consummated in accordance with its terms and (b) would result in a transaction more favorable to the stockholders of the Company (solely in their capacities as such) from a financial point of view than the transactions contemplated by this Agreement (after taking into account any revisions to the terms of this Agreement proposed by Parent pursuant to Section 7.3(d)(ii)); provided that such Acquisition Proposal was not obtained or made as a direct or indirect result of a breach of Section 7.3. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    38219,
                    40005
                ],
                "answer": "\u201cIntervening Event\u201d means any event, occurrence, fact, condition, change, development, circumstance or effect or cause thereof (\u201cEffect\u201d) occurring or arising after the date of this Agreement that is material to the Company and its Subsidiaries, taken as a whole, and (a) was not known to, or reasonably foreseeable by, the Company Board as of or prior to the execution of this Agreement (or if known or reasonably foreseeable, the material consequences of which were not known or reasonably foreseeable by the Company Board), which Effect, or any material consequence thereof, becomes known to, or reasonably foreseeable by, the Company Board prior to the time the Requisite Company Vote is obtained and (b) does not in any way involve or relate to (i) an Acquisition Proposal, (ii) any changes in the market price or trading volume of the Company or Parent or the major stock indexes in the U.S. market, (iii) any changes in the Company\u2019s credit ratings, (iv) the Company or Parent meeting, failing to meet or exceeding published or unpublished revenue or market consensus earnings projections, in each case in and of itself or (v) any changes or conditions generally affecting the economies or the industries in which the Company and its Subsidiaries operate, except to the extent such Effect has a materially disproportionate effect on the Company and its Subsidiaries, taken as a whole, relative to others in such industries in respect of the business conducted in such industries (it being understood that with respect to each of the foregoing clauses (i) through (iv) the Effect giving rise or contributing to such change or event may be taken into account when determining whether an Intervening Event has occurred to the extent not otherwise excluded from this definition). \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    302239,
                    302392
                ],
                "answer": "9.3 Termination by the Company. This Agreement may be terminated and the transactions contemplated by this Agreement may be abandoned by the Company: \n\n\n"
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    303544,
                    303889
                ],
                "answer": "(b) prior to the time the Requisite Company Vote is obtained, to enter into an Alternative Acquisition Agreement in compliance with the terms of this Agreement, including Section 7.3(d)(ii); provided that the Company pays the Company Termination Fee to Parent prior to or concurrently with such termination in accordance with Section 9.5(b). \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    304295,
                    304341
                ],
                "answer": "9.5 Effect of Termination and Abandonment. \n\n\n"
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    305380,
                    306495
                ],
                "answer": "(b) The Company shall pay to Parent, by wire transfer of immediately available funds, a termination fee in the amount of $575,000,000 (the \u201cCompany Termination Fee\u201d) in the event that this Agreement is terminated: \n\n\n(i) by either the Company or Parent pursuant to Section 9.2(a), or Section 9.2(b) and, in each case; \n\n\n(A) any Person shall have made an Acquisition Proposal to the Company or its stockholders (whether or not conditional or not withdrawn) or publicly announced an intention (whether or not conditional and whether or not withdrawn) to make an Acquisition Proposal with respect to the Company or any of its Subsidiaries, and \n\n\n(B) within twelve (12) months after such termination, the Company enters into any Alternative Acquisition Agreement with respect to any Acquisition Proposal (with \u201cfifty percent (50%)\u201d being substituted in lieu of \u201cfifteen percent (15%)\u201d in each instance thereof in the definition of \u201cAcquisition Proposal\u201d for purposes of this Section 9.5(b)(i)(B)), then immediately prior to or concurrently with the occurrence of such entry into an Alternative Acquisition Agreement, "
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    46004,
                    46511
                ],
                "answer": "\u201cOrdinary Course of Business\u201d means, with respect to any Person, the conduct by a Person of the relevant business in the ordinary course, which in the case of the Company or any of its Subsidiaries shall be deemed to include, without limitation, the manner in which the Company and its Subsidiaries have been operating at any time since the Original Signing Date through the date of this Agreement and any COVID-19 Measures taken by the Company and its Subsidiaries following the date of this Agreement. \n\n\n"
            },
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    199960,
                    200984
                ],
                "answer": "7.1 Conduct of the Company. \n\n\n(a) From and after the execution and delivery of this Agreement until the earlier to occur of the Effective Time or the termination of this Agreement in accordance with Article IX, the Company shall, and shall cause each of its Subsidiaries to, except as set forth in Section 7.1(a)(i)-(xxiv) of the Company Disclosure Letter, consented to in writing by Parent (such consent (x) not to be unreasonably conditioned, withheld or delayed and (y) to be provided as set forth in Section 7.2), previously approved in writing by Parent pursuant to the Original Merger Agreement or in compliance with a Company Material Contract, and except (A) as otherwise specifically contemplated by this Agreement, (B) as is required by a Governmental Entity or applicable Law or (C) COVID-19 Measures, (1) comply in all material respects with all applicable Laws and the material requirements of all Company Material Contracts and conduct its business in all material respects in the Ordinary Course of Business "
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"LVMH Mo\u00ebt Hennessy-Louis Vuitton SE\" and Target \"Tiffany & Co.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt",
                "span": [
                    321431,
                    322602
                ],
                "answer": "10.6 Specific Performance; Remedies. \n\n\n(a) Each of the Parties acknowledges and agrees that irreparable harm would occur in the event that the provisions of this Agreement are not performed in accordance with their specific terms or are otherwise breached or threatened to be breached and for which money damages would not be an adequate remedy. Accordingly, each Party agrees that, in addition to any other available remedies a Party may have in equity or at law, each Party shall be entitled to seek to enforce specifically the terms and provisions of this Agreement and to obtain or to seek an injunction restraining any breach or violation or threatened breach or violation of the provisions of this Agreement, consistent with the provisions of Section 10.5(a), in the Chosen Courts without necessity of posting a bond or similar instrument. In the event that any Proceeding should be brought in equity to enforce the provisions of this Agreement, no Party shall allege, and each Party hereby waives the defense, that there is an adequate remedy at law, and any right it may have to require the obtaining, furnishing or posting of any bond or similar instrument. \n\n\n"
            }
        ],
        "file_set": [
            "TIFFANY_&_CO._LVMH_MO\u00cbT_HENNESSY-LOUIS_VUITTON.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    262932,
                    263258
                ],
                "answer": "Section 7.02 Conditions to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or written waiver by each of Parent and Merger Sub, if permissible under Applicable Law), at or prior to the Closing, of the following further conditions: \n\n\n"
            },
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    265283,
                    265494
                ],
                "answer": "(b) Covenants. Each of the covenants and obligations that the Company is required to comply with or to perform at or prior to the Closing shall have been complied with and performed in all material respects. \n\n\n"
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    110957,
                    111587
                ],
                "answer": "Section 4.07 Absence of Certain Changes. Between the Company Balance Sheet Date and the date of this Agreement, except as otherwise contemplated or permitted by this Agreement, (i) a Company Material Adverse Effect has not occurred, (ii) the business of the Acquired Companies has been conducted, in all material respects, in the ordinary course and (iii) no Acquired Company has taken any action which would have required the prior written consent of Parent pursuant to clauses (i), (iii), (v), (vii), (ix), (xii), (xiii), (xv), (xvii) and (xviii) of Section 6.01 had such actions been taken after the date of this Agreement. \n\n\n"
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    37391,
                    37755
                ],
                "answer": "\u201cKnowledge\u201d means, (i) with respect to the Company the actual knowledge, after reasonable inquiry, of each of Keith R. Dunleavy, M.D., Beverly Allen, Jonathan Boldt, Geoff Charron, Monica Keeneth and Ingrid E. Olsen, and (ii) with respect to Parent and Merger Sub, the actual knowledge, after reasonable inquiry, of each of Fredrik N\u00e4slund and Aditya Desaraju. \n\n\n"
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    43442,
                    43711
                ],
                "answer": "\u201cRepresentatives\u201d means, with respect to any Person, (i) such Person\u2019s Affiliates and (ii) such Person\u2019s and each such Affiliate\u2019s respective officers, directors, employees, agents, attorneys, accountants, advisors, consultants and other authorized representatives. \n\n\n"
            },
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    186487,
                    186823
                ],
                "answer": "Section 6.02 Non-Solicitation \n\n\n(a) Except as otherwise expressly permitted by this Section 6.02, the Company shall, and shall cause its Subsidiaries and each of its and their respective directors, officers and employees to, and shall instruct and direct, and use its reasonable best efforts to cause, its other Representatives to: \n\n\n"
            },
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    187932,
                    189855
                ],
                "answer": "(ii) from and after the execution of this Agreement until the Effective Time or the date, if any, on which this Agreement is validly terminated in accordance with Article VIII, not to, directly or indirectly (A) solicit, initiate, seek, propose, o r knowingly facilitate or encourage any inquiry, discussion, offer or request that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal, (B) enter into, continue, initiate or otherwise participate in any discussions or negotiations with, or furnish any non-public information or data relating to the Acquired Companies to, or afford access to the properties, books, records, officers or personnel of the Acquired Companies to, any Third Party with respect to an Acquisition Proposal or any inquiry, discussion or request that would reasonably be expected to lead to an Acquisition Proposal; provided, that notwithstanding the foregoing, the Company shall be permitted to grant a waiver of or terminate any \u201cstandstill\u201d or similar bona fide agreement or obligation of any Third Party with respect to the Acquired Companies to allow such Third Party to submit an Acquisition Proposal if the Company Special Committee has determined that failure to so waive or terminate would be inconsistent with the Company\u2019s directors\u2019 fiduciary duties under Applicable Law, (C) approve, endorse, recommend or enter into, or publicly propose to approve, endorse, recommend or execute or enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or other definitive agreement or Contract with respect to or relating to any Acquisition Proposal (other than an Acceptable Confidentiality Agreement) or requiring the Company to abandon, terminate, breach or fail to consummate the Transactions (an \u201cAlternative Acquisition Agreement\u201d), or (E) resolve, commit or agree to do any of the foregoing. \n\n\n"
            },
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    204300,
                    204555
                ],
                "answer": "(g) Any breach of this Section 6.02 by any director, officer or Subsidiary of the Company or any action by any Representative acting on the Company\u2019s behalf in breach of this Section 6.02 will be deemed to be a breach of this Agreement by the Company. \n\n\n"
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    277943,
                    277986
                ],
                "answer": "Section 8.03 Expenses; Termination Fee. \n\n\n"
            },
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    278826,
                    280118
                ],
                "answer": "(b) Company Termination Fee. If, but only if, this Agreement is validly terminated: \n\n\n(i) (x) by Parent or the Company pursuant to Section 8.01(b) before obtaining the Required Company Stockholder Approval or Section 8.01(d) or by Parent pursuant to Section 8.01(e) and (y) (A) an Acquisition Proposal has been made to the Company after the date hereof and, if public, has not been withdrawn prior to the earlier of (1) the date of the Company Stockholder Meeting (including any adjournments and postponements thereof) and (2) the date of such termination, and (B) within twelve (12) months of the termination of this Agreement, the Company enters into a definitive agreement for the consummation of any Acquisition Proposal and such Acquisition Proposal is subsequently consummated (regardless of whether such consummation occurs within the twelve (12)-month period), then the Company shall pay, or cause to be paid, to Parent (or one or more of its designees), the Company Termination Fee on the date of the consummation of such transaction involving any Acquisition Proposal (provided, however, that for purposes of this Section 8.03(b)(i), the references to \u201cfifteen percent (15%)\u201d in the definition of Acquisition Proposal shall be deemed to be references to \u201cfifty percent (50%)\u201d); \n\n\n"
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    174272,
                    175732
                ],
                "answer": "Section 6.01 Conduct of the Company Pending the Merger. \n\n\n(a) The Company agrees that, from the date of this Agreement until the earlier of the Effective Time or the valid termination of this Agreement in accordance with Section 8.01, except as (w) set forth on Section 6.01(a) of the Company Disclosure Letter (x) as required by Applicable Law, (y) expressly required by this Agreement or (z) otherwise with the prior written consent of Parent (which shall not be unreasonably withheld, conditioned or delayed), the Company will, and will cause each of its Subsidiaries to, (i) conduct its operations, in all material respects, in the ordinary course of business, and (ii) use its commercially reasonable efforts to preserve the goodwill and current relationships of the Acquired Companies with employees, customers, suppliers and other Persons with which the Company or any of its Subsidiaries has significant business relations; provided, however, that no action by the Acquired Companies with respect to matters specifically addressed by any provision of the following sentence shall be deemed a breach of the covenants contained in this sentence unless such action would constitute a breach of such specific provision in the following sentence; provided, further, that the failure by an Acquired Company to take any action prohibited by any clause in the following sentence shall not be deemed to be a breach of the covenants contained in this sentence. "
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Ocala Bidco, Inc.\" and Target \"Inovalon Holdings, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Inovalon_Holdings_Management_Led_Buyout.txt",
                "span": [
                    294260,
                    295364
                ],
                "answer": "Section 9.02 Remedies Cumulative; Specific Performance. The parties hereto agree that irreparable damage would occur, and that the parties would not have any adequate remedy at law, in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached (including failing to take such actions as are required of it hereunder to consummate the Transactions). It is accordingly agreed that the parties shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages or otherwise, in addition to any other remedy to which any party is entitled at law or in equity. Each party agrees that it will not oppose the granting of an injunction, specific performance and other equitable relief on the basis that any other party has an adequate remedy at law or that any award of specific performance is not an appropriate remedy for any reason at law or in equity. "
            }
        ],
        "file_set": [
            "Inovalon_Holdings_Management_Led_Buyout.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    271723,
                    272031
                ],
                "answer": "Section 6.02      Additional Conditions to Obligations of Parent and Sub. The obligations of Parent and Sub to effect the Merger are also subject to the satisfaction (or to the extent permitted by applicable Law, waiver by Parent) at or prior to the Closing of each of the following additional conditions:   "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    275128,
                    275379
                ],
                "answer": "(b)            Agreements and Covenants. The Company shall have performed or complied with, in all material respects, all obligations and covenants required by this Agreement to be performed or complied with by the Company on or before the Closing.   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    72702,
                    72754
                ],
                "answer": "Section 3.09          Absence of Certain Changes.   "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    73552,
                    73779
                ],
                "answer": "(b)           Since September 30, 2020 to the date of this Agreement, there has not been any Effect that, individually or in the aggregate, has had, or would reasonably be expected to have, a Company Material Adverse Effect.   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    352887,
                    353076
                ],
                "answer": "\u201cknowledge\u201d means, in each case after reasonable inquiry, (a) with respect to the Company, the actual knowledge of the individuals listed in Section 1.1(A) of the Company Disclosure Letter "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    179918,
                    183560
                ],
                "answer": "Section 5.03          Solicitation; Change of Company Recommendation.   (a)            Except as expressly permitted by this Section 5.03, from and after the execution of this Agreement, (i) the Company shall, and shall cause the Company Subsidiaries and the Company\u2019s directors, officers and employees to, and shall use reasonable best efforts to cause the other Representatives of the Company to, (A) promptly cease any solicitations, discussions, communications or negotiations with any person and its Representatives that may be ongoing with respect to any Competing Proposal made by or on behalf of such person and (B) (1) promptly cease furnishing non-public information regarding the Company or any Company Subsidiary to such person and its Representatives with respect to any Competing Proposal to the person that made such Competing Proposal and its Representatives, (2) promptly request the return or destruction of all such non-public information that was previously furnished or made available to such person (and its Representatives) by or on behalf of the Company with respect to a Competing Proposal made by or on behalf such person and (3) promptly terminate all physical and electronic data room access previously granted to such person and its Representatives, and (ii) until the earlier of the Effective Time and the termination of this Agreement in accordance with its terms, the Company shall not, shall cause the Company Subsidiaries and the Company\u2019s directors, officers and employees not to, and shall use reasonable best efforts to cause any other Representative of the Company not to, directly or indirectly, (A) initiate, solicit, knowingly encourage or knowingly facilitate the submission of any Competing Proposal, (B) furnish any non-public information regarding the Company or any Company Subsidiary, or afford to any person access to the non-public business, properties, assets, books or records of the Company or any Company Subsidiary, to any third party that the Company knows is seeking to make, or has made, a Competing Proposal in connection with such Competing Proposal, (C) enter into, engage in, continue or participate in any discussions or negotiations with any third party with respect to any Competing Proposal made by such third party, or otherwise knowingly cooperate with, or knowingly assist, participate in, facilitate or knowingly encourage any effort by, any third party that the Company knows is seeking to make, or has made, a Competing Proposal in connection with such Competing Proposal, (D) approve, endorse, recommend or enter into, or publicly propose to approve, endorse, recommend or enter into, any letter of intent, memorandum of understanding, acquisition agreement, merger agreement, option agreement, joint venture agreement, partnership agreement or other similar definitive agreement relating to any Competing Proposal or requiring the Company to abandon, terminate or fail to consummate the Transactions (an \u201cAlternative Acquisition Agreement\u201d) or (E) agree, propose or resolve to take, or take, any of the actions prohibited by the foregoing clauses (A) through (D); provided that, notwithstanding anything to the contrary in this Section 5.03(a), from and after the execution of this Agreement, if the Company receives any inquiry, expression of interest, proposal or offer that constitutes or would reasonably be expected to lead to a Competing Proposal from any third party, the Company may inform such third person that the Company is contractually prohibited from engaging in discussions with, or otherwise responding to, such third party in response thereto.   \n\n\n\n\n"
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    179918,
                    179990
                ],
                "answer": "Section 5.03          Solicitation; Change of Company Recommendation.   "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    183572,
                    186017
                ],
                "answer": "(b)            Notwithstanding anything to the contrary contained in this Agreement but subject to the last sentence of this Section 5.03(b), if, at any time following the execution of this Agreement and prior to the earlier of the Company obtaining the Company Stockholder Approval or the termination of this Agreement (and in no event after the Company obtains the Company Stockholder Approval), (i) the Company has received a bona fide written Competing Proposal from a person after the date of this Agreement that did not result from a breach of Section 5.03(a) (other than an immaterial and unintentional breach), and (ii) the Company Board (or any committee thereof) determines in good faith, after consultation with its outside financial advisors and outside legal counsel, that such Competing Proposal constitutes or would reasonably be expected to lead to a Superior Proposal and the failure to take any of the following actions would be reasonably likely to be inconsistent with the Company Board\u2019s fiduciary duties under applicable Law, then the Company, the Company Subsidiaries and the Company\u2019s Representatives may, subject to compliance with the applicable provisions of this Section 5.03 with respect to such Competing Proposal (other than immaterial or unintentional failures to comply), (A) furnish information, including with respect to the Company and the Company Subsidiaries, to the person making such Competing Proposal and its Representatives and (B) participate in discussions or negotiations with the person making such Competing Proposal and its Representatives in connection with such Competing Proposal; provided, however, that the Company shall not disclose any material non-public information regarding the Company or the Company Subsidiaries pursuant to the foregoing without first entering into an Acceptable Confidentiality Agreement with such person if such person is not already party to an Acceptable Confidentiality Agreement with the Company. The Company shall provide Parent and Sub any non- public information that is provided to any such person in connection with such Competing Proposal that was not previously made available (whether prior to or after the execution of this Agreement) to Parent or Sub reasonably promptly following the time it is provided to such person or, with respect to such information conveyed verbally, promptly (and, in any event, within forty-eight (48) hours thereafter).   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    350965,
                    352257
                ],
                "answer": "\u201cIntervening Event\u201d means a material Effect or state of facts that (a) was not known to, or reasonably foreseeable by, the Company Board prior to the execution of this Agreement, which Effect, or any material consequence thereof, becomes known to, or reasonably foreseeable by, the Company Board prior to the receipt of the Company Stockholder Approval and (b) does not relate to a Competing Proposal; provided, however, that an \u201cIntervening Event\u201d shall not include (i) any Competing Proposal or other inquiry, offer or proposal that could lead to a Competing Proposal, (ii) an Effect resulting from a breach of this Agreement by the Company or any of the Company Subsidiaries, (iii) changes in the price of the Shares, in and of itself (provided, however, the underlying reasons for such changes may constitute an Intervening Event unless excluded by any other exclusion in this definition) or (iv) the fact that, in and of itself, the Company exceeds any internal or published projections, estimates or expectations of the Company\u2019s revenue, earnings or other financial performance or results of operations for any period (provided, however, the underlying reasons for such events may constitute an Intervening Event unless expressly excluded by any other exclusion in this definition).   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    278265,
                    278620
                ],
                "answer": "Section 7.01      Termination. This Agreement may be terminated, in the case of clauses (a), (b), (e), (f) or (g) below, at any time prior to the Effective Time, whether before or after receipt of the Company Stockholder Approval or, in the case of clauses (c) or (d) below, at any time prior to receipt of the Company Stockholder Approval, as follows:   "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    280809,
                    281584
                ],
                "answer": "(d)            by the Company, at any time prior to the receipt of the Company Stockholder Approval, if (i) the Company has received a Superior Proposal, (ii) the Company Board (or any committee thereof), as permitted by Section 5.03(e), has authorized the Company to enter into an Alternative Acquisition Agreement to consummate the Superior Proposal, (iii) the Company has complied in all respects with Section 5.03 in respect of such Superior Proposal (other than any non-compliance that was both immaterial and unintentional), (iv) the Company pays the Company Termination Fee in accordance with Section 7.02(b) and (v) substantially concurrently with such termination, the Company enters into an Alternative Acquisition Agreement to consummate such Superior Proposal;   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    284755,
                    284798
                ],
                "answer": "Section 7.02      Effect of Termination.   "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    287009,
                    287103
                ],
                "answer": "(b)            Company Payments.   (i)            If (A) this Agreement is validly terminated "
            },
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    287542,
                    288862
                ],
                "answer": "(C) concurrently with or within twelve (12) months after the date of any such termination, (1) the Company or any Company Subsidiary enters into a definitive agreement to effect any Competing Proposal (regardless of when made or the counterparty thereto) with an aggregate equity purchase price (after giving effect to any reductions thereof for Indebtedness or similar adjustments) greater than the Aggregate Merger Consideration or (2) any Competing Proposal is consummated (regardless of when made or the counterparty thereto), then the Company shall pay to Parent or its designee the Company Termination Fee (I) if the person with which the Company enters into such definitive agreement to effect, or consummates, such Competing Proposal is the same person or an affiliate of the person who made the Competing Proposal described in Section 7.02(b)(i)(B), then concurrently with the earlier of (a) the date of execution of any such definitive agreement and (b) the consummation of such Competing Proposal or (II) if the person with which the Company enters into such definitive agreement to effect, or consummates, such Competing Proposal is not the person or an affiliate of the person who made the Competing Proposal described in Section 7.02(b)(i)(B), then the date of the consummation of such Competing Proposal. "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    163017,
                    163788
                ],
                "answer": "Section 5.01         Conduct of Business by the Company Pending the Merger. The Company agrees that between the date of this Agreement and the earlier of the Effective Time and the termination of this Agreement in accordance with its terms, except as expressly set forth in Section 5.01 of the Company Disclosure Letter, as expressly contemplated or required by any other provision of this Agreement or as required by applicable Law (including any COVID-19 Measures), unless Parent otherwise agrees in writing (which agreement shall not be unreasonably withheld, delayed or conditioned), the Company will, and will cause each Company Subsidiary to, use commercially reasonable efforts to conduct its operations in all material respects in the ordinary course of business "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Atlas CC Acquisition Corp.\" and \"Cubic Corporation\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt",
                "span": [
                    322320,
                    323308
                ],
                "answer": "Section 8.10      Specific Performance.   (a)            The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, the parties acknowledge and agree that the parties shall be, subject to Section 8.10(c) (including the limitations therein), entitled to an injunction, specific performance and other equitable relief to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which they are entitled at law or in equity. Subject to Section 8.10(c), the parties further agree not to assert that a remedy of specific performance is unenforceable, invalid, contrary to applicable Law or inequitable for any reason, nor to assert that a remedy of monetary damages or other remedy at law would provide an adequate remedy for any such breach.   "
            }
        ],
        "file_set": [
            "Cubic Corporation_Investment Group.pdf||Cubic_Corporation_Investment_Group_Amendment No.1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    56561,
                    57315
                ],
                "answer": "(a)               Conversion of Company Common Stock. At the Effective Time, by virtue of the Merger and without any action on the part of Parent, Merger Sub or the Company, their respective stockholders or any other Person, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (but excluding any Cancelled Shares and any Dissenting Shares) shall be cancelled and extinguished and automatically converted into and shall thereafter represent the right to receive an amount in cash equal to $37.00 (such amount of cash, as may be adjusted pursuant to Section 3.01(e), is hereinafter referred to as the \u201cMerger Consideration\u201d), payable to the holder thereof, without interest, in accordance with Section 3.02.   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    256407,
                    256730
                ],
                "answer": "Section 8.02       Conditions to the Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger are subject to the satisfaction (or waiver by each of Parent and Merger Sub, if permissible under Applicable Law), at or prior to the Closing, of the following further conditions:   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    257985,
                    258308
                ],
                "answer": "(b)               Covenants. Each of the covenants and obligations that the Company is required to comply with or to perform at or prior to the Closing shall have been complied with and performed in all material respects, except for Section 6.01(a)(xxi) which shall have been complied with and performed in all respects.   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    97086,
                    97711
                ],
                "answer": "Section 4.07       Absence of Certain Changes. Since the Company Balance Sheet Date and through the date of this Agreement, except as otherwise contemplated or permitted by this Agreement, (a) there has not been a Company Material Adverse Effect, (b) the business of the Acquired Companies has been conducted, in all material respects, in the ordinary course of business and (c) the Acquired Companies have not taken any action, or failed to take any action, in each case, that would have required the consent of Parent pursuant to the clauses of Section 6.01(a) set forth in Section 4.07 of the Company Disclosure Letter.   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    13012,
                    17836
                ],
                "answer": "\u201cCompany Material Adverse Effect\u201d means any event, change, effect, fact, circumstance, development, condition or occurrence (each an \u201cEffect\u201d) that (a) has, or would reasonably be expected to, prevent or materially impair the ability of the Company to consummate the Transactions, or (b) has had, or would reasonably be expected to have a material adverse effect on the results of operations or financial condition of the Acquired Companies, taken as a whole; provided, however, that, for purposes of this clause (b), in no event would any of the following, alone or in combination, be deemed to constitute, nor shall any of the following (including the Effect of any of the following) be taken into account in determining whether there has been or will be, a \u201cCompany Material Adverse Effect\u201d: (i) any change in Applicable Law, GAAP or any applicable accounting standards or any interpretation thereof; (ii) general economic, political or business conditions or changes therein, or acts of terrorism, epidemics or pandemics (including COVID-19), disease outbreaks or changes in geopolitical conditions (including commencement, continuation or escalation of war, armed hostilities or national or international calamity) or any escalation or worsening relating to the foregoing, including any escalation or worsening of stoppages, shutdowns or habits or behavior of people, or any response of any Governmental Authority (including requirements for business closures or \u201csheltering-in-place\u201d), related to any of the foregoing; (iii) financial and capital markets conditions, including interest rates and currency exchange rates, and any changes therein; (iv) seasonal fluctuations in the business of the Acquired Companies; (v) any change generally affecting the industries in which the Acquired Companies operate; (vi) the negotiation, entry into or announcement of this Agreement, the pendency or consummation of the Transactions or the performance of this Agreement (including (A) the initiation of litigation by any stockholder of the Company (or a derivative or similar claim) to the extent asserting allegations of breach of fiduciary duty or under securities laws relating to this Agreement or the Transactions or (B) any termination of, reduction in or similar negative impact on the Company\u2019s reputation or relationships, contractual or otherwise, with any customers, suppliers, distributors, partners or employees of the Acquired Companies, in each case, to the extent resulting from the negotiation, entry into, announcement, pendency or performance of this Agreement or identity of the parties to this Agreement or any communication by Parent regarding the plans or intentions of Parent with respect to the conduct of business of the Acquired Companies) (provided that this clause (vi) shall not apply to, and shall be disregarded with respect to, references to \u201cCompany Material Adverse Effect\u201d in representations and warranties made by the Company in Section 4.02, Section 4.03, Section 4.04 and Section 4.16(h)); (vii) the compliance with the terms of this Agreement; (viii) the taking of any action (or the omission of any action) expressly required or permitted by this Agreement or requested by Parent in writing; (ix) any act of God or natural disaster; (x) any change in the price or trading volume of the Company\u2019s securities or other financial instruments, in and of itself (provided that this clause (x) shall not prevent a determination that any change or Effect underlying such change has resulted in a Company Material Adverse Effect (to the extent such change or Effect is not otherwise excluded from this definition of Company Material Adverse Effect)); (xi) any failure of the Acquired Companies to meet any internal or published projections, estimates or forecasts (provided that this clause (xi) shall not prevent a determination that any change or Effect underlying such failure to meet projections or forecasts has resulted in a Company Material Adverse Effect (to the extent such change or Effect is not otherwise excluded from this definition of Company Material Adverse Effect)); or (xii) for purposes of Section 8.02(c), (A) any matters set forth in the Company Disclosure Letter or (B) subject to the preamble to Article IV, any matters set forth in the Company SEC Documents that modifies a representation or warranty set forth in Article IV, solely to the extent the effect of which is reasonably foreseeable and reasonably apparent on the face of such disclosure as of the date hereof; provided, further, that in the case of the foregoing clauses (i), (ii), (iii), (iv), (v) and (ix), except to the extent that such matters disproportionately impact the Acquired Companies (taken as a whole) relative to other businesses in the industries in which the Acquired Companies operate.   \n\n\n"
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    31510,
                    32060
                ],
                "answer": "\u201cKnowledge\u201d means, (a) with respect to the Company, the actual knowledge, after reasonable inquiry, of each of Maria Perrin, Doug Williams, Jacob Sims (in each case of the foregoing individuals, solely with respect to the representations and warranties contained in Article IV that are relevant to their respective roles at the Company), Jeffrey Sherman, Meredith Bjorck (for purposes of Section 4.09(a)(xiv), the reasonable inquiry of Meredith Bjorck shall be deemed to include reasonable inquiry of Bill Lucia), David Alexander and Greg Aunan, and "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    183595,
                    184065
                ],
                "answer": "Section 6.02       No Solicitation; Adverse Recommendation Change.   (a)               Except as otherwise permitted by this Section 6.02, from the date of this Agreement until the earlier of the Effective Time or the termination of this Agreement in accordance with Section 9.01, the Company shall, and shall cause its Subsidiaries and its and their respective directors, officers and employees to, and use reasonable best efforts to cause its other Representatives:   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    185017,
                    186336
                ],
                "answer": "(ii)              to not (A) solicit, initiate, seek or knowingly encourage or facilitate or encourage any inquiry, discussion, offer or request that constitutes, or would reasonably be expected to lead to, an Acquisition Proposal, (B) enter into, continue or otherwise participate in any discussions or negotiations with, or furnish any non-public information relating to the Acquired Companies to, or afford access to the books or records or officers of the Acquired Companies to, any Third Party with respect to, or in a manner that would reasonably be expect to lead to, an Acquisition Proposal; provided, that notwithstanding the foregoing, the Company shall be permitted to grant a waiver of or terminate any \u201cstandstill\u201d or similar agreement or obligation of any Third Party with respect to the Acquired Companies to allow such Third Party to submit an Acquisition Proposal, (C) approve, endorse, recommend or enter into, or publicly propose to approve, endorse, recommend or enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or other definitive agreement with respect to any Acquisition Proposal (an \u201cAlternative Acquisition Agreement\u201d) or (D) take or agree any of the actions prohibited by the foregoing clauses (A) through (C).   \n\n\n"
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    183595,
                    183664
                ],
                "answer": "Section 6.02       No Solicitation; Adverse Recommendation Change.   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    186346,
                    187844
                ],
                "answer": "(b)               Notwithstanding anything to the contrary contained in Section 6.02(a), if at any time following the date hereof and prior to adoption of this Agreement by the Required Company Stockholder Approval (i) the Company has received a written Acquisition Proposal from a Third Party that did not result from a breach of Section 6.02(a) (other than any such breach that is immaterial and unintentional) and (ii) the Company Board determines in good faith, after consultation with its financial and outside legal advisors, that (A) such Acquisition Proposal constitutes, or could reasonably be expected to lead to, a Superior Proposal and (B) the failure to take such action would be reasonably likely to be inconsistent with the Company Board\u2019s fiduciary duties under Applicable Law, then the Company and its Representatives may (1) furnish non-public information, and afford access to the books or records or officers of the Acquired Companies, to such Third Party and its Affiliates and Representatives and (2) engage in discussions and negotiations with such Third Party and its Affiliates and Representatives with respect to the Acquisition Proposal (provided, that any material non-public information concerning the Acquired Companies made available to any Third Party shall, to the extent not previously made available to Parent, be made available to Parent as promptly as reasonably practicable (and, in any event, within 48 hours) after it is made available to such Third Party); "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    43063,
                    43859
                ],
                "answer": "\u201cSuperior Proposal\u201d means an Acquisition Proposal (except the references therein to \u201ctwenty percent (20%)\u201d shall be replaced by \u201cfifty percent (50%)\u201d) made by a Third Party (other than resulting from a breach of Section 6.02(a) (other than any such breach that is immaterial and unintentional)) that the Company Board determines in good faith, after consultation with its financial and outside legal advisors, taking into account such factors as the Company Board considers to be appropriate (including the conditionality, timing and likelihood of consummation of such proposal), would result in a transaction that is more favorable from a financial perspective to the Company\u2019s stockholders than the Transactions (including taking into account any the Company Termination Fee, if applicable).   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    30630,
                    31139
                ],
                "answer": "\u201cIntervening Event\u201d means any Effect (other than an Acquisition Proposal) that, individually or in the aggregate, is material to the Acquired Companies, taken as a whole, that is not known or reasonably foreseeable (or the magnitude of which is not known or reasonably foreseeable) to or by the Company Board as of the date of this Agreement, which Effect (or the magnitude of which) becomes known to or by the Company Board prior to adoption of this Agreement by the Required Company Stockholder Approval.   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    261429,
                    261780
                ],
                "answer": "Section 9.01       Termination. Notwithstanding anything contained in this Agreement to the contrary, this Agreement may be terminated and the Merger and the other Transactions may be abandoned at any time prior to the Effective Time notwithstanding receipt of the Required Company Stockholder Approval (except as expressly noted), only as follows:   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    265881,
                    266352
                ],
                "answer": "(h)               by the Company, at any time prior to the receipt of the Required Company Stockholder Approval, in order to enter into a definitive agreement with respect to a Superior Proposal; provided, that (i) the Company has complied with the provisions of Section 6.02(d), (ii) the Company pays to Parent the Company Termination Fee in accordance with Section 9.03 and (iii) concurrently with such termination, the Company enters into such definitive agreement;   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    268172,
                    268220
                ],
                "answer": "Section 9.03       Expenses; Termination Fee.   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    269069,
                    269161
                ],
                "answer": "(b)               Company Termination Fee. If, but only if, this Agreement is terminated:   "
            },
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    269571,
                    270390
                ],
                "answer": "(D) within twelve (12) months following the termination of this Agreement, (1) the Company enters into a definitive agreement for the consummation of any Acquisition Proposal (regardless of when made or the counterparty thereto) or (2) any Acquisition Proposal is consummated (regardless of whether when made or the counterparty thereto), then the Company shall pay, or cause to be paid, to Parent the Company Termination Fee, in each case, within three (3) Business Days after the date on which the Company enters into such definitive agreement or the date on which such Acquisition Proposal is consummated (provided, however, that for purposes of this Section 9.03(b)(i), the references to \u201ctwenty percent (20%)\u201d in the definition of Acquisition Proposal shall be deemed to be references to \u201cfifty percent (50%)\u201d);   "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    171032,
                    171708
                ],
                "answer": "Section 6.01       Conduct of the Company Pending the Merger.   (a)               The Company agrees that, from the date of this Agreement until the earlier of the Effective Time or the termination of this Agreement in accordance with Section 9.01, except as set forth in Section 6.01(a) of the Company Disclosure Letter or as required by Applicable Law or expressly contemplated by this Agreement or otherwise with the prior written consent of Parent (which shall not be unreasonably withheld, conditioned or delayed), the Company will, and will cause each of its Subsidiaries to, (x) conduct its operations, in all material respects, in the ordinary course of business, and "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gainwell Acquisition Corp.\" and Target \"HMS Holdings Corp.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/HMS Holdings Corp._Veritas Capital.txt",
                "span": [
                    279404,
                    280234
                ],
                "answer": "Section 10.02   Remedies Cumulative; Specific Performance. The parties hereto agree that irreparable damage would occur, and that the parties would not have any adequate remedy at law, in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached (including failing to take such actions as are required of it hereunder to consummate the Transactions). It is accordingly agreed that the parties shall be entitled to seek to obtain an injunction or injunctions, specific performance and other equitable relief to prevent breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages or otherwise, in addition to any other remedy to which any party is entitled at law or in equity. "
            }
        ],
        "file_set": [
            "HMS Holdings Corp._Veritas Capital.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    14281,
                    14552
                ],
                "answer": "SECTION 2.01           Effect of Merger on Capital Stock.   (a )           Treatment of Capital Stock. At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or any holder of shares of Company Common Stock:   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    15291,
                    15894
                ],
                "answer": "(ii)           Conversion of Company Common Stock. Subject to Section 2.01(b) and except as otherwise provided in this Agreement, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (except for shares to be cancelled and retired in accordance with Section 2.01(a)(i) and the Dissenting Shares) shall be converted automatically into the right to receive an amount in cash (without interest) equal to the Merger Consideration, payable as provided in Section 2.02, and, when so converted, shall automatically be cancelled and retired and shall cease to exist; "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    302028,
                    302075
                ],
                "answer": "\u201cMerger Consideration\u201d means $70.00 in cash.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Information about the Closing Condition: Accuracy of Target's Representations and Warranties",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    37114,
                    37561
                ],
                "answer": "SECTION 3.02      Company Subsidiaries. All the outstanding shares of capital stock or voting securities of, or other equity interests in, each Company Subsidiary have been validly issued and are fully paid and nonassessable, and all of the outstanding shares of capital stock or voting securities of, or other equity interests in, each Company Subsidiary that are owned by the Company or by another Company Subsidiary are so owned free and clear "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    42857,
                    42926
                ],
                "answer": "SECTION 3.04      Authority; Execution and Delivery; Enforceability. "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    43199,
                    43335
                ],
                "answer": "he Company Board has unanimously adopted resolutions, at a meeting duly called at which a quorum of directors of the Company was present"
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    43497,
                    43641
                ],
                "answer": "(b) approving the Company\u2019s execution, delivery and performance of this Agreement and the consummation of the transactions contemplated thereby "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    44595,
                    44859
                ],
                "answer": "The Company has duly executed and delivered this Agreement and, assuming the due authorization, execution and delivery by Parent and Merger Sub, this Agreement constitutes its legal, valid and binding obligation, enforceable against it in accordance with its terms"
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    75607,
                    75645
                ],
                "answer": "SECTION 3.15       Takeover Statutes. "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    76037,
                    76182
                ],
                "answer": "the Company has no rights plan, \u201cpoison pill\u201d or similar agreement that is applicable to this Agreement or the transactions contemplated hereby; "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    223453,
                    225315
                ],
                "answer": "SECTION 7.03           Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger is further subject to the satisfaction or waiver (by Parent and Merger Sub) at or prior to the Closing of each of the following conditions:   ( a )           Representations and Warranties . (i) The representations and warranties of the Company contained herein (other than those specified in clause (ii) below) shall be true and correct (without giving effect to any limitation as to \u201cmateriality\u201d or \u201cCompany Material Adverse Effect\u201d set forth therein) as of the date of this Agreement and as of the Closing Date as if made as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date), except where the failure of any such representation or warranty to be true and correct (without giving effect to any limitation as to \u201cmateriality\u201d or \u201cCompany Material Adverse Effect\u201d set forth therein), individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect and (ii) the representations and warranties of the Company contained in Section 3.01 (Organization, Standing and Power), Section 3.03 (Capital Structure), Section 3.04 (Authority; Execution and Delivery; Enforceability), Section 3.07(b) (Absence of Certain Changes or Events), Section 3.15 (Takeover Statutes), Section 3.25 (Brokers\u2019 Fees and Expenses ) and Section 3.26 (Opinion of Financial Advisors) shall be true and correct in all respects as of the date of this Agreement and as of the Closing Date as if made as of such date (except to the extent expressly made as of an earlier date, in which case as of such earlier date) except, in each case, for any de minimis failures of such representations and warranties to be so true and correct.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    223453,
                    223736
                ],
                "answer": "SECTION 7.03           Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to consummate the Merger is further subject to the satisfaction or waiver (by Parent and Merger Sub) at or prior to the Closing of each of the following conditions:   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    225315,
                    225562
                ],
                "answer": "( b )          Performance of Covenants and Agreements of the Company. The Company shall have performed in all material respects all of the covenants and agreements required to be performed by it under this Agreement at or prior to the Closing.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    55109,
                    55541
                ],
                "answer": "SECTION 3.07      Absence of Certain Changes or Events. Since December 31, 2020, to the date of this Agreement, (a) the Company has conducted its business in the ordinary course of business in all material respects and (b) there has not occurred any fact, circumstance, effect, change, event or development that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    282796,
                    288279
                ],
                "answer": "\u201cCompany Material Adverse Effect\u201d means any fact, circumstance, effect, change, event or development that, individually or in the aggregate, has or would reasonably be expected to have a material adverse effect on the business, properties, assets, liabilities, financial condition or results of operations of the Company and the Company Subsidiaries, taken as a whole; provided that, no fact, circumstance, effect, change, event or development resulting from or arising out of any of the following, individually or in the aggregate, shall constitute or be taken into account in determining whether a Company Material Adverse Effect has occurred: (a) any change generally affecting the industries in which the Company and the Company Subsidiaries operate in the United States or elsewhere (including changes in commodity prices or general market prices generally affecting such industries and changes in the global demand environment generally affecting such industries); (b) any change generally affecting any economic, legislative or political condition (including trade wars and sanctions) or any change generally affecting any securities, credit, financial, commodities or capital markets condition, in each case in the United States or elsewhere; (c) any failure in and of itself by the Company or any Company Subsidiary to meet any internal or public projection, budget, forecast, estimate or prediction in respect of revenues, earnings or other financial or operating metrics or measures for any period (it being understood that the changes and effects giving rise to or contributing to such failure may (to the extent not otherwise excluded hereby) constitute or be taken into account in determining whether a Company Material Adverse Effect has occurred); (d)  any change resulting from the announcement, execution or delivery of this Agreement, including (i) the failure of the Company or its Subsidiaries to take any action if Parent\u2019s prior consent is required hereunder and Parent unreasonably withholds consent to taking of such action after receipt of the written request therefor from the Company; (ii) any stockholder litigation related to this Agreement or the transactions contemplated by this Agreement (but not any finally adjudicated breach of fiduciary duty or any violation of Law itself); (iii) any action taken by Parent or any Affiliate thereof to obtain any Required Statutory Approval from any Governmental Entity or satisfy any condition to the consummation of the Merger and the result of such actions; (iv) any change to the extent that arises out of or relates to the identity of Parent or any of its Affiliates as the acquirer of the Company; or (v) the impact of the announcement, execution or delivery on relationships with employees and labor unions, customers, suppliers, distributors, Governmental Entities and other Persons (it being understood that this clause (d) shall not apply with respect to the representations or warranties in Section 3.05 (or any condition to any Party\u2019s obligation to consummate the Merger relating to such representation and warranty); (e) any change in the market price or trading volume of shares of Company Common Stock on the NYSE (it being understood that the changes and effects giving rise to or contributing to any such change may (if not otherwise excluded hereby) constitute or be taken into account in determining whether a Company Material Adverse Effect has occurred); (f) any change in applicable Law, regulation or GAAP (or authoritative interpretation thereof); (g) any applicable quarantine, \u201cshelter in place,\u201d \u201cstay at home,\u201d workforce reduction, social distancing, shut down, closure, sequester, safety or similar Laws, promulgated by any Governmental Entity, including the Centers for Disease Control and Prevention and the World Health Organization, in each case, in connection with or in response to COVID-19 (\u201cCOVID-19 Measures\u201d); (h) any geopolitical conditions, the outbreak or escalation of hostilities, any act of war, sabotage or purported terrorism, or any escalation or worsening of any such act of war, sabotage or purported terrorism; (i) any change or effect arising from any hurricane, strong winds, ice event, fire, tornado, tsunami, flood, earthquake, pandemics (including SARS-CoV-2 or COVID-19, any evolutions or mutations thereof or related or associated epidemics, pandemics or disease outbreaks (\u201cCOVID-19\u201d)), epidemics or other outbreaks of diseases, or other natural disaster or extreme weather-related event, circumstance or development (or escalation or worsening of any such events or occurrences, including, as applicable, second or subsequent wave(s)); and (j) any change or effect arising from any requirements imposed by any Governmental Entity as a condition to obtaining the Required Statutory Approvals; provided, however, that any fact, circumstance, effect, change, event or development set forth in clauses (a), (b), (f), (h) and (i) above may be taken into account in determining whether a Company Material Adverse Effect has occurred to the extent such change or effect has a disproportionate adverse effect on the Company and the Company Subsidiaries, taken as a whole, as compared to other participants in the industries in which the Company and the Company Subsidiaries operate (in which case, only the incremental disproportionate impact may be taken into account in determining whether there has been, or would be, a Company Material Adverse Effect).  "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    296405,
                    296724
                ],
                "answer": "\u201cKnowledge\u201d means (a) with respect to the Company, the actual knowledge, after reasonable inquiry, of the individuals listed in Section 1.01 o f the Company Disclosure Schedule and (b) with respect to Parent or the Merger Sub, the actual knowledge, after reasonable inquiry, of David J. Winter and David S. Millstone.  "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    136532,
                    140358
                ],
                "answer": "SECTION 5.02           No Solicitation by the Company; Company Board Recommendation.   (a)           The Company shall not, shall cause the Company Subsidiaries not to, and shall use reasonable best efforts to cause its Affiliates and any of its and their respective officers, directors, principals, partners, managers, members, attorneys, accountants, agents, employees, consultants, financial advisors or other authorized representatives (collectively, \u201cRepresentatives\u201d) not to, directly or indirectly (i) solicit, initiate or knowingly encourage, induce or facilitate any Company Takeover Proposal or any inquiry or proposal that would reasonably be expected to lead to a Company Takeover Proposal, in each case, except for this Agreement and the transactions contemplated hereby, or (ii) continue, enter into, maintain, participate or engage in any discussions or negotiations with any Person (except for the Company\u2019s Affiliates and its and their respective Representatives or Parent and Parent\u2019s Affiliates and its and their respective Representatives) regarding, furnish to any such Person any nonpublic information with respect to, any Company Takeover Proposal or any inquiry or proposal that would reasonably be expected to lead to a Company Takeover Proposal. The Company shall, and shall cause its Affiliates and its and their respective Representatives to, immediately cease and cause to be terminated all existing discussions, solicitations or negotiations with or of any Person (except for Parent and Parent\u2019s Affiliates and its and their respective Representatives) conducted heretofore with respect to any Company Takeover Proposal, or any inquiry or proposal that would reasonably be expected to lead to a Company Takeover Proposal, request the prompt return or destruction of all confidential information previously furnished and terminate all physical and electronic data room access previously granted to any such Person or its Representatives. Notwithstanding anything to the contrary herein, at any time prior to obtaining the Company Stockholder Approval, in response to the receipt of a bona fide, written Company Takeover Proposal made after the date of this Agreement that does not result from a material breach of this Section 5.02(a) and that the Company Board determines in good faith (after consultation with its outside legal counsel and financial advisors) constitutes or could reasonably be expected to lead to a Superior Company Proposal, the Company and its Representatives may (A) furnish information with respect to the Company and the Company Subsidiaries to the Person making such Company Takeover Proposal (and its Representatives) (provided that all such information has previously been provided to Parent or is provided to Parent substantially concurrently with the provision of such information to such Person) pursuant to a confidentiality agreement containing confidentiality restrictions substantially not less favorable to the Company than the Confidentiality Agreement, and (B) participate in discussions regarding the terms of such Company Takeover Proposal, including terms of a Company Acquisition Agreement with respect thereto, and the negotiation of such terms with the Person making such Company Takeover Proposal (and such Person\u2019s Representatives) but, in each case referred to in the foregoing clauses (A) and (B), if and only if (1) the Company Board determines in good faith (after consultation with its outside legal counsel and financial advisors) that the failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties to stockholders under applicable Law and (2) the Company shall have delivered to Parent prior written notice advising Parent that it intends to take the action(s) contemplated by clauses (A) and/or (B). "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    136532,
                    136619
                ],
                "answer": "SECTION 5.02           No Solicitation by the Company; Company Board Recommendation.   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    138499,
                    140358
                ],
                "answer": "Notwithstanding anything to the contrary herein, at any time prior to obtaining the Company Stockholder Approval, in response to the receipt of a bona fide, written Company Takeover Proposal made after the date of this Agreement that does not result from a material breach of this Section 5.02(a) and that the Company Board determines in good faith (after consultation with its outside legal counsel and financial advisors) constitutes or could reasonably be expected to lead to a Superior Company Proposal, the Company and its Representatives may (A) furnish information with respect to the Company and the Company Subsidiaries to the Person making such Company Takeover Proposal (and its Representatives) (provided that all such information has previously been provided to Parent or is provided to Parent substantially concurrently with the provision of such information to such Person) pursuant to a confidentiality agreement containing confidentiality restrictions substantially not less favorable to the Company than the Confidentiality Agreement, and (B) participate in discussions regarding the terms of such Company Takeover Proposal, including terms of a Company Acquisition Agreement with respect thereto, and the negotiation of such terms with the Person making such Company Takeover Proposal (and such Person\u2019s Representatives) but, in each case referred to in the foregoing clauses (A) and (B), if and only if (1) the Company Board determines in good faith (after consultation with its outside legal counsel and financial advisors) that the failure to take such action would reasonably be expected to be inconsistent with its fiduciary duties to stockholders under applicable Law and (2) the Company shall have delivered to Parent prior written notice advising Parent that it intends to take the action(s) contemplated by clauses (A) and/or (B). "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    150238,
                    153276
                ],
                "answer": "(i)            \u201cCompany Takeover Proposal\u201d means any proposal, indication, interest or offer (whether or not in writing), from any Person (other than Parent and its Subsidiaries) involving a (A) merger, consolidation, share exchange, consolidation, joint venture, other business combination, recapitalization, liquidation, dissolution or similar transaction involving (1) the Company or (2) any of the Company Subsidiaries whose revenues, net income or assets, taken together, constitute more than 15% of the consolidated revenues, net income or assets of the Company and the Company Subsidiaries, taken as a whole, (B) sale, lease, license, contribution or other disposition, directly or indirectly (including by way of merger, consolidation, share exchange, other business combination, partnership, joint venture, sale of capital stock of or other equity interests in a Company Subsidiary or otherwise) of any business or assets of the Company or the Company Subsidiaries representing more than 15% of the consolidated revenues, net income or assets of the Company and the Company Subsidiaries, taken as a whole, (C) issuance, sale or other disposition, directly or indirectly, to any Person (or the stockholders of any Person) or group of securities (or options, rights or warrants to purchase, or securities convertible into or exchangeable for, such securities) representing more than 15% of the voting power of the Company, (D) transaction (including any tender offer or exchange offer) in which any Person (or the stockholders of any Person) or group would acquire, if consummated, directly or indirectly, beneficial ownership or the right to acquire beneficial ownership, or formation of any group that beneficially owns or has the right to acquire beneficial ownership of more than 15% of any class of capital stock of the Company, or (E) any combination of the foregoing.   ( i i )         \u201cSuperior Company Proposal\u201d means a bona fide written Company Takeover Proposal (provided that for purposes of this definition, the applicable percentage in the definition of Company Takeover Proposal shall be \u201c50%\u201d rather than \u201c15%\u201d), that did not result from, or arise in connection with, any material breach of this Section 5.02, that the Company Board determines in good faith, after consultation with its outside legal counsel and financial advisors, and taking into account the legal, financial, regulatory and other aspects of such Company Takeover Proposal, the conditionality of and contingencies related to such proposal, the expected timing and risk of completion, the identity of the Person making such proposal and such other factors that are deemed relevant by the Company Board, is (A) reasonably capable of being completed on the terms proposed and (B) is more favorable to the holders of Company Common Stock from a financial point of view than the transactions contemplated by this Agreement (after taking into account any proposed revisions to the terms of this Agreement that are committed to in writing by Parent).   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    153310,
                    155181
                ],
                "answer": "(iii)           \u201cCompany Intervening Event\u201d means a material change or effect relating to the Company that is unknown and not reasonably foreseeable to the Company Board as of the date hereof, or if known or reasonably foreseeable to the Company Board as of the date hereof, the material consequences of which were not known or reasonably foreseeable to the Company Board as of the date hereof; provided that in no event shall any of the following be deemed to constitute a Company Intervening Event: (A) the receipt, existence or terms of a Company Takeover Proposal or a Superior Company Proposal or any inquiry or communications or matters relating thereto, (B) any event, change or effect that results from the announcement or pendency of this Agreement or the transactions contemplated by this Agreement or any actions required to be taken or to be refrained from being taken pursuant to this Agreement (including the timing of any consent, registration, approval, permit or authorization to be obtained from any Governmental Entity or any other actions by or in respect of any Governmental Entity with respect to the transactions contemplated by this Agreement), (C) any event, change or effect that results from a breach of this Agreement by the Company, (D) the fact that the Company meets or exceeds any internal or analysts\u2019 expectations or projections (it being understood that the facts and occurrences giving rise or contributing to such changes may be taken into account to the extent not otherwise excluded by this definition) or (E) any change after the execution and delivery of this Agreement in the market price or trading volume of the Company Common Stock on the NYSE (it being understood that the facts and occurrences giving rise or contributing to such changes may be taken into account to the extent not otherwise excluded by this definition).   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    226047,
                    226092
                ],
                "answer": "SECTION 8.01           Termination Rights.   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    230184,
                    230750
                ],
                "answer": "(c)           Termination by the Company. The Company shall have the right to terminate this Agreement:   (i)            if at any time prior to obtaining the Company Stockholder Approval and in accordance with Section 5.02, the Company enters into a Company Acquisition Agreement with respect to a Superior Company Proposal, so long as (1) the Company has not Willfully Breached its obligations under Section 5.02 and (2) the Company prior to or concurrently with such termination pays to Parent the Company Termination Fee in accordance with Section 8.02(b)(i);   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    234441,
                    234507
                ],
                "answer": "SECTION 8.02           Effect of Termination; Termination Fees.   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    235646,
                    235705
                ],
                "answer": "(b)           Termination Fees.   (i)       In the event   "
            },
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    235940,
                    237118
                ],
                "answer": "(C)         this Agreement is terminated by (1) either the Company or Parent pursuant to Section 8.01(b)(i) (End Date) or Section 8.01(b)(iii) (Company Stockholder Approval Not Obtained), or Parent pursuant to Section 8.01(d)(ii) (Company Breach), (2) after the execution of this Agreement and prior to the date of termination the Company has received a bona fide Company Takeover Proposal or a bona fide Company Takeover Proposal has been publicly disclosed and not withdrawn at least five (5) Business Days prior to such termination, and (3)  within six (6) months of the date of termination by either the Company or Parent pursuant to Section 8.01(b)(i) (End Date) or within twelve (12) months of the date of any termination by either the Company or Parent pursuant to Section 8.01(b)(iii) (Company Stockholder Approval Not Obtained) or Parent pursuant to Section 8.01(d)(ii) (Company Breach), the Company enters into a definitive agreement with respect to, or consummates, any Company Takeover Proposal; provided that for purposes of this Section 8.02(b), the references to \u201c15%\u201d in the definition of \u201cCompany Takeover Proposal\u201d shall be deemed to be references to \u201c50%\u201d;   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    120249,
                    122034
                ],
                "answer": "SECTION 5.01           Conduct of Business.   ( a )             Conduct of Business by the Company. Except (i) for matters set forth in Section 5.01 of the Company Disclosure Schedule, (ii) as required or expressly contemplated by this Agreement, (iii) as mandated by a Governmental Entity or required by applicable Law, (iv) for any actions that the Company reasonably determines are necessary to comply with COVID-19 Measures or to respond to COVID-19 in a manner consistent with past practice, provided that prior to taking any actions in reliance on this clause (iv), which would otherwise be prohibited by any provision of this Agreement, the Company will use commercially reasonable efforts to provide advance notice to and consult with Parent (if reasonably practicable) with respect thereto, or (v) with the prior written consent of Parent (which consent shall not be unreasonably withheld, conditioned or delayed and in the event Parent does not provide a decision within five (5) Business Days after such consent is requested by the Company in the manner set forth in Section 9.02, Parent shall be deemed to have consented to such request; provided that in the event Parent reasonably requests additional information in connection with such request, the five (5) Business Period day described above shall be tolled until the date such additional information is provided to Parent, whereupon Parent shall have three (3) Business Days to provide a decision), from the date of this Agreement until the Effective Time or the date which this Agreement is validly terminated pursuant to Section 8.01, the Company shall, and shall cause each Company Subsidiary to, (A)  use reasonable best efforts to conduct its business in the ordinary course of business in all material respects "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    162658,
                    165067
                ],
                "answer": "SECTION 6.02           Further Actions; Regulatory Approvals; Required Actions.   (a)           Subject to the terms and conditions of this Agreement, each of the Parties shall, and shall cause its Affiliates (and, in the case of Parent, the Equity Investor and their Affiliates) to, take, or cause to be taken, all actions, and do, or cause to be done, and assist and cooperate with the other Parties in doing all things necessary or advisable to cause the conditions to the Closing set forth in Article VII to be satisfied as promptly as reasonably practicable and to effect the Closing as promptly as reasonably practicable and in any event before the End Date, including (i) making all necessary Filings with Governmental Entities or third parties, (ii) obtaining the Required Consents and all other third-party Consents that are necessary to consummate the Merger, (iii) obtaining the Required Statutory Approvals and all other Consents of Governmental Entities that are necessary to consummate the Merger and (iv) executing and delivering any additional instruments that are necessary to consummate the Merger. Parent shall be responsible for all fees, costs and expenses (except for the fees, costs and expenses of the Company\u2019s advisors), including any filing fees, associated with any Filings or Consents contemplated by this Section 6.02. Notwithstanding the foregoing or any other provision of this Agreement, Parent will control (in a manner consistent with this Section 6.02) and lead all communications and strategy relating to obtaining the Required Statutory Approvals, and the Company will not, and will cause its representatives not to, (A) make any proposal to, or (except to the extent required by Law) any Filings with, Governmental Entities in respect of any matter related to the Required Statutory Approvals without the prior written consent of Parent or its counsel, given or withheld in Parent\u2019s sole discretion or (B) otherwise contact Governmental Entities to communicate with them in respect of any matter related to the Required Statutory Approvals without the prior written consent of Parent or its counsel, given or withheld in Parent\u2019s reasonable discretion; provided that Parent shall keep the Company reasonably informed on a current basis, consult with and consider in good faith the views and comments of the Company in connection with such communications and strategy.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Gibraltar Acquisition Holdings LLC\" and Target \"W. R. Grace & Co.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/W_R_Grace_Co_40_North_Management_LLC.txt",
                "span": [
                    263917,
                    265947
                ],
                "answer": "SECTION 9.10           Specific Enforcement.   (a)           The Parties acknowledge and agree that irreparable damage for which monetary damages, even if available, would not be an adequate remedy, would occur in the event that any Party does not perform any of the provisions of this Agreement (including failing to take such actions as are required of it hereunder to consummate this Agreement) in accordance with their specific terms or otherwise breach or threaten to breach any such provisions. It is accordingly agreed that, at any time prior to the termination of this Agreement pursuant to Article VIII, subject to the limitations in Section 8.02(d)(i), Section 8.02(d)(ii) and Section 9.10(b), the Parties shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent breaches or threatened breaches of this Agreement and to enforce specifically the performance of terms and provisions of this Agreement, including the right of a Party to cause each other Party to consummate the Merger and the other transactions contemplated by this Agreement on the terms and subject to the conditions of this Agreement in any court referred to in Section 9.11 without proof of actual damages (and each Party hereby waives any requirement for the securing or posting of any bond in connection with such remedy), this being in addition to any other remedy to which they are entitled at law or in equity. The Parties further agree not to assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable or not appropriate for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy for any such breach. The Parties hereto agree that, notwithstanding any other provision of this Agreement to the contrary, but subject to Section 9.10(b), the Company shall be entitled to specific performance (or any other equitable relief) to cause Parent and Merger Sub to consummate the Closing on the terms set forth herein.   "
            }
        ],
        "file_set": [
            "W_R_Grace_Co_40_North_Management_LLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    14804,
                    16236
                ],
                "answer": "Section 2.1. Effect on Capital Stock. At the Effective Time, by virtue of the Merger and without any action on the part of the Company, Parent, Merger Sub or the holders of any of the following securities: \n\n\n(a) Merger Consideration. Each share of Common Stock issued and outstanding immediately prior to the Effective Time (each, a \u201cShare\u201d) (other than (i) Shares owned by Parent, Merger Sub or any other direct or indirect wholly owned Subsidiary of Parent immediately prior to the Effective Time and Shares owned by the Company, including Shares held in treasury by the Company, and in each case not held on behalf of third parties (collectively, the \u201cCancelled Shares\u201d) and (ii) the Dissenting Shares (as defined below)) shall be converted automatically into and shall thereafter represent the right to receive $11.50 per share in cash, without interest (the \u201cPer Share Merger Consideration\u201d). At the Effective Time, all of the Shares that have been converted into a right to receive the Per Share Merger Consideration as provided in this Section 2.1(a) shall cease to be outstanding, shall be cancelled and shall cease to exist, and each non-certificated Share represented by book-entry (other than Cancelled Shares and Dissenting Shares) (a \u201cBook-Entry Share\u201d) shall thereafter represent only the right to receive the Per Share Merger Consideration to be paid in consideration therefor in accordance with this Article II. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Information about the Closing Condition: Accuracy of Target's Representations and Warranties",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    35166,
                    35225
                ],
                "answer": "Section 3.1. Organization and Qualification\u037e Subsidiaries. "
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    37216,
                    37245
                ],
                "answer": "Section 3.3. Capitalization. "
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    45146,
                    45173
                ],
                "answer": "Section 3.4. Authority. \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    45764,
                    46536
                ],
                "answer": "The execution and delivery of this Agreement and the consummation by the Company of the Merger have been duly authorized by the Board of Directors, and this Agreement has been duly and validly executed and delivered by the Company and, assuming the due authorization, execution and delivery hereof by Parent and Merger Sub, constitutes a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to the effects of applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other similar Laws relating to or affecting creditors\u2019 rights generally and general equitable principles (whether considered in a Proceeding in equity or at Law) (the \u201cBankruptcy and Equity Exception\u201d). \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    108610,
                    108633
                ],
                "answer": "Section 3.22. Brokers. "
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    262445,
                    264435
                ],
                "answer": "Section 7.2. Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to effect the Merger shall be further subject to the satisfaction (or waiver by Parent) at or prior to the Effective Time of the following conditions: \n\n\n(a) Representations and Warranties. Each of (i) the representations and warranties of the Company set forth in Section 3.1, Section 3.3(a), Section 3.3(b), Section 3.3(c), Section 3.3(d), Section 3.4 and Section 3.22 (except, subject to the terms of Section 6.1, in the event that the Company or any of its Subsidiaries or the Board of Directors (or a duly authorized committee thereof) engages another financial advisor in connection with the evaluation of an Acquisition Proposal) shall be true and correct in all material respects as of the Closing Date as if made at such date (except to the extent such representations and warranties speak as of a specified date, in which case they need only be true and correct in all material respects as of such specified date), which in the case of (x) Section 3.3(a), shall mean only inaccuracies that are de minimis and (y) Section 3.3(d), shall mean only inaccuracies that would not increase the aggregate consideration payable pursuant to this Agreement by more than a de minimis amount\u037e and (ii) the other representations and warranties of the Company set forth in Article III shall be true and correct as of the Closing Date as if made at such date (except to the extent such representations and warranties speak as of a specified date, in which case they need only be true and correct as of such specified date) interpreted without giving effect to the words \u201cmaterially\u201d or \u201cmaterial\u201d or to any qualifications based on such terms or based on the term \u201cMaterial Adverse Effect,\u201d except where the failure of such representations and warranties to be true and correct, in the aggregate, would not constitute or would not reasonably be expected to have a Material Adverse Effect\u037e \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    262445,
                    262705
                ],
                "answer": "Section 7.2. Conditions to Obligations of Parent and Merger Sub. The obligations of Parent and Merger Sub to effect the Merger shall be further subject to the satisfaction (or waiver by Parent) at or prior to the Effective Time of the following conditions: \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    264465,
                    264719
                ],
                "answer": "(b) Performance of Obligations of the Company. The Company shall have performed and complied with in all material respects all covenants and obligations required to be performed or complied with under this Agreement at or prior to the Effective Time\u037e \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    70239,
                    70860
                ],
                "answer": "Section 3.9. Absence of Certain Changes or Events. Since June 30, 2020, (a) except as contemplated by this Agreement or in connection with the formation or financing or refinancing of any Clinic Joint Ventures in the ordinary course of business consistent with past practice, the Company and its Subsidiaries have conducted their business in all material respects in the ordinary course consistent with past practice and (b) there has not occurred any event, development, change, effect or occurrence that, individually or in the aggregate, has had, or would reasonably be expected to have, a Material Adverse Effect. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    303924,
                    309233
                ],
                "answer": "(v) \u201cMaterial Adverse Effect\u201d means any fact, event, development, change, effect, circumstance or occurrence (each, an \u201cEffect\u201d) that, individually or in the aggregate with all other Effects, (A) has had or would reasonable be expected to have a material adverse effect on or with respect to the business, results of operation or financial condition of the Company and its Subsidiaries taken as a whole or (B) would reasonably be expected to prevent or materially delay the consummation of the Merger past the End Date\u037e provided that, with respect to clause (A) only, no Effects relating to, arising out of or in connection with or resulting from any of the following shall be deemed, either alone or in combination, to constitute or contribute to a Material Adverse Effect (subject to the limitations set forth below): (i) general changes or developments in the economy, political conditions in the United States or elsewhere in the world (including protests or political unrest) or the financial, debt, capital, credit, commodities or securities markets in the United States or elsewhere in the world, (ii) general changes or developments in the industries in which the Company or its Subsidiaries operate, (iii) the negotiation, execution or delivery of this Agreement or the public announcement or pendency of the Merger or other transactions contemplated hereby, including any impact thereof on relationships, contractual or otherwise, with customers, suppliers, patients, payors, regulators, lenders, partners, employees, joint venture partners or similar relationships of the Company and its Subsidiaries, or the compliance with the terms of this Agreement and the transactions contemplated hereby, including compliance with the covenants set forth herein (except that this clause (iii) shall not apply to the representations and warranties made in Section 3.5 (and to the extend related to Section 3.5, the condition in Section 7.2(a)), (iv) any action taken or omitted to be taken by the Company at the written request of or with the written consent of Parent or Merger Sub or expressly required by this Agreement, (v) changes or prospective or anticipated changes, occurring after the date of this Agreement, in any applicable Laws (including any Health Care Laws) or applicable accounting regulations or principles or interpretation or enforcement thereof, (vi) any hurricane, tornado, earthquake, flood, tsunami, mudslide or other natural disaster, weather condition, explosion or fire or other force majeure event or act of God or other comparable events or outbreak or escalation of hostilities or war (whether or not declared), military actions or any, act of sabotage, terrorism, epidemics or pandemics (including COVID-19), disease outbreaks or national or international political or social conditions (including social unrest) or any escalation or worsening relating to the foregoing, including any escalation or worsening of any stoppages or shutdowns, or any response of any Governmental Entity (including requirements for business closures or \u201csheltering-in-place\u201d), related to any of the foregoing, (vii) any matter (including actions taken by the SEC or the DOJ) relating to the restatement of the Company\u2019s financial statements filed in the Company\u2019s Annual Report on Form 10-K on September 5, 2019 or the underlying causes thereof and all related claims, investigations, proceedings, actions or actions taken by a Governmental Entity with respect thereto, (viii) any change in the market price or trading volume of the Shares or the credit rating of the Company or any of its Subsidiaries, (ix) any failure by the Company to meet any published analyst estimates or expectations of the Company\u2019s revenue, earnings or other financial performance or results of operations for any period, in and of itself, or any failure by the Company to meet its internal or published projections, budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (it being understood that the underlying facts, events or circumstances giving rise to or contributing to such change or failure may be deemed to constitute, and may be taken into account in determining, whether there has been a Material Adverse Effect), (x) any determination or decision by, or delay of a determination or decision by, or any recommendation, statement or other pronouncement made or proposed by, any Governmental Entity or any panel or advisory body empowered or appointed thereby with respect to the uses, reimbursement scheme, pricing, or status for any services offered by the Company or any of its Subsidiaries, or any such determinations, decisions, recommendations, statements or pronouncements with respect thereto or (xi) any matter disclosed in the Company Disclosure Schedule\u037e except in the cases of clauses (i), (ii), (v), (vi) or (x), to the extent that the Company and its Subsidiaries, taken as a whole, are materially disproportionately affected thereby as compared with other participants operating in the industry in which the Company and its Subsidiaries conduct business (in which case solely the incremental disproportionate impact or impacts may be taken into account in determining whether there has been a Material Adverse Effect). \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    303043,
                    303405
                ],
                "answer": "(s) \u201cknowledge\u201d (i) with respect to the Company means the actual knowledge of any of the individuals listed in Section 9.5(r) of the Company Disclosure Schedule and (ii) with respect to Parent or Merger Sub means the actual knowledge of any of the individuals listed in Section 9.5(r) of the Parent Disclosure Schedule, in each case after reasonable inquiry. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    159730,
                    159769
                ],
                "answer": "Section 6.1. Acquisition Proposals. \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    160047,
                    160211
                ],
                "answer": "their respective directors, officers, employees, investment bankers, attorneys, accountants and other advisors or representatives (collectively, \u201cRepresentatives\u201d) "
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    163370,
                    168313
                ],
                "answer": "(b) Except as it may relate to any Excluded Party or as permitted by this Section 6.1, including the last sentence of this Section 6.1(b), from 11:59 p.m. (New York City time) on the No-Shop Period Start Date until the Effective Time or, if earlier, the termination of this Agreement in accordance with Section 8.1, the Company shall not, shall cause its Subsidiaries not to and shall direct the Representatives of the Company and its Subsidiaries not to, (i) initiate, solicit, knowingly facilitate or knowingly encourage any inquiries or discussions with respect to, or the making of, any proposal or offer that constitutes or would be reasonably likely to result in an Acquisition Proposal, (ii) engage in, enter into, continue or otherwise participate in any discussions or negotiations concerning, or provide access to its business, properties, assets, books and records or any non-public information or data to, any Person relating to an Acquisition Proposal, (iii) approve, endorse, declare advisable or recommend, or propose publicly to approve, endorse, declare advisable or recommend, any Acquisition Proposal, (iv) execute or enter into, any merger agreement, acquisition agreement or similar agreement or binding letter of intent, term sheet, or similar binding agreement or understanding (other than an Acceptable Confidentiality Agreement) with respect to an Acquisition Proposal or (v) authorize, commit to, agree or publicly propose to do any of the foregoing\u037e provided that it is understood and agreed that any determination or action by the Board of Directors (or a duly authorized committee thereof) permitted under Section 6.1(c) or Section 6.1(e) shall not be deemed to be a breach or violation of this Section 6.1(b) or, in the case of Section 6.1(c), give Parent a right to terminate this Agreement pursuant to Section 8.1(e)(ii). Except as it may relate to any Excluded Party, the Company also agrees that immediately following 11:59 p.m. (New York City time) on the No-Shop Period Start Date it shall cease, and shall cause its Subsidiaries to cease, and shall direct the Representatives of the Company and its Subsidiaries to cease, any solicitations, discussions or negotiations with any Person (other than the Parties and their respective Representatives and the parties to the Subsequent Transaction and their respective Representatives) in connection with any Acquisition Proposal. Except as it may relate to an Excluded Party, the Company also agrees that following the No-Shop Period Start Date it will promptly (and in any event within three (3) Business Days thereof) request each Person (other than the Parties and their respective Representatives) that has executed a confidentiality agreement in connection with its consideration of a potential transaction involving the acquisition of the Company to return or destroy all confidential information furnished to such Person by or on behalf of the Company or any of its Subsidiaries. Except as it may relate to an Excluded Party, the Company shall promptly (and in any event within forty-eight (48) hours thereof) notify in writing Parent of the receipt of any Acquisition Proposal after the No-Shop Period Start Date, which notice shall include a copy of any such Acquisition Proposal made in writing and any other written terms and proposals provided (including financing commitments) to the Company or its Representatives and a written summary of material terms and conditions of any such Acquisition Proposal not made in writing. Thereafter, the Company shall keep Parent reasonably informed of the status and material terms of any such Acquisition Proposal including any material changes in respect of any such Acquisition Proposal and the material terms thereof. Notwithstanding anything to the contrary herein, the Company may grant a waiver, amendment or release under any confidentiality or standstill agreement to allow for a confidential Acquisition Proposal to be made to the Company or the Board of Directors (or a duly authorized committee thereof) so long as the Company promptly (and in any event within forty-eight (48) hours thereof) notifies Parent thereof after granting any such waiver, amendment or release and, if requested by Parent, grants Parent an equivalent waiver, amendment or release under the Confidentiality Agreement, if applicable. For the avoidance of doubt, notwithstanding the commencement of the No-Shop Period Start Date, until the receipt of the Company Requisite Vote, the Company, its Subsidiaries and their Representatives may continue to engage in the activities described in Section 6.1(a) with respect to any Excluded Party so long as such Excluded Party remains an Excluded Party, including with respect to any amended or modified Acquisition Proposal submitted by any Excluded Party following the No-Shop Period Start Date, and the restrictions in this Section 6.1(b) shall not apply with respect thereto. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    179137,
                    180180
                ],
                "answer": "(i) \u201cAcquisition Proposal\u201d means any proposal or offer from any Person or group of Persons (other than Parent, Merger Sub or their respective Affiliates) relating to (A) any direct or indirect acquisition, purchase, sale, lease or other disposition of assets of the Company or its Subsidiaries, in one transaction or a series of related transactions, that constitutes 15% or more of the consolidated revenues, net income or assets of the Company and its Subsidiaries, taken as a whole, (B) any issuance of Shares representing 15% or more of the total voting power of the equity securities of the Company, (C) any tender offer or exchange offer that if consummated would result in any Person beneficially owning 15% or more of the total voting power of the equity securities of the Company, (D) any merger, reorganization, consolidation, share exchange, business combination, recapitalization, liquidation, dissolution or similar business combination transaction involving the equity of the Company, or (E) any combination of the foregoing. \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    182616,
                    183725
                ],
                "answer": "(iv) \u201cSuperior Proposal\u201d means a bona fide written Acquisition Proposal (except that the references therein to \u201c15%\u201d shall be replaced by \u201c50%\u201d), in each case, that the Board of Directors (or a duly authorized committee thereof) in good faith determines, after consultation with its outside legal counsel and financial advisor, after taking into account all such factors and matters deemed relevant in good faith by the Board of Directors (or a duly authorized committee thereof), including legal, financial (including the financing terms of any such proposal), regulatory (including antitrust), timing or other aspects of such proposal or offer (including any break-up fee, expense reimbursement provisions, and conditions to consummation) and the transactions contemplated hereby and after taking into account any changes to the terms of this Agreement proposed in writing by Parent in response to such Superior Proposal pursuant to, and in accordance with, Section 6.1(e), to be more favorable from a financial point of view to the stockholders of the Company than the transactions contemplated hereby. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    181360,
                    182586
                ],
                "answer": "(iii) \u201cIntervening Event\u201d means any material event, occurrence, development or change in circumstances with respect to the Company and its Subsidiaries, taken as a whole, which (A) (i) was unknown to, and was not reasonably foreseeable by, the Board of Directors (or a duly authorized committee thereof) as of the date hereof, or (ii) if known to, or reasonably foreseeable by, the Board of Directors (or a duly authorized committee thereof) as of the date hereof, the material consequences of which were not known and reasonably foreseeable to the Board of Directors (or a duly authorized committee thereof) as of the date hereof and (B) becomes known to or by the Board of Directors (or a duly authorized committee thereof) prior to the time the Company Requisite Vote is obtained\u037e provided, however, that none of the following will alone constitute an Intervening Event: changes in the market price or trading volume of the Shares or the fact that the Company meets or exceeds internal or published projections, budgets, forecasts or estimates of revenues, earnings or other financial results for any period (provided, however, that the underlying causes of such changes or fact shall not be excluded by the foregoing). \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    267865,
                    268083
                ],
                "answer": "Section 8.1. Termination. This Agreement may be terminated and the Merger may be abandoned at any time prior to the Effective Time, notwithstanding the adoption of this Agreement by the stockholders of the Company: \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    271250,
                    271306
                ],
                "answer": "(d) by written notice from the Company to Parent if: \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    272199,
                    272573
                ],
                "answer": "(ii) prior to obtaining the Company Requisite Vote, in accordance with, and subject to, and in compliance with, all of the terms and conditions of, Section 6.1(e) in order to enter into a definitive agreement with respect to a Superior Proposal, if prior to or concurrently with such termination, the Company pays the Company Termination Fee due under Section 8.2(b)(i)\u037e \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    275266,
                    275305
                ],
                "answer": "Section 8.2. Effect of Termination. \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    277246,
                    277272
                ],
                "answer": "(b) In the event that: \n\n\n"
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    277818,
                    279455
                ],
                "answer": "(ii) this Agreement is terminated by either Parent or the Company pursuant to Section 8.1(f) or by Parent pursuant to Section 8.1(e)(i) and (A) at any time after the date of this Agreement and prior to the taking of a vote to approve this Agreement at the Stockholders Meeting or any postponement or adjournment thereof an Acquisition Proposal shall have been made directly to the Company\u2019s stockholders or an Acquisition Proposal shall have otherwise become publicly known or, in the case of a termination pursuant to Section 8.1(e)(i), an Acquisition Proposal shall have been provided to the Company or the Board of Directors (or a duly authorized committee thereof), and such Acquisition Proposal shall have not been withdrawn prior to such taking of a vote to approve this Agreement or, in the case of a termination pursuant to Section 8.1(e)(i), prior to the breach that forms the basis of such termination and (B) within nine (9) months after such termination, the Company shall have consummated an Acquisition Proposal or entered into a definitive agreement with respect to an Acquisition Proposal (which is subsequently consummated, whether within such nine (9) month period or thereafter), then, in any such event, the Company shall pay to Parent (or its designee) the Company Termination Fee, such payment to be made within two (2) Business Days from the consummation of an Acquisition Proposal, by wire transfer of immediately available funds. For the purpose of this Section 8.2(b)(ii), all references in the definition of the term Acquisition Proposal to \u201c15% or more\u201d will be deemed to be references to \u201cmore than 50%\u201d. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    141441,
                    142590
                ],
                "answer": "Section 5.1. Conduct of Business of the Company Pending the Merger. From the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement in accordance with Article VIII, except (i) as otherwise contemplated by this Agreement, (ii) as set forth in Section 5.1 of the Company Disclosure Schedule, (iii) as required by applicable Laws or (iv) unless Parent shall otherwise consent in writing (which consent shall not be unreasonably withheld, conditioned or delayed), (a) the Company shall and shall cause its Subsidiaries to, conduct their respective businesses in all material respects in the ordinary course of business consistent with past practice and the Company shall use its commercially reasonable efforts to preserve substantially intact in all material respects its business organization and material business relationships, provided, however, that no action by the Company or its Subsidiaries with respect to matters specifically addressed by any provision of Section 5.1(b) shall be deemed a breach of this sentence unless such action would constitute a breach of such provision of Section 5.1(b), "
            },
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    155091,
                    156344
                ],
                "answer": "Notwithstanding anything to the contrary in this Agreement: (i) any action taken, or omitted to be taken, by the Company or any of its Subsidiaries pursuant to any applicable Law or any other directive, pronouncement or guideline issued by a Governmental Entity or industry group providing for business closures, \u201csheltering-in-place\u201d or other restrictions that relates to, or arises out of, any pandemic (including COVID- 19), epidemic or disease outbreak shall in no event be deemed to constitute a breach of this Section 5.1 and shall be deemed to be in the ordinary course of business consistent with past practices for all purposes under this Agreement\u037e and (ii) any action taken, or omitted to be taken, by the Company of any of its Subsidiaries that may be reasonably necessary to protect health and safety as a result of any pandemic (including COVID- 19), epidemic or disease outbreak, in each case as determined by the Company and its Subsidiaries in their sole discretion and that is reasonable in light of the applicable circumstances, shall in no event be deemed to constitute a breach of this Section 5.1 and shall be deemed to be in the ordinary course of business consistent with past practices for all purposes under this Agreement. \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"IRC Superman Midco, LLC\" and Target \"American Renal Associates Holdings, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/American_Renal_Associates_Holdings_IRC_Superman_Midco.txt",
                "span": [
                    316961,
                    318038
                ],
                "answer": "Section 9.12. Specific Performance. \n\n\n(a) Each Party acknowledges that (i) money damages would be an insufficient remedy for any actual or threatened breach of this Agreement by such Party, (ii) any such breach or threatened breach would cause the other Party irreparable harm and (iii) in addition to any other remedies available at Law or in equity that are expressly provided to a Party under this Agreement, the Parties will be entitled to equitable relief by way of injunction, specific performance or other equitable relief, without posting any bond or other undertaking, for any actual or threatened breach of this Agreement by such Party. Neither Party will (i) contest the appropriateness or granting of any injunction or specific performance as a remedy for a breach of this Agreement or (ii) assert that a remedy of specific enforcement is unenforceable, invalid, contrary to Law or inequitable for any reason, nor to assert that a remedy of monetary damages would provide an adequate remedy, subject in all cases to the terms and conditions of Section 9.12(b). \n\n\n"
            }
        ],
        "file_set": [
            "American_Renal_Associates_Holdings_IRC_Superman_Midco.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    13468,
                    14266
                ],
                "answer": "(c)    Merger Consideration for Company Common Stock. Subject to Section 2.2, each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than shares to be cancelled in accordance with Section 2.1(b) and Dissenting Shares) shall be automatically converted into the right to receive $9.50, without interest thereon (the \u201cMerger Consideration\u201d). As of the Effective Time, all such shares of Company Common Stock shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and each holder of a Certificate or Uncertificated Shares shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration pursuant to this Section 2.1(c) in accordance with the provisions of Section 2.2. \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    210795,
                    211106
                ],
                "answer": "7.3    Conditions to the Obligations of the Parent and the Merger Sub. The obligation of the Parent and the Merger Sub to effect the Merger is also subject to the satisfaction, or waiver by the Parent (on behalf of the Parent and the Merger Sub), on or prior to the Closing Date of the following conditions: \n\n\n"
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    212822,
                    213009
                ],
                "answer": "(b)    the Company shall have performed in all material respects its covenants and obligations required to be performed by it under this Agreement on or prior to the Closing Date; and \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    248225,
                    248426
                ],
                "answer": "\u201cCompany\u2019s Knowledge\u201d means the actual knowledge as of the date hereof (without any duty to inquire or investigate) of the individuals identified in Section 10.1 of the Company Disclosure Schedule. \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    133654,
                    133681
                ],
                "answer": "6.1    No Solicitation. \n\n\n"
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    134884,
                    136835
                ],
                "answer": "Notwithstanding the foregoing or anything to the contrary set forth in this Agreement, subject to compliance with Section 6.1(c), at any time prior to receipt of the Company Stockholder Approval the Company may (A) furnish non-public information with respect to the Company and its Subsidiaries to any Qualified Person (and the Representatives of such Qualified Person), pursuant to a confidentiality agreement not materially less restrictive with respect to the confidentiality obligations of the Qualified Person than the Confidentiality Agreement, provided that such confidentiality agreement shall not (x) grant any exclusive right to negotiate with such counterparty, (y) prohibit the Company from satisfying its obligations hereunder or (z) require the Company or its Subsidiaries to pay or reimburse the Company the counterparty\u2019s fees, costs or expenses, (B) engage in discussions or negotiations (including solicitation of revised Acquisition Proposals) with any Qualified Person (and the Representatives of such Qualified Person) regarding any Acquisition Proposal, or (C) amend, or grant a waiver or release under, any standstill or similar agreement with respect to any Company Common Stock with any Qualified Person; provided, however, that Company may only furnish such non-public information and engage in such discussions or negotiations if: (x) the Company and its Subsidiaries are not in material breach their obligations pursuant to this Section 6.1 and (y) the Company Board has determined that the failure to take the actions contemplated by this sentence would be reasonably likely to be inconsistent with its fiduciary obligations under applicable law and; and provided, further, however, that the Company will promptly make available to Parent any non-public information concerning the Company and its Subsidiaries that is provided to any such Person or its Representatives that was not previously made available to Parent. \n\n\n"
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    272903,
                    273221
                ],
                "answer": "\u201cQualified Person\u201d means any Person making an Acquisition Proposal that did not result from any material breach of Section 6.1(a) that the Company Board determines in good faith (after consultation with outside counsel and its financial advisor) is, or could reasonably be expected to lead to, a Superior Proposal. \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    277058,
                    278097
                ],
                "answer": "\u201cSuperior Proposal\u201d means any bona fide Acquisition Proposal, (a) on terms which the Company Board determines in its good faith judgment to be more favorable to the holders of Company Common Stock than the transactions contemplated by this Agreement (after consultation with its financial and legal advisors), taking into account all the terms and conditions of such proposal and this Agreement (including any written, binding offer by the Parent to amend the terms of this Agreement, which offer is not revocable for at least five Business Days) that the Company Board determines to be relevant and (b) which the Company Board determines to be reasonably capable of being completed on the terms proposed, taking into account all financial, regulatory, legal and other aspects of such proposal that the Company Board determines to be relevant. For purposes of the reference to an \u201cAcquisition Proposal\u201d in this definition, all references to \u201c15%\u201d in the definition of \u201cAcquisition Transaction\u201d will be deemed to be references to \u201c50%.\u201d \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    260979,
                    261186
                ],
                "answer": "\u201cIntervening Event\u201d means a material change in circumstances or development that (a) was not known by the Company Board as of the date of this Agreement and (b) does not relate to an Acquisition Proposal.   "
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    213257,
                    213541
                ],
                "answer": "8.1    Termination. This Agreement may be terminated and the Merger may be abandoned (with respect to Sections 8.1(b) through 8.1(h), by written notice by the terminating party to the other party), whether before or, subject to the terms hereof, after stockholder approval hereof: \n\n\n"
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    216553,
                    219099
                ],
                "answer": "(f)    by the Company, at any time prior to receipt of the Company Stockholder Approval, in the event that: (i) the Company shall have received a Superior Proposal; (ii) the Company Board has determined in good faith (after consultation with outside counsel) that the failure proceed pursuant to this Section 8.1(f) would be reasonably likely to be inconsistent with its fiduciary obligations under applicable law; (iii) so long as the Company and its Subsidiaries are not in material breach of their obligations pursuant to Section 6.1 with respect to such Superior Proposal; (iv) the Company has notified the Parent in writing that it intends to enter into a definitive agreement relating to such Superior Proposal, specifying the material terms and conditions of such Superior Proposal (a \u201cSuperior Proposal Notice\u201d) (it being understood that the Superior Proposal Notice shall not constitute a Company Board Recommendation Change or a Trigger Event for purposes of this Agreement); (v) if requested by the Parent, the Company shall have made its Representatives available to negotiate with the Parent\u2019s Representatives any proposed modifications to the terms and conditions of this Agreement during the three (3) Business Day period following delivery by the Company to the Parent of such Superior Proposal Notice; provided, however, that in the event of any material revisions to such Superior Proposal, the Company will be required to notify Parent of such revisions and the applicable three (3) Business Day period described above shall be extended until two (2) Business Days after the time Parent receives notification from the Company of such revisions; (vi) if the Parent shall have delivered to the Company a written, binding and irrevocable offer to alter the terms or conditions of this Agreement during such three (3) Business Day period, the Company Board shall have determined in good faith (after consultation with outside counsel), after considering the terms of such offer by the Parent, that the Superior Proposal giving rise to such Superior Proposal Notice continues to be a Superior Proposal and it would still be reasonably likely to be inconsistent with its fiduciary obligations of the Company Board under applicable law not to accept such Superior Proposal; and (vii) concurrently with the termination of this Agreement, the Company pays the Parent the Termination Fee contemplated by Section 8.3(b)(ii) and enters into the definitive agreement to consummate the transaction contemplated by such Superior Proposal; \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    222334,
                    222360
                ],
                "answer": "8.3    Fees and Expenses. "
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    222673,
                    222784
                ],
                "answer": "(b)    The Company shall pay the Parent the Termination Fee in the event that this Agreement is terminated: \n\n\n"
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    223540,
                    223781
                ],
                "answer": "(C) within twelve (12) months after the date of termination, the Company shall have consummated any Acquisition Transaction or entered into a definitive agreement with respect to an Acquisition Transaction that is thereafter consummated; \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Razorback Technology Intermediate Holdings, Inc.\" and Target \"Endurance International Group Holdings, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    119699,
                    120527
                ],
                "answer": "5.1    Covenants of the Company. Except (w)(1) as required by applicable law, (2) by any Company Material Contract that has been made available to Parent or other agreement, plan or arrangement in effect on the date hereof that is listed in the Company Disclosure Schedule, or (3) as taken in connection with any COVID-19 Responses (clauses (1) through (3), the \u201cSpecified Exceptions\u201d), (x) as otherwise expressly contemplated or permitted by this Agreement, (y) as set forth in Section 5.1 of the Company Disclosure Schedule, or (z) with the Parent\u2019s consent (which shall not be unreasonably withheld, conditioned or delayed), during the Pre-Closing Period, the Company shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to act and carry on its business in the Ordinary Course of Business, "
            },
            {
                "file_path": "maud/Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt",
                "span": [
                    268293,
                    268420
                ],
                "answer": "\u201cOrdinary Course of Business\u201d means the ordinary course of business consistent in all material respects with past practice. \n\n\n"
            }
        ],
        "file_set": [
            "Endurance International Group Holdings, Inc._Clearlake Capital Group, L.P..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    78143,
                    79018
                ],
                "answer": "(a)         other than (i) shares of Company Common Stock to be cancelled or converted pursuant to Section 2.03(b) and (ii) Dissenting Shares (such shares together with the shares of Company Common Stock to be cancelled or converted pursuant to Section 2.03(b), collectively, the \u201cExcluded Shares\u201d), each share of Company Common Stock outstanding immediately prior to the First Effective Time shall be converted into, and shall thereafter represent only, the right to receive, (A) 2.1243 (the \u201cExchange Ratio\u201d) Parent ADSs (the \u201cShare Consideration\u201d), subject to Section 2.09 with respect to fractional Parent ADSs, and (B) $60.00 in cash without interest (the \u201cCash Consideration\u201d and, together with the Share Consideration, the \u201cMerger Consideration\u201d) and, immediately following such conversion, shall be automatically cancelled and cease to exist (the \u201cCancellation\u201d); \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    381516,
                    382005
                ],
                "answer": "Section 9.02          Conditions to the Obligations of Parent, Bidco and each Merger Sub.  The obligations of Parent, Bidco and each Merger Sub to consummate the Mergers are subject to the satisfaction (or, to the extent permitted by Applicable Law, waiver by Parent) of the following further conditions: \n\n\n(a)          the Company shall have performed, in all material respects, all of its obligations hereunder required to be performed by it at or prior to the First Effective Time; \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    18508,
                    26110
                ],
                "answer": "\u201cCompany Material Adverse Effect\u201d means any event, change, effect, circumstance, fact, development or occurrence that has a material adverse effect on the business, operations or financial condition of the Company and its Subsidiaries, taken as a whole; provided, that no event, change, effect, circumstance, fact, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Company Material Adverse Effect or shall be taken into account in determining whether there has been or would reasonably be expected to be a Company Material Adverse Effect: (i) any changes in general United States or global economic conditions or other general business, financial or market conditions, (ii) any changes in conditions generally affecting the industries in which the Company or any of its Subsidiaries operates, (iii) fluctuations in the value of any currency, (iv) any decline, in and of itself, in the market price or trading volume of the Company Common Stock (provided, that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Company Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (v) regulatory, legislative or political conditions or conditions in securities, credit, financial, debt or other capital markets, in each case in the United States or any foreign jurisdiction, (vi) any failure, in and of itself, by the Company or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (provided, that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Company Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (vii) the execution and delivery of this Agreement, the public announcement or the pendency of this Agreement or the pendency or consummation of the transactions contemplated by this Agreement (including the Mergers), the taking of any action required or expressly contemplated by this Agreement (other than, to the extent not excluded by another clause of this definition, the Company\u2019s compliance with its obligations pursuant to Section 6.01(a), except to the extent that Parent has unreasonably withheld a consent under Section 6.01(a)) or the identity of, or any facts or circumstances relating to Parent or any of its Subsidiaries, including the impact of any of the foregoing on the relationships, contractual or otherwise, of the Company or any of its Subsidiaries with Governmental Authorities, customers, suppliers, partners, officers, employees or other material business relations (provided, that the foregoing shall not apply with respect to any representation or warranty that is expressly intended to address the consequences of the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby (including Section 4.04(c)) or with respect to the condition to Closing contained in Section 9.02(b), to the extent it relates to such representations and warranties), (viii) any adoption, implementation, promulgation, repeal, modification, amendment, authoritative interpretation, change or proposal of any Applicable Law (or the interpretation thereof) of or by any Governmental Authority, (ix) any changes or prospective changes in GAAP (or authoritative interpretations thereof), (x) geopolitical conditions, the outbreak or escalation of hostilities, civil or political unrest, any acts of war, sabotage, cyberattack or terrorism, or any escalation or worsening of any such acts of war, sabotage, cyberattack or terrorism threatened or underway as of the date of this Agreement, (xi) any reduction in the credit rating of the Company or any of its Subsidiaries (it being understood and agreed that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such reduction that are not otherwise excluded from the definition of Company Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect), (xii) any epidemic, plague, pandemic or other outbreak of illness or public health event, hurricane, earthquake, flood, calamity or other natural disasters, acts of God or any change resulting from weather conditions (or any worsening of any of the foregoing), including the response of governmental and non- governmental entities, including any impact on new drug approval processes or drug trials, (xiii) any claims, actions, suits or proceedings arising from allegations of a breach of fiduciary duty or violation of Applicable Law relating to this Agreement or the transactions contemplated hereby (including the Mergers) or (xiv) any regulatory, preclinical, clinical, pricing or reimbursement, or manufacturing events, changes, effects, developments or occurrences relating to any Company Product or any product of a competitor of the Company, including (A) any suspension, rejection or refusal of, any request to refile or any delay in obtaining or making any regulatory application or filing, (B) any actions, requests, recommendations or decisions of (or the failure to take or delay in taking any actions or make any requests, recommendations or decisions by) any Governmental Authority, (C) any recommendations, statements or other pronouncements made, published or proposed by professional medical organizations, (D) any pre-clinical or clinical studies, tests or results or announcements thereof, (E) any decision or action by any Governmental Authority (or other payor) with respect to pricing and/or reimbursement, (F) any delay, hold or termination of any clinical trial or any delay, hold or termination of any planned application for marketing approval, (G) any delay, hold or termination of approval with respect to the manufacture, processing, packing or testing of any Company Product or with respect to any manufacturing facilities, or (H) any increased incidence or severity of any previously identified side effects, adverse effects, adverse events or safety observations or reports of new side effects, adverse effects, adverse events or safety observations, but excluding in the case of this clause (xiv) side effects, adverse effects, adverse events, safety observations or manufacturing events that result in a broad based product recall of, or withdrawal from the market of, ULTOMIRIS, SOLIRIS or STRENSIQ, except that the matters referred to in clauses (i), (ii), (iv), (v), (viii), (ix), (x) or (xii) may be taken into account (to the extent not excluded by another clause of this definition) to the extent that the impact of any such event, change, effect, circumstance, fact, development or occurrence on the Company and its Subsidiaries, taken as a whole, is disproportionately adverse relative to the adverse impact of such event, change, effect, circumstance, fact, development or occurrence on the operations in the biopharmaceutical industry of other participants in such industry, and then solely to the extent of such disproportionality. "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    37054,
                    37555
                ],
                "answer": "\u201cknowledge\u201d means (i) with respect to the Company, the actual knowledge of those individuals set forth in Section 1.01 of the Company Disclosure Schedule and (ii) with respect to Parent, the actual knowledge of those individuals set forth in Section 1.01 of the Parent Disclosure Schedule.  None of the individuals set forth in Section 1.01 of the Company Disclosure Schedule or Section 1.01 of the Parent Disclosure Schedule shall have any personal liability or obligations regarding such knowledge. "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    268625,
                    269988
                ],
                "answer": "Section 6.02          No Solicitation by the Company. \n\n\n(a)          From the date of this Agreement until the earlier of the First Effective Time and the termination of this Agreement, except as otherwise set forth in this Section 6.02, the Company shall not, and shall cause its Subsidiaries and its and its Subsidiaries\u2019 respective directors and officers to not, and shall use its reasonable best efforts to cause its and its Subsidiaries\u2019 other respective Representatives to not, directly or indirectly, (i) solicit, initiate, knowingly facilitate or knowingly encourage (including by way of furnishing information) any inquiries regarding, or the making or submission of any Company Acquisition Proposal, (ii) (A) enter into or participate in any discussions or negotiations regarding, (B) furnish to any Third Party any information, or (C) otherwise assist, participate in, knowingly facilitate or knowingly encourage any Third Party, in each case, in connection with or for the purpose of knowingly encouraging or facilitating, a Company Acquisition Proposal, (iii) approve, recommend or enter into, or publicly or formally propose to approve, recommend or enter into, any letter of intent or similar document, agreement, commitment, or agreement in principle (whether written or oral, binding or nonbinding) with respect to a Company Acquisition Proposal"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    268625,
                    268682
                ],
                "answer": "Section 6.02          No Solicitation by the Company. \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    270917,
                    273770
                ],
                "answer": "(b)          The foregoing notwithstanding, if at any time prior to the receipt of the Company Stockholder Approval (the \u201cCompany Approval Time\u201d), the Board of Directors of the Company receives a bona fide written Company Acquisition Proposal made after the date of this Agreement that has not resulted from a violation of this Section 6.02, the Board of Directors of the Company, directly or indirectly through its Representatives, may (i) contact the Third Party that has made such Company Acquisition Proposal in order to ascertain facts or clarify terms for the sole purpose of the Board of Directors of the Company informing itself about such Company Acquisition Proposal and such Third Party and (ii) if the Board of Directors of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel, that such Company Acquisition Proposal is or could reasonably be expected to lead to a Company Superior Proposal, (A) subject to compliance with this Section 6.02, engage in negotiations or discussions with such Third Party and (B) furnish to such Third Party and its Representatives and financing sources non-public information relating to the Company or any of its Subsidiaries pursuant to a confidentiality agreement that (1) does not contain any provision that would prevent the Company from complying with its obligation to provide disclosure to Parent pursuant to this Section 6.02 and (2) contains confidentiality and use provisions that, in each case, are no less favorable in the aggregate to the Company than those contained in the Confidentiality Agreement; provided, that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party.  Nothing contained herein shall prevent the Board of Directors of the Company from (x) taking and disclosing to the stockholders of the Company a position contemplated by Rule 14e-2(a), Rule 14d-9 or Item 1012(a) of Regulation M-A promulgated under the 1934 Act, or (y) making any required disclosure to the stockholders of the Company if the Board of Directors of the Company determines in good faith, after consultation with its outside legal counsel, that the failure to take such action would be reasonably likely to be inconsistent with Applicable Law; provided, that any such action or disclosure that constitutes a Company Adverse Recommendation Change shall be made in compliance with the applicable provisions of this Section 6.02.  A \u201cstop, look and listen\u201d disclosure pursuant to Rule 14d-9(f) under the 1934 Act in connection with a tender or exchange offer shall not constitute a Company Adverse Recommendation Change. \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    26757,
                    28443
                ],
                "answer": "\u201cCompany Superior Proposal\u201d means any bona fide, written Company Acquisition Proposal made after the date of this Agreement, in circumstances not involving a breach of this Agreement, from any Person (other than Parent and its Subsidiaries or Affiliates) to acquire, directly or indirectly, pursuant to a tender offer, exchange offer, merger, consolidation or other business combination or similar acquisition transaction, (i) all or substantially all of the non-\u201ccash or cash equivalent\u201d assets of the Company or (ii) more than fifty percent (50%) of the outstanding shares of Company Common Stock on terms that the Board of Directors of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel, and taking into account all the terms and conditions of the Company Acquisition Proposal that the Board of Directors of the Company considers to be appropriate (including the identity of the Person making the Company Acquisition Proposal and the expected timing and likelihood of consummation, any governmental or other approval requirements (including divestitures and entry into other commitments and limitations), break-up fees, expense reimbursement provisions, conditions to consummation and availability of necessary financing (including, if a cash transaction (in whole or in part), the availability of such funds and the nature, terms and conditionality of any committed financing)), would result in a transaction that is more favorable to the Company\u2019s stockholders than the Mergers and (A) is not subject to any financing or due diligence conditionality and (B) is reasonably capable of being completed on the terms proposed. "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    17028,
                    18479
                ],
                "answer": "\u201cCompany Intervening Event\u201d means any material event, change, effect, development or occurrence that (i) was not known or reasonably foreseeable to the Board of Directors of the Company as of or prior to the date of this Agreement and (ii) does not relate to or involve (A) any Company Acquisition Proposal, (B) any change in the market price or trading volume of the Company Common Stock (provided, that the underlying cause of such change may be taken into account, to the extent otherwise permitted by this definition), (C)  any event, change or circumstance relating to Parent or any of its Affiliates (unless such event, change or circumstance constitutes a Parent Material Adverse Effect), (D) any change in conditions generally (including any regulatory changes) affecting the industries or sectors in which the Company, Parent or any of their respective Subsidiaries operates, (E) clearance of the Mergers under the Antitrust Laws or any matters relating thereto or arising therefrom, (F) the taking of any action required or expressly contemplated by this Agreement or (G) the fact, in and of itself, that the Company or any of its Subsidiaries has met or exceeded any internal or published projections, forecasts, estimates or predictions, revenues, earnings or other financial or operating metrics for any period (provided, that the underlying cause thereof may be taken into account, to the extent otherwise permitted by this definition). "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    387979,
                    388276
                ],
                "answer": "Section 10.01          Termination.  This Agreement may be terminated and the Mergers and the other transactions contemplated hereby may be abandoned at any time prior to the First Effective Time (notwithstanding receipt of the Company Stockholder Approval or the Parent Shareholder Approval): \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    393053,
                    393085
                ],
                "answer": "(d)          by the Company: \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    395067,
                    395331
                ],
                "answer": "(iii) prior to obtaining the Company Stockholder Approval, in order to enter into a definitive agreement providing for a Company Superior Proposal promptly following such termination in accordance with, and subject to the terms and conditions of, Section 6.02. \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    396754,
                    396801
                ],
                "answer": "Section 10.03          Termination Payment. \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    397451,
                    397500
                ],
                "answer": "(b)          If (i) this Agreement is terminated "
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    397830,
                    398471
                ],
                "answer": "(iii) on or prior to the twelve-month anniversary of such termination of this Agreement: (A) a transaction constituting a Company Acquisition Proposal is consummated; or (B) a definitive agreement relating to a Company Acquisition Proposal is entered into by the Company or any of its Affiliates (in each case, whether or not such Company Acquisition Proposal is the same as the original Company Acquisition Proposal publicly made known or publicly announced), then, the Company shall pay to Parent (or its designee) by way of compensation the Company Termination Payment no later than the consummation of such Company Acquisition Proposal; "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What happens during a Breach of No-Shop clause",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    268625,
                    268682
                ],
                "answer": "Section 6.02          No Solicitation by the Company. \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    387979,
                    388276
                ],
                "answer": "Section 10.01          Termination.  This Agreement may be terminated and the Mergers and the other transactions contemplated hereby may be abandoned at any time prior to the First Effective Time (notwithstanding receipt of the Company Stockholder Approval or the Parent Shareholder Approval): \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    390972,
                    392070
                ],
                "answer": "(c)          by Parent: \n\n\n(i) prior to the receipt of the Company Stockholder Approval, if (A) a Company Adverse Recommendation Change shall have occurred, (B) a tender or exchange offer subject to Regulation 14D under the 1934 Act that constitutes a Company Acquisition Proposal shall have been commenced (within the meaning of Rule 14d-2 under the Exchange Act) and the Company shall not have communicated to its stockholders, within ten Business Days after such commencement, a statement disclosing that the Company recommends rejection of such tender or exchange offer (or shall have withdrawn any such rejection thereafter) or (C) the Company has committed a Willful Breach of Section 6.02 or Section 8.04(a), provided, that this Agreement may not be terminated pursuant to this clause (C)  if Parent, Bidco or either Merger Sub is then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by Parent, Bidco or either Merger Sub would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied; \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    396754,
                    397451
                ],
                "answer": "Section 10.03          Termination Payment. \n\n\n(a)          If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i) or (ii) by the Company pursuant to Section 10.01(d)(iii), then the Company shall pay to Parent (or its designee), in cash and by way of compensation, a payment in an amount equal to $1,180,000,000 (the \u201cCompany Termination Payment\u201d) at or prior to, and as a condition to the effectiveness of, the termination of this Agreement in the case of a termination pursuant to Section 10.01(d)(iii) or as promptly as practicable (and, in any event, within two Business Days following such termination) in the case of a termination pursuant to Section 10.01(c)(i). \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What happens during a Breach of Shareholder Meeting Covenant",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    358867,
                    358949
                ],
                "answer": "Section 8.04          Company Stockholder Meeting; Parent Shareholder Meeting. \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    387979,
                    388276
                ],
                "answer": "Section 10.01          Termination.  This Agreement may be terminated and the Mergers and the other transactions contemplated hereby may be abandoned at any time prior to the First Effective Time (notwithstanding receipt of the Company Stockholder Approval or the Parent Shareholder Approval): \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    390972,
                    392070
                ],
                "answer": "(c)          by Parent: \n\n\n(i) prior to the receipt of the Company Stockholder Approval, if (A) a Company Adverse Recommendation Change shall have occurred, (B) a tender or exchange offer subject to Regulation 14D under the 1934 Act that constitutes a Company Acquisition Proposal shall have been commenced (within the meaning of Rule 14d-2 under the Exchange Act) and the Company shall not have communicated to its stockholders, within ten Business Days after such commencement, a statement disclosing that the Company recommends rejection of such tender or exchange offer (or shall have withdrawn any such rejection thereafter) or (C) the Company has committed a Willful Breach of Section 6.02 or Section 8.04(a), provided, that this Agreement may not be terminated pursuant to this clause (C)  if Parent, Bidco or either Merger Sub is then in breach of any of its representations, warranties, covenants or agreements set forth in this Agreement, which breach by Parent, Bidco or either Merger Sub would cause any condition set forth in Section 9.03(a) or Section 9.03(b) not to be satisfied; \n\n\n"
            },
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    396754,
                    397451
                ],
                "answer": "Section 10.03          Termination Payment. \n\n\n(a)          If this Agreement is terminated: (i) by Parent pursuant to Section 10.01(c)(i) or (ii) by the Company pursuant to Section 10.01(d)(iii), then the Company shall pay to Parent (or its designee), in cash and by way of compensation, a payment in an amount equal to $1,180,000,000 (the \u201cCompany Termination Payment\u201d) at or prior to, and as a condition to the effectiveness of, the termination of this Agreement in the case of a termination pursuant to Section 10.01(d)(iii) or as promptly as practicable (and, in any event, within two Business Days following such termination) in the case of a termination pursuant to Section 10.01(c)(i). \n\n\n"
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    248717,
                    249704
                ],
                "answer": "Section 6.01          Conduct of the Company. \n\n\n(a)          From the date of this Agreement until the earlier of the First Effective Time and the termination of this Agreement, except (x) as prohibited or required by Applicable Law, (y) as set forth in Section 6.01 of the Company Disclosure Schedule, or (z) as otherwise required or expressly contemplated by this Agreement, unless Parent shall have given its prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to conduct its business in all material respects in the ordinary course of business and to preserve intact its business organization, keep available the services of its present key employees and maintain its existing relations and goodwill with material customers, members, suppliers, licensors, licensees and other Third Parties with whom it has material business relations; "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"AstraZeneca PLC\" and Target \"Alexion Pharmaceuticals, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt",
                "span": [
                    428040,
                    428992
                ],
                "answer": "Section 11.13          Specific Performance.  The parties\u2019 rights in this Section 11.13 are an integral part of the transactions contemplated by this Agreement.  The parties acknowledge and agree that irreparable harm would occur and that the parties would not have any adequate remedy at law (a) for any breach of any of the provisions of this Agreement or (b) in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms.  It is accordingly agreed that (except where this Agreement is validly terminated in accordance with Section 10.01) the parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages, and each party further agrees to waive any requirement for the securing or posting of any bond in connection with such remedy.  "
            }
        ],
        "file_set": [
            "Alexion Pharmaceuticals, Inc._AstraZeneca PLC.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    50546,
                    51574
                ],
                "answer": "(a) Except as provided in Section 2.04(b) or in Section 2.07, each Company Common Share issued and outstanding immediately prior to the Effective Time (the \u201cShares\u201d), other than the Excluded Shares and the Company RSAs, shall be canceled and shall, by virtue of the Merger and without any action on the part of the holder thereof, be converted automatically into the right to receive (i) an amount in cash, without interest, equal to $23.30 (the \u201cMerger Consideration\u201d), (A) upon surrender of the Certificate representing such Shares as provided in Article III, in the case of certificated Shares, and (B) automatically, in the case of Book-Entry Shares.  All Shares, at the Effective Time, shall no longer be outstanding and shall automatically be retired and shall cease to exist, and each holder of a Certificate representing Shares or Book- Entry Shares shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration into which such Shares have been converted, as provided herein. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    202295,
                    202568
                ],
                "answer": "Section 7.02 Conditions to the Obligations of Parent and Merger Sub.  The obligations of Parent and Merger Sub to effect the Merger on the Closing Date are subject to the satisfaction (or waiver by Parent and Merger Sub) as of the Closing Date of the following conditions: "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    203881,
                    204125
                ],
                "answer": "(b) Covenants and Agreements.  The covenants and agreements of the Company set forth in this Agreement to be performed or complied with at or prior to the Effective Time shall have been duly performed or complied with in all material respects. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    88079,
                    88130
                ],
                "answer": "Section 4.09 Absence of Certain Changes or Events. "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    88591,
                    88696
                ],
                "answer": "(b) Since December 31, 2019, through the date hereof, there has been no Company Material Adverse Effect. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    15923,
                    20969
                ],
                "answer": "\u201cCompany Material Adverse Effect\u201d means any fact, effect, change, event, circumstance, occurrence or development that, individually or in the aggregate, has or is reasonably likely to have a material adverse effect on the business, assets, liabilities, condition (financial or otherwise) or results of operations of the Company and its Subsidiaries, taken as a whole; provided, however, that in no event shall any of the following, alone or in combination, be deemed to constitute, nor be taken into account in determining whether there has been or will be, a Company Material Adverse Effect: (a) changes within or affecting the general property and casualty insurance industry, the United States or global economy, or changes within or affecting global or United States economic or capital market conditions (including changes in the credit, debt, financial, or currency markets), (b) changes in or adoption of any applicable Laws or applicable accounting regulations or principles or interpretations thereof (including changes in GAAP or in SAP prescribed or permitted by the applicable Insurance Regulators and accounting pronouncements by the SEC, the National Association of Insurance Commissioners and the Financial Accounting Standards Board), (c) changes in global or national political conditions (including political action or inaction, the outbreak or escalation of war, military action, insurrection, sabotage or acts of terrorism), (d) changes due to any acts of God, natural disasters, man-made disasters, disease outbreak, global public health emergency (as declared by the World Health Organization), epidemics or pandemics (including COVID-19 and any worsening thereof or any COVID-19 Measures), (e) change, event, effect, development or circumstance arising out of the announcement of this Agreement and the transactions contemplated hereby or the pendency of the Merger or the identity of the parties to this Agreement, including any termination of, reduction in or similar negative impact on relationships, contractual or otherwise, with any Governmental Authorities or any customers, suppliers, reinsurers, agents, policyholders, partners, officers or employees of the Company and its Subsidiaries; provided, however, that this clause (e) shall not apply with respect to the representations and warranties made by the Company in Section 4.05 of this Agreement, (f) actions taken or omitted to be taken pursuant to the express provisions of this Agreement to obtain any consent, approval, authorization or waiver under applicable Law in connection with the Merger and the other transactions contemplated hereby, (g) the entering into and performance of this Agreement and the transactions contemplated hereby, including compliance with the covenants set forth herein, or any action taken or omitted to be taken by the Company at the express written request or with the prior written consent of Parent or Merger Sub, (h) the effects of any breach, violation or non- performance of any provision of this Agreement by Parent or any of its Affiliates, (i) any initiated or threatened Action against the Company, any of its Affiliates or any of their respective directors or officers arising out of this Agreement or the transactions contemplated hereby, (j) any failure in and of itself (but not the underlying cause thereof) by the Company to meet any published analyst estimates or expectations of the Company\u2019s revenues, premiums written, earnings or other financial performance or results of operations for any period or any failure in and of itself (but not the underlying cause thereof) by the Company to meet its internal or published projections, budgets, plans or forecasts of its revenues, premiums written, earnings or other financial performance or results of operations or any change in the price or trading volume of the Company Common Shares, (k) changes in the value of the investment assets owned by a Company Insurance Subsidiary (but not the underlying cause thereof) or (l) changes or developments in and of itself (but not the underlying cause thereof) in the credit, financial strength or other rating of the Company, any of its Subsidiaries or its outstanding debt, (m) any effect, change, event, occurrence or circumstance arising out of, resulting from or related to the matters described in Section 1.01A of the Company Disclosure Letter; provided, further, however, that any effect, change, event or occurrence referred to in clause (a), (b), (c) or (d) may be taken into account in determining whether or not there has been a Company Material Adverse Effect to the extent such effect, change, event or occurrence has a disproportionate adverse effect on the Company and its Subsidiaries, taken as a whole, relative to other participants operating in the industries and geographies in which the Company and its Subsidiaries operate (in which case the incremental disproportionate effect or effects may be taken into account in determining whether or not a Company Material Adverse Effect has occurred). "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    27876,
                    28164
                ],
                "answer": "\u201cKnowledge\u201d means, with respect to (a) the Company as it relates to any fact or other matter, the actual knowledge of the natural Persons set forth in Section 1.01B of the Company Disclosure Letter of such fact or matter as of the date hereof, in each case, after reasonable inquiry, and "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    28406,
                    28708
                ],
                "answer": "provided that, in the case of the foregoing (a) and (b), for clarity, with respect to Intellectual Property, such inquiry is not required to include freedom to operate analyses, clearance searches, validity or noninfringement analyses or opinions, or any other similar analyses or opinions of counsel. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    168034,
                    171775
                ],
                "answer": "Section 6.06 No Solicitation of Transactions. (a) The Company agrees that (i) the Company and its Subsidiaries shall not, and (ii) the Company and its Subsidiaries shall cause their officers and directors not to, and use reasonable best efforts to cause their employees not to, and direct their respective Representatives not to (and use reasonable best efforts to ensure that their respective Representatives not), directly or indirectly, (A) solicit, initiate or knowingly encourage, induce or facilitate the making of any proposal that constitutes or is reasonably likely to lead to a Takeover Proposal (other than contacting or engaging in discussions with the Person making a Takeover Proposal or its Representatives for the sole purpose of clarifying such Takeover Proposal), (B) enter into, continue or otherwise participate in any discussions or negotiations regarding, or furnish to any Person any of the Company\u2019s or its Subsidiaries\u2019 confidential information with respect to, any Takeover Proposal, (C) enter into any Takeover Proposal Documentation with respect to a Takeover Proposal or (D) fail to enforce, or grant any waiver under, any standstill or similar agreement with any Person (unless, and only to the extent, the Company Board of Directors determines, after consultation with its outside counsel, that enforcement or failure to grant a waiver would be inconsistent with its fiduciary duties of directors under Indiana Law, in which case it may enable such Persons to confidentially submit a Takeover Proposal to the Company Board of Directors).  The Company shall, shall cause its Subsidiaries to, and shall direct its Representatives to, immediately cease and cause to be terminated all then existing discussions and negotiations with any Person conducted theretofore with respect to any Takeover Proposal and terminate all access to nonpublic information of the Company or its Subsidiaries that any such Person may have.  Notwithstanding the foregoing or anything else in this Agreement to the contrary, at any time prior to obtaining the Company Required Vote, in response to a bona fide written Takeover Proposal received after the date of this Agreement that did not arise in whole or part due to a material breach of this Section 6.06, if the Company Board of Directors determines, after consultation with its financial advisor and outside counsel, that such Takeover Proposal constitutes or would reasonably be expected to lead to a Superior Proposal, the Company may (and may authorize and permit its Subsidiaries and Representatives to), subject to compliance with Section 6.06(c) and only prior to obtaining the Company Required Vote, (x) furnish information with respect to the Company and its Subsidiaries to the Person making such Takeover Proposal (and its Representatives) pursuant to a confidentiality agreement containing confidentiality provisions no more favorable in the aggregate to such Person than those contained in the Company Confidentiality Agreement (it being understood that such confidentiality agreement need not prohibit the making or amendment of a Takeover Proposal); provided that all material information provided to such Person has previously been provided or made available to Parent or is provided to Parent prior to or substantially concurrently with the time it is provided to such Person (which nonpublic information shall, for the avoidance of doubt, be subject to the Company Confidentiality Agreement and may, in order to comply with applicable Law, be restricted to certain designated Representatives of Parent), and (y) participate in discussions and negotiations with the Person making such Takeover Proposal (and its Representatives) regarding such Takeover Proposal. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    168034,
                    168084
                ],
                "answer": "Section 6.06 No Solicitation of Transactions. (a) "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    169982,
                    171775
                ],
                "answer": "Notwithstanding the foregoing or anything else in this Agreement to the contrary, at any time prior to obtaining the Company Required Vote, in response to a bona fide written Takeover Proposal received after the date of this Agreement that did not arise in whole or part due to a material breach of this Section 6.06, if the Company Board of Directors determines, after consultation with its financial advisor and outside counsel, that such Takeover Proposal constitutes or would reasonably be expected to lead to a Superior Proposal, the Company may (and may authorize and permit its Subsidiaries and Representatives to), subject to compliance with Section 6.06(c) and only prior to obtaining the Company Required Vote, (x) furnish information with respect to the Company and its Subsidiaries to the Person making such Takeover Proposal (and its Representatives) pursuant to a confidentiality agreement containing confidentiality provisions no more favorable in the aggregate to such Person than those contained in the Company Confidentiality Agreement (it being understood that such confidentiality agreement need not prohibit the making or amendment of a Takeover Proposal); provided that all material information provided to such Person has previously been provided or made available to Parent or is provided to Parent prior to or substantially concurrently with the time it is provided to such Person (which nonpublic information shall, for the avoidance of doubt, be subject to the Company Confidentiality Agreement and may, in order to comply with applicable Law, be restricted to certain designated Representatives of Parent), and (y) participate in discussions and negotiations with the Person making such Takeover Proposal (and its Representatives) regarding such Takeover Proposal. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    35662,
                    36686
                ],
                "answer": "\u201cSuperior Proposal\u201d means a bona fide written Takeover Proposal that did not result from a breach of Section 6.06 and that the Company Board of Directors determines in good faith (after consultation with its financial advisor and outside counsel), considering all financial, legal, regulatory and other factors as the Company Board of Directors considers to be appropriate, is reasonably expected to be consummated and, if consummated, would be more favorable to the shareholders of the Company than the Merger; provided that for the purposes of this definition of \u201cSuperior Proposal,\u201d all references in the term Takeover Proposal to \u201c10% or more\u201d shall be deemed to be references to \u201cmore than 50%,\u201d all references to \u201cCompany Class A Shares, Company Class B Shares or Company Common Shares\u201d shall be deemed references to \u201cCompany Class A Shares, Company Class B Shares and Company Common Shares\u201d and all references to \u201cany class of equity securities\u201d shall be deemed to be references to \u201ceach class of equity securities.\u201d "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    13887,
                    14641
                ],
                "answer": "\u201cChange in Circumstance\u201d means any event or development that is material to the Company and its Subsidiaries, taken as a whole, occurring after the execution and delivery of this Agreement, that was not known to, or reasonably foreseeable by, the Company Board of Directors or any committee thereof prior to the date hereof and which does not relate to (a) a Takeover Proposal or any matter related thereto or consequences thereof, (b) events or developments arising from the announcement or existence of this Agreement or actions taken pursuant to this Agreement or in connection with the transactions contemplated hereby, or (c) changes in the market price or trading volume of the Company Common Shares (but not the underlying cause thereof).\n\n\n\n\n\n\n\n\n"
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    206493,
                    206740
                ],
                "answer": "Section 8.01 Termination.  This Agreement may be terminated and the Merger (and the other transactions contemplated hereby) may be abandoned at any time prior to the Effective Time (notwithstanding if the Company Required Vote has been obtained): "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    207834,
                    208344
                ],
                "answer": "(d) by the Company, prior to the receipt of the Company Required Vote in accordance with Section 6.06(c) in order to substantially concurrently with such termination enter into a binding definitive written agreement to effect a Superior Proposal that did not arise as a result of a material breach of Section 6.06 so long as the Company pays, or causes to be paid, to Parent the Company Termination Fee prior to or substantially concurrently with, and as a condition to the effectiveness of, such termination; "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    211998,
                    212030
                ],
                "answer": "Section 8.02 Fees and Expenses. "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    213181,
                    213218
                ],
                "answer": "(ii) If this Agreement is terminated "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    214300,
                    215584
                ],
                "answer": "(B) within twelve (12) months of such termination, the Company either consummates such Takeover Proposal or enters into a definitive agreement to consummate such Takeover Proposal and the Company thereafter consummates such Takeover Proposal (whether or not within such twelve (12) month period), then the Company shall pay Parent, as liquidated damages and not as a penalty, the Company Termination Fee; provided that for the purposes of this Section 8.02(b)(ii), all references in the term Takeover Proposal to \u201c10% or more\u201d shall be deemed to be references to \u201cmore than 50%.\u201d  If the Company Termination Fee is payable, the Company Termination Fee shall be paid upon the consummation of such Takeover Proposal by wire transfer of immediately available funds to an account designated by Parent in writing.  For purposes of clause (A) of this Section 8.02(b)(ii), any Takeover Proposal deemed to have been made pursuant to the Amended and Restated Stockholder Support and Contingent Sale Agreement, dated as of August 17, 2020, by and among certain of the Company\u2019s shareholders and the other parties thereto will be considered to have been withdrawn absent subsequent action on or after the date of this Agreement by any party thereto that would constitute a Takeover Proposal. \n\n\n"
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What happens during a Breach of No-Shop clause",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    168034,
                    168080
                ],
                "answer": "Section 6.06 No Solicitation of Transactions. "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    206493,
                    206553
                ],
                "answer": "Section 8.01 Termination.  This Agreement may be terminated "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    208344,
                    208413
                ],
                "answer": "(e) by Parent, prior to the receipt of the Company Required Vote, if "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    208500,
                    208925
                ],
                "answer": "(ii) the Company shall have Willfully Breached its obligations or agreements in Section 6.06 (provided that for purposes of this Section 8.01(e)(ii), a Willful Breach by any Representative of the Company of clauses (A) and (B) of Section 6.06 (treating each such Representative as being bound to such covenant in the same manner as the Company as a direct party thereto) shall be deemed to be a Willful Breach of the Company)"
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    211998,
                    212030
                ],
                "answer": "Section 8.02 Fees and Expenses. "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    212466,
                    212699
                ],
                "answer": "(i) If this Agreement is terminated (A) by the Company pursuant to Section 8.01(d) or (B) by Parent pursuant to Section 8.01(e), the Company shall pay Parent, as liquidated damages and not as a penalty, the Company Termination Fee.  "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    45603,
                    45785
                ],
                "answer": "(g) References to the \u201cordinary course of business\u201d shall mean any action taken by the Company that is generally consistent with the usual customs and past practices of the Company. "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    140882,
                    141569
                ],
                "answer": "Section 6.01 Conduct of Business by the Company Pending the Merger.  During the period from the date of this Agreement through the earlier of the Closing and the termination of this Agreement, except for any COVID-19 Measures, as expressly permitted or required by this Agreement, as required by applicable Law or Order, as otherwise consented to by Parent in writing (which consent shall not be unreasonably withheld, conditioned or delayed), or as set forth in Section 6.01 of the Company Disclosure Letter, (x) the Company shall and shall cause each of its Subsidiaries to conduct their respective businesses and operations in the ordinary course of business in all material respects "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    154369,
                    155264
                ],
                "answer": "each of Parent and the Company shall, and shall cause their respective Subsidiaries to, use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, and to assist and cooperate with the other parties in doing, all things necessary, proper or advisable to fulfill all conditions applicable to such party pursuant to this Agreement and to consummate and make effective, as promptly as practicable, the Merger and the other transactions contemplated hereby, including (i) obtaining all necessary, proper or advisable consents, approvals, authorizations or waivers from Governmental Authorities and making all necessary, proper or advisable registrations, filings and notices and taking all steps as may be necessary to obtain a consent, approval, authorization or waiver from any Governmental Authority (including under Insurance Laws and the HSR Act) "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    10485,
                    13604
                ],
                "answer": "\u201cBurdensome Condition\u201d means a condition that Parent or any of its Subsidiaries (including the Surviving Corporation and its Subsidiaries after the Closing) take or refrain from taking any action (including any amendment, waiver or termination of any material agreement, including this Agreement) or suffer to exist any restriction, condition or requirement which (i) is imposed by an Insurance Regulator and would require Parent or any of its Subsidiaries to agree to any material operational restriction on its business or any restriction on the payment of dividends (other than restrictions on dividends imposed by applicable Indiana insurance Laws or any incremental limitation on dividends or distributions specifically imposed by an Insurance Regulator with a duration of two (2) years or less following the Closing), (ii) is imposed by a Governmental Authority and would require Parent or any of its Subsidiaries to make any divestiture or disposition, discontinue or license any portion of its business or assets, to accept or enter into any hold separate order or consent decree or to place any assets in trust (other than any that relates to the Company and its Subsidiaries and would not be material to the Company and its Subsidiaries, taken as a whole), (iii) is imposed by an Insurance Regulator and would require Parent or any of its Subsidiaries to make any capital commitment or capital guarantee or keep well or similar capital maintenance undertaking, in each case that would be material relative to Parent and its Subsidiaries, taken as a whole (with \u201cmaterial\u201d for this purpose measured relative to the size of the Company and its Subsidiaries, taken as a whole), as a result of the transactions contemplated by this Agreement or (iv) individually or in the aggregate has or would reasonably be likely to have a material adverse effect on the Company and its Subsidiaries, taken as a whole, as a result of the transactions contemplated by this Agreement; provided that none of the following shall constitute or be taken into account in determining whether a Burdensome Condition has occurred or exists: (A) any proposed changes to the business and operations of the Company and its Subsidiaries by Parent or its Subsidiaries or (B) other than for purposes of clause (ii) above, the identity of Parent and its Subsidiaries.  Prior to Parent being entitled to invoke a Burdensome Condition, each of the parties and their respective Representatives shall promptly confer in good faith in order to (x) exchange and review their respective views and positions as to any Burdensome Condition or potential Burdensome Condition and (y) discuss and present to, and engage with, the applicable Governmental Authority regarding any approaches or actions that would avoid any actual Burdensome Condition or mitigate its impact so it is no longer a Burdensome Condition, and Parent shall use its reasonable best efforts to take, or cause to be take, any such actions in respect thereof which may mitigate a Burdensome Condition (other than any actions which themselves would constitute a Burdensome Condition). "
            },
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    161186,
                    162093
                ],
                "answer": "Notwithstanding anything to the contrary contained in this Agreement, in no event shall Parent or its Subsidiaries be required to (i) initiate litigation or an appeal process in any court or administrative or other tribunal against any Governmental Authority in order to prevent the entry of, and have vacated, lifted, reversed or overturned, any Order that would prevent, prohibit, restrict or delay the consummation of the Merger (provided that Parent shall, and shall cause its Subsidiaries to, use reasonable best efforts to defend on the merits any claim, cause of action, proceeding or litigation in any court or administrative or other tribunal initiated by any Governmental Authority in order to prevent the entry of, and have vacated, lifted, reversed or overturned, any Order that would prevent, prohibit, restrict or delay the consummation of the Merger) or (ii) agree to a Burdensome Condition. "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"The Progressive Corporation\" and Target \"Protective Insurance Corporation\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Protective Insurance Corporation_The Progressive Corporation.txt",
                "span": [
                    230106,
                    230930
                ],
                "answer": "Section 9.10 Specific Performance.  The parties agree that irreparable damage would occur and that the parties would not have an adequate remedy at law in the event that any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached and that money damages would not be an adequate remedy for any such failure to perform or breach.  The parties accordingly agree that, without posting a bond or other undertaking, the parties (or any of them) shall be entitled to injunctive or other equitable relief to prevent a breach or breaches of this Agreement or to enforce specifically the terms and provisions of this Agreement in addition to and without precluding or otherwise rendering unavailable any other remedy to which they are or could be entitled at law or in equity.  "
            }
        ],
        "file_set": [
            "Protective Insurance Corporation_The Progressive Corporation.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    12534,
                    13342
                ],
                "answer": "1.4 Conversion of Stock At the Effective Time, by virtue of the Merger and without any action on the part of the Company or Parent or the shareholders of any of the foregoing: \n\n\n(a) Company Common Stock. Each share of Company Common Stock excluding Treasury Shares, issued and outstanding immediately prior to the Effective Time shall be converted into the right to receive a number of shares of Parent Common Stock equal to the Exchange Ratio, subject to any adjustments pursuant to Sections 1.4(f)(ii) and 8.1(e) (the \u201cMerger Consideration\u201d) and subject to the payment of any cash in lieu of fractional shares pursuant to Section 2.2(f). At the Effective Time, all shares of Company Common Stock shall no longer be outstanding and shall automatically be cancelled and retired and shall cease to exist. \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    223324,
                    223533
                ],
                "answer": "7.2 Conditions to Obligations of Parent. The obligation of Parent to effect the Merger is also subject to the satisfaction, or waiver by Parent, at or prior to the Effective Time, of the following conditions: "
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    225445,
                    225822
                ],
                "answer": "(b) Performance of Obligations of Company. The Company shall have performed in all material respects all obligations required to be performed by it under this Agreement at or prior to the Effective Time; and Parent shall have received a certificate signed on behalf of the Company by the Chief Executive Officer or the Chief Financial Officer of the Company to such effect. \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    58500,
                    61255
                ],
                "answer": "As used in this Agreement, the term \u201cMaterial Adverse Effect\u201d means, with respect to any party, a material adverse effect on (a) the business, assets or deposit liabilities, properties, operations, condition (financial or otherwise), or results of operations of such party and its Subsidiaries, taken as a whole or (b) the ability of such party to consummate the transactions contemplated by this Agreement on a timely basis and in any event on or before the End Date; provided, however, that, with respect to clause (a) only, a Material Adverse Effect shall not be deemed to include Effects to the extent arising out of, relating to or resulting from (A) changes after the date hereof in applicable GAAP or regulatory accounting requirements generally affecting other companies in the banking industries in which such party and its Subsidiaries operate, (B) changes after the date hereof in Laws of general applicability to companies of similar size in the banking industries in which such party and its Subsidiaries operate or interpretations thereof, (C) changes after the date hereof in global, national or regional political conditions or general economic or market conditions (including changes in prevailing interest rates, credit availability and liquidity, currency exchange rates, and price levels or trading volumes in the United States or foreign securities markets) affecting financial institutions generally, (D) changes after the date hereof in the credit markets, any downgrades in the credit markets, or adverse credit events resulting in deterioration in the credit markets generally and not specifically relating to such party or its Subsidiaries, (E) a decline in the trading price of a party\u2019s common stock or a failure, in and of itself, to meet earnings projections, but not, in either case, including any underlying causes thereof, (F) the entry into or announcement of this Agreement or the transactions contemplated hereby or the consummation of the transactions contemplated hereby, (G) any outbreak or escalation of hostilities, declared or undeclared acts of war or terrorism or (H) actions or omissions taken with the prior written consent of the other party or expressly required by this Agreement; provided, further, that any Effect attributable to or resulting from any of the changes, events, conditions or trends described in clauses (A), (B), (C), (D), (E) and (G) may constitute, and may be taken into account in determining the occurrence of, a Material Adverse Effect if and only to the extent they have a disproportionate adverse impact on such party and its Subsidiaries, taken as a whole, as compared to other companies of similar size in the banking industry in which such party and its Subsidiaries operate. \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    248043,
                    248226
                ],
                "answer": "the phrase \u201cKnowledge of the Company\u201d means the actual knowledge, after reasonable inquiry, of any of the Company\u2019s officers listed on Section 9.4 of the Company Disclosure Schedule, "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    200147,
                    200869
                ],
                "answer": "6.9 No Solicitation; Change in Company Board Recommendation. \n\n\n(a) The Company agrees that none of it or any of its Subsidiaries or any of their respective officers, directors and employees will, and will cause its and its Subsidiaries\u2019 officers, directors, agents, representatives, advisors and Affiliates not to, initiate, solicit, encourage or knowingly facilitate any inquiries or the making of proposals with respect to, or engage in any negotiations concerning, or provide any confidential or nonpublic information or data to, or have any discussions with, any Person relating to, any Company Acquisition Proposal or otherwise facilitate any effort to attempt or make or implement a Company Acquisition Proposal.   "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    200147,
                    200211
                ],
                "answer": "6.9 No Solicitation; Change in Company Board Recommendation. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    200901,
                    204122
                ],
                "answer": "(b) Notwithstanding anything to the contrary contained in this Agreement, if at any time after the date hereof and prior to, but not after, obtaining the Company Shareholder Approval the Company receives an unsolicited bona fide Company Acquisition Proposal and the Company Board concludes in good faith that such Company Acquisition Proposal constitutes, or is reasonably expected to result in, a Company Superior Proposal, then the Company and the Company Board may, and may permit its Subsidiaries and its and its Subsidiaries\u2019 representatives to, furnish or cause to be furnished nonpublic information and participate in such negotiations or discussions to the extent that the Company Board concludes in good faith (after consultation with outside legal counsel) that failure to take such actions would reasonably be expected to result in a violation of its fiduciary duties under applicable Law; provided that prior to providing any nonpublic information permitted to be provided pursuant to the foregoing proviso or engaging in any negotiations, it shall have entered into a confidentiality agreement with such third party on terms no less restrictive in the aggregate to the counterparty than those contained in the Confidentiality Agreement and which expressly permits the Company to comply with its obligations pursuant to this Section 6.9. Subject to the foregoing and Section 6.9(c) below, the Company will immediately cease and cause to be terminated any activities, discussions or negotiations conducted on or before the date of this Agreement with any persons other than Parent with respect to any Company Acquisition Proposal and will use its reasonable best efforts, subject to applicable Law, to (i) enforce any confidentiality or similar agreement relating to a Company Acquisition Proposal and (ii) within ten (10) Business Days after the date hereof, request and confirm the return or destruction of any confidential information provided to any Person (other than Parent and its Affiliates) pursuant to any such confidentiality or similar agreement. The Company will promptly (and in any event within twenty-four (24) hours) advise Parent following receipt of any Company Acquisition Proposal, of any discussions or negotiations that are sought to be initiated or continued or any request for nonpublic information or inquiry that would reasonably be expected to lead to any Company Acquisition Proposal and the substance thereof (including the identity of the Person making such Company Acquisition Proposal), and will keep Parent promptly apprised of any related developments, discussions and negotiations (including the terms and conditions of any such request, inquiry or Company Acquisition Proposal, or all amendments or proposed amendments thereto) on a current basis (it being understood that no such communications to Parent shall be deemed a Company Adverse Change of Recommendation). The Company agrees that it shall contemporaneously provide to Parent any confidential or nonpublic information concerning the Company or any of its Subsidiaries that may be provided to any other Person in connection with any Company Acquisition Proposal which has not previously been provided to Parent.   "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    207389,
                    209365
                ],
                "answer": "As used in this Agreement, \u201cCompany Acquisition Proposal\u201d means a tender or exchange offer, proposal for a merger, consolidation, sale of assets or other business combination involving the Company or any of its Subsidiaries or any proposal or offer to acquire in any manner more than 15% of the voting power in, or more than 15% of the fair market value of the business, assets or deposits of, the Company or any of its Subsidiaries or any public announcement of a proposed plan or intention to do any of the foregoing or any agreements to engage in any of the foregoing, other than the transactions contemplated by this Agreement and any sale of whole loans and securitizations in the ordinary course. As used in this Agreement, \u201cCompany Superior Proposal\u201d means an unsolicited bona fide written Company Acquisition Proposal that the Company Board concludes in good faith to be more favorable from a financial point of view to its shareholders than the Merger and the other transactions contemplated hereby and to be reasonably capable of being consummated on the terms proposed, (i) after receiving the advice of its financial advisors (who shall be a nationally recognized investment banking or financial advisory firm), (ii) after taking into account the likelihood of consummation of such transaction on the terms set forth therein and (iii) after taking into account all legal (with the advice of counsel), financial (including the financing terms of any such proposal), regulatory and other aspects of such proposal (including any expense reimbursement provisions and conditions to closing) and any other relevant factors permitted under applicable Law, and after taking into account any amendment or modification to this Agreement agreed to by Parent; provided that for purposes of the definition of \u201cCompany Superior Proposal,\u201d the references to \u201cmore than 15%\u201d in the definition of Company Acquisition Proposal shall be deemed to be references to \u201cat least 50%.\u201d \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    231216,
                    231479
                ],
                "answer": "8.1 Termination. This Agreement may be terminated at any time prior to the Effective Time, whether before or after approval of the matters presented in connection with the Merger by the shareholders of the Company or Parent (except as otherwise set forth below): "
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    235974,
                    236416
                ],
                "answer": "(d) Company Superior Proposal\u2014by the Company, prior to such time as the Company Shareholder Approval is obtained, in order to enter into a definitive agreement providing for a Company Superior Proposal; provided that (i) the Company is not in material breach of any of the terms of this Agreement, and (ii) the Company Termination Fee is paid to Parent in advance of or concurrently with such termination in accordance with Section 8.3(b);   "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    239462,
                    239488
                ],
                "answer": "8.3 Fees and Expenses. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    240489,
                    241779
                ],
                "answer": "(ii) In the event that any Person shall have made a Company Acquisition Proposal, which proposal has been publicly announced, disclosed or proposed and not withdrawn, and: (1) thereafter this Agreement is terminated: (a) by either party pursuant to Section 8.1(b)(ii) (Delay), or Section 8.1(b)(iv) (No Shareholder Approval); or (b) by Parent pursuant to Section 8.1(b)(iii) (Breach); and (2) within twelve (12) months after such termination of this Agreement, a Company Acquisition Proposal shall have been consummated or any definitive agreement with respect to a Company Acquisition Proposal shall have been entered into (provided that for purposes of the foregoing, the term \u201cCompany Acquisition Proposal\u201d shall have the meaning assigned to such term in Section 6.9(d) except that the references to \u201cmore than 15%\u201d in the definition of Company Acquisition Proposal shall be deemed to be references to \u201cat least 50%\u201d); then the Company shall pay Parent the Company Termination Fee by wire transfer to an account specified by Parent prior to the earlier of the execution of a definitive agreement with respect to, or the consummation of, such Company Acquisition Proposal. In no event shall the Company be obligated to pay Parent the Company Termination Fee on more than one occasion. \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What happens during a Breach of No-Shop clause",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    200147,
                    200211
                ],
                "answer": "6.9 No Solicitation; Change in Company Board Recommendation. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    231216,
                    231266
                ],
                "answer": "8.1 Termination. This Agreement may be terminated "
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    234523,
                    234732
                ],
                "answer": "(c) No Company Recommendation \u2013 by Parent, at any time prior to such time as the Company Shareholder Approval is obtained, in the event (i) the Company shall have breached in any material respect Section 6.9; "
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    239462,
                    239488
                ],
                "answer": "8.3 Fees and Expenses. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    239893,
                    240489
                ],
                "answer": "(b) Company Termination Fee. (i) In the event that this Agreement is terminated by the Company pursuant to Section 8.1(d) (Company Superior Proposal) or Parent pursuant to Section 8.1(c) (No Company Recommendation), then the Company shall pay Parent a fee, in immediately available funds, in the amount of $12,000,000 (the \u201cCompany Termination Fee\u201d) by wire transfer to an account specified by Parent promptly, but in any event prior to or concurrently with a termination pursuant to Section 8.1(d) or no later than two (2) Business Days after the date of termination pursuant to Section 8.1(c). "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    159220,
                    159689
                ],
                "answer": "5.1 Conduct of Businesses Prior to the Effective Time. Except as Previously Disclosed, as expressly contemplated by or permitted by this Agreement, as required by applicable Law, or with the prior written consent of Parent, during the period from the date of this Agreement to the Effective Time, (a) the Company shall, and shall cause each of its Subsidiaries to, (i) conduct its business in the ordinary course consistent with past practice in all material respects, "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    174845,
                    174872
                ],
                "answer": "6.1 Regulatory Matters. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    175898,
                    176583
                ],
                "answer": "(b) The parties shall reasonably cooperate with each other and use their respective commercially reasonable efforts to promptly prepare all necessary documentation, to effect all applications, notices, petitions and filings, to obtain as promptly as practicable all permits, consents, approvals and authorizations of all third parties and Governmental Entities that are necessary or advisable to consummate the Merger, the Bank Merger and the other transactions contemplated by this Agreement as soon as reasonably practicable, and to comply with the terms and conditions of all such permits, consents, approvals, and authorizations of all such third parties or Governmental Entities. "
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    174845,
                    174872
                ],
                "answer": "6.1 Regulatory Matters. \n\n\n"
            },
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    180438,
                    181489
                ],
                "answer": "(d) Notwithstanding the foregoing, nothing contained herein shall be deemed to require Parent or any of its Subsidiaries to take any action, or commit to take any action, or agree to any condition or restriction, in connection with obtaining the foregoing permits, consents, approvals and authorizations of Governmental Entities that would reasonably be likely, in each case following the Effective Time (but regardless when the action, condition or restriction is to be taken or implemented), to have a Material Adverse Effect on Parent (measured on a scale relative to the Company) or a Material Adverse Effect on the Company or materially restrict or impose a material burden on Parent or any of its Subsidiaries (including, after the Effective Time, the Company and its Subsidiaries) in connection with the transactions contemplated hereby or with respect to the business or operation of Parent or any of its Subsidiaries (including, after the Effective Time, the Company and its Subsidiaries) (a \u201cMaterially Burdensome Regulatory Condition\u201d). \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Columbia Banking System, Inc.\" and Target \"Bank of Commerce Holdings\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Bank of Commerce Holdings_Columbia Banking System, Inc..txt",
                "span": [
                    255141,
                    255543
                ],
                "answer": "9.11 Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at Law or equity. \n\n\n"
            }
        ],
        "file_set": [
            "Bank of Commerce Holdings_Columbia Banking System, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    27281,
                    27853
                ],
                "answer": "\u201cPer Share Stock Consideration\u201d means 0.7971 shares of GBCI Common Stock, which is subject to adjustment pursuant to Sections 7.2.2 and 7.3.2, and subject to further adjustment by an amount per share equal to the Stock Consideration Per Share Adjustment Amount, if any, pursuant to Section 4.15.2. Further, if GBCI declares or effects a stock dividend, reclassification, recapitalization, split-up, combination, exchange of shares or similar transaction between the Execution Date and the Effective Date, the Per Share Stock Consideration will be adjusted accordingly. \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    35558,
                    35896
                ],
                "answer": "1.2.2 Outstanding AB Stock. Each share of AB Stock issued and outstanding as of the Effective Time will be converted into and represent the right to receive from GBCI in accordance with Section 1.6 (a) the Per Share Stock Consideration and (b) any cash in lieu of fractional shares of GBCI Common Stock in accordance with Section 1.3. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    174246,
                    174441
                ],
                "answer": "5.2 Conditions to Obligations of GBCI. The obligations of GBCI to consummate the Merger are subject to satisfaction or written waiver by GBCI of the following conditions at or before Closing: \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    176164,
                    176511
                ],
                "answer": "5.2.2 Compliance. AB will have performed and complied, and will have caused the Bank to perform and comply, in all material respects with all terms, covenants and conditions of this Agreement on or before Closing. AB will have delivered to GBCI a certificate to that effect, executed by a duly authorized officer of AB and dated as of Closing. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Information about the Closing Condition: No Litigation clause",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    174246,
                    174441
                ],
                "answer": "5.2 Conditions to Obligations of GBCI. The obligations of GBCI to consummate the Merger are subject to satisfaction or written waiver by GBCI of the following conditions at or before Closing: \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    177537,
                    177711
                ],
                "answer": "5.2.6 No Legal Proceedings. No action or proceeding will have been commenced or threatened by any Governmental Authority to restrain or prohibit or invalidate the Merger. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    22731,
                    25861
                ],
                "answer": "\u201cMaterial Adverse Effect\u201d with respect to a Person means an effect that: (a) is materially adverse to the business, financial condition or results of operations of the Person and its Subsidiaries taken as a whole; or (b) materially and adversely affects the ability of the Person to consummate the Merger on or by the Termination Date or to perform its material obligations under this Agreement; provided, however, that a Material Adverse Effect shall not be deemed to include the impact of or be deemed to occur as a result of, either alone or in combination, any effects to the extent attributable to: (i) any changes in Laws or other changes affecting depository institutions generally; (ii) any changes to GAAP or regulatory accounting requirements; (iii) any changes in general economic conditions; (iv) any changes in prevailing interest and deposit rates, or changes in financial, securities or credit markets; (v) any changes in national or international political or social conditions, including any outbreak or escalation of major hostilities or acts of terrorism which involves the United States, declarations of any national or global epidemic, pandemic or disease outbreak (including the Covid-19 virus), or the material worsening of such conditions threatened or existing as of the date of this Agreement; (vi) any modifications or changes to valuation policies and practices in connection with the Transactions or restructuring charges taken in connection with the Transactions, in each case in accordance with GAAP; (vii) (A) any actions taken or not taken or (B) modifications or changes made, or failure to make modifications or changes, by AB or the Bank to AB\u2019s or the Bank\u2019s general business, practices or policies, in each case, at the request of GBCI; (viii) the impact of the public announcement of, pendency of or completion of the Transactions on relationships with customers and employees; (ix) any failure, in and of itself, to meet internal projections or forecasts (except that the facts or circumstances giving rise or contributing to such failure may nonetheless constitute, or be taken into account in determining whether there has been, a Material Adverse Effect); (x) any actions or omissions of a party taken with the prior consent of the other, or which have been waived in writing by the other party, or in contemplation of the Transactions as required or permitted hereunder, or as required under any regulatory approval received in connection with the Transactions; or (xi) any changes in the trading price or trading volume of securities of such Person on the NASDAQ Global Select Market or NASDAQ Capital Market (except that the facts or circumstances giving rise or contributing to such failure may nonetheless constitute, or be taken into account in determining whether there has been, a Material Adverse Effect), as applicable, or any other securities trading market, except, in the case of clauses (i), (ii), (iii), (iv), and (v), to the extent such event does not have a materially more adverse effect on such party than experienced by similarly situated depository institutions. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    20116,
                    20641
                ],
                "answer": "\u201cKnowledge\u201d or any similar knowledge qualification in this Agreement has the following meanings: (a) AB will be deemed to have \u201cKnowledge\u201d of a particular fact or matter if any Executive Officer of AB or the Bank has actual knowledge of such fact or matter or if any such Person would reasonably be expected to discover or otherwise become aware of such fact or matter in the course of making a reasonable inquiry into such areas of AB\u2019s and the Bank\u2019s business that are under such individual\u2019s general area of responsibility"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    142263,
                    145881
                ],
                "answer": "4.1.9 Acquisition Proposal. AB and the Bank will immediately cease and cause to be terminated any existing activities, discussions or negotiations with any Persons conducted heretofore with respect to any Acquisition Proposal. AB agrees that neither it nor any of its Subsidiaries will, and AB will direct and use its commercially reasonable efforts to cause its and its Subsidiaries\u2019 directors, officers, employees, agents and representatives (including, without limitation, any investment banker, attorney or accountant retained by it or any of its Subsidiaries) not to initiate, solicit, encourage or take any other action to facilitate any inquiries or the making of any proposal or offer (including, without limitation, any proposal or offer to shareholders of AB) with respect to an Acquisition Event (any such proposal or offer, an \u201cAcquisition Proposal\u201d) or engage in any negotiations concerning, or provide any confidential information or data to, or have any discussions with, any Person relating to an Acquisition Proposal, or otherwise facilitate any effort or attempt to make or implement an Acquisition Proposal; except that, in the event AB receives an unsolicited bona fide Acquisition Proposal and the board of directors of AB determines prior to approval of this Agreement and the Merger by AB\u2019s shareholders at the AB Meeting, in good faith and after consultation with independent legal counsel, that (a) such Acquisition Proposal constitutes or is reasonably expected to result in a Superior Proposal, and (b) fiduciary duties applicable to it require it to engage in negotiations with, provide confidential information or data to, or have any discussions with a Person in connection with such Acquisition Proposal, AB may do so to the extent the board of directors of AB determines it is required by its fiduciary duties. In such event, prior to providing any confidential information or data to any such Person, AB and such Person shall have executed a confidentiality agreement on terms at least as favorable to AB as those contained in the Confidentiality Agreement. AB will further notify GBCI in writing promptly (and in any event within two Business Days) if any such inquiries or proposals are received by, any such information is requested from, or any such negotiations or discussions are sought to be initiated or continued with AB, or if any such inquiry, proposal or request is thereafter materially modified or amended, including providing to GBCI the material terms and conditions of any such proposal or inquiry in connection with each required notice, together with a copy of any written proposals received (it being understood that the name of Person making the Acquisition Proposal may be redacted from the copy of the written proposal provided to GBCI). AB will take the necessary steps to inform the appropriate individuals or entities referred to in the second sentence of this Section 4.1.9 of the obligations to be undertaken in this Section 4.1.9. Nothing contained in this Section 4.1.9 shall prohibit AB or the board of directors of AB from complying with AB\u2019s obligations required under Rule 14e-2(a) promulgated under the Exchange Act; provided, however, that any such disclosure relating to an Acquisition Proposal (other than a \u201cstop, look and listen\u201d or similar communication of the type contemplated by Rule 14d-9(f) under the Exchange Act) shall be deemed a change in the board of directors of AB\u2019s recommendation that AB\u2019s shareholders approve this Agreement and the Merger unless the board of directors of AB reaffirms such recommendation in such disclosure. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    142263,
                    142291
                ],
                "answer": "4.1.9 Acquisition Proposal. "
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    143390,
                    144106
                ],
                "answer": "except that, in the event AB receives an unsolicited bona fide Acquisition Proposal and the board of directors of AB determines prior to approval of this Agreement and the Merger by AB\u2019s shareholders at the AB Meeting, in good faith and after consultation with independent legal counsel, that (a) such Acquisition Proposal constitutes or is reasonably expected to result in a Superior Proposal, and (b) fiduciary duties applicable to it require it to engage in negotiations with, provide confidential information or data to, or have any discussions with a Person in connection with such Acquisition Proposal, AB may do so to the extent the board of directors of AB determines it is required by its fiduciary duties. "
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    11384,
                    12360
                ],
                "answer": "\u201cAcquisition Event\u201d means any of the following: (a) a merger, consolidation, share exchange, or similar transaction involving AB, the Bank, or any successor, (b) a purchase or other acquisition in one or a series of related transactions of assets of AB or any AB Subsidiaries representing 25 percent or more of the consolidated assets of AB and its Subsidiaries, or 25 percent or more of any class of equity or voting securities of AB or any AB Subsidiaries whose assets constitute 25 percent or more of the consolidated assets of AB and its Subsidiaries, or (c) a purchase or other acquisition (including by way of tender offer, exchange offer, or any similar transaction) that if consummated, would result in an acquisition in one or a series of related transactions of beneficial ownership of securities representing 50 percent or more of the voting power of AB or its Subsidiaries, in each case with or by a Person or entity other than GBCI or one of its Subsidiaries. \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    30933,
                    31715
                ],
                "answer": "\u201cSuperior Proposal\u201d means, with respect to AB and/or the Bank, any Acquisition Proposal that the board of directors of AB in good faith concludes (after consultation with its financial advisors and outside counsel, and after taking into account, among other things, the terms and conditions of this Agreement (as it may be proposed to be amended by GBCI) and all legal, financial, regulatory, and other aspects of the proposal and the Person making the proposal), (a) would, if consummated, result in a transaction that is more favorable to AB shareholders (in their capacities as shareholders), from a financial point of view, than the transactions contemplated by this Agreement (as it may be proposed to be amended by GBCI), and (b) is reasonably probable of being completed. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    195598,
                    195923
                ],
                "answer": "7.4 Other Grounds for Termination. This Agreement and the Merger may be terminated at any time before Closing (whether before or after applicable approval of this Agreement by AB\u2019s shareholders, unless otherwise provided) by AB (on behalf of itself and the Bank) or GBCI (on behalf of itself and Glacier Bank) as follows: \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    200293,
                    201593
                ],
                "answer": "7.4.6 Superior Proposal\u2014Termination by AB. By the board of directors of AB upon written notice to GBCI if AB\u2019s board of directors has in good faith determined that an Acquisition Proposal received by AB constitutes a Superior Proposal; provided, however, that AB may not terminate this Agreement pursuant to this Section 7.4.6 unless (a) it has not materially breached Section 4.1.9 or Section 4.3.2, (b) promptly following the delivery of such notice of termination, it enters into a definitive acquisition agreement relating to such Superior Proposal, (c) it has provided GBCI at least 10 days\u2019 prior written notice advising GBCI that the board of directors of AB is prepared to accept a Superior Proposal (the \u201cSuperior Proposal Notice Period\u201d) and has given GBCI, if it so elects, an opportunity to amend the terms of this Agreement during the Superior Proposal Notice Period (and negotiated with GBCI in good faith with respect to such terms during the Superior Proposal Notice Period) in such a manner as would enable AB\u2019s board of directors to proceed with the Merger without violating their fiduciary duties, and (d) simultaneously upon entering into such definitive acquisition agreement relating to such Superior Proposal referred to in clause (b), it delivers to GBCI the Break-Up Fee. \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    201719,
                    201769
                ],
                "answer": "7.5 Break-Up Fee. If this Agreement is terminated "
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    202051,
                    202378
                ],
                "answer": "within 18 months after such termination, AB or the Bank enters into an agreement, or publicly announces an intention, to engage in an Acquisition Event, or within 18 months after such termination an Acquisition Event occurs, then AB will promptly following such entry, announcement, or occurrence pay to GBCI the Break-Up Fee. "
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    26490,
                    26862
                ],
                "answer": "\u201cordinary course of business\u201d means an action taken, or omitted to be taken, in the ordinary course of such business in all respects that is materially consistent with past practice, without taking into account the transactions contemplated hereby including the Transactions; provided that \u201cordinary course of business\u201d shall be deemed to include all Covid-19 Actions. \n\n\n"
            },
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    128411,
                    129071
                ],
                "answer": "4.1.2 Ordinary and Usual Course. Without prior written consent of GBCI (which consent shall not be unreasonably withheld, conditioned or delayed under subparagraphs (d), (e), (k), and (o) below), subject to applicable Law and except (y) as set forth on Schedule 4.1.2 and (z) for Permitted Actions, from the date of this Agreement until the earlier of the Effective Time or an earlier Termination Date, AB and the Bank will use commercially reasonable efforts to conduct their respective businesses only in the ordinary course of business in all material respects and will not do, and AB will not permit any other AB Subsidiary to do, any of the following: \n\n\n"
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    156339,
                    157183
                ],
                "answer": "GBCI and AB will use commercially reasonable efforts to promptly prepare, promptly file (but in any event within 45 days of the Execution Date) and timely effect all documentation, applications, notices, petitions and filings, and to obtain all permits, approvals, consents, authorizations, waivers, clearances and orders of or from the Federal Reserve, the FDIC, the Montana Commissioner and Utah Department of Financial Institutions and any other Governmental Authority, in each case, required to consummate the transactions contemplated by this Agreement, including the Transactions (the \u201cRequisite Regulatory Approvals\u201d), and to comply with the terms and conditions of all Requisite Regulatory Approvals, and to obtain as promptly as practicable all consents of third parties which are necessary or advisable to consummate the Transaction. "
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    171829,
                    172143
                ],
                "answer": "provided that GBCI shall not be required to take any action in furtherance of this Section 4.16 that would be reasonably likely to deprive GBCI of the economic or business benefits of the Transactions in a manner that is material relative to the aggregate economic or business benefits of the Transaction to GBCI. "
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Glacier Bancorp, Inc.\" and \"Altabancorp\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Altabancorp_Glacier Bancorp, Inc..txt",
                "span": [
                    213537,
                    213936
                ],
                "answer": "8.10 Specific Performance. The parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms. It is accordingly agreed that the parties shall be entitled to seek specific performance of the terms hereof, this being in addition to any other remedies to which they are entitled at law or equity. "
            }
        ],
        "file_set": [
            "Altabancorp_Glacier Bancorp, Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    12009,
                    12929
                ],
                "answer": "(iii)             All Other Shares. Each Share that is outstanding immediately prior to the Effective Time (other than (A)  Shares to be cancelled in accordance with Section 1.5(a)(i) and Section 1.5(a)(ii) (collectively, the \u201cCancelled Shares\u201d) and (B) Dissenting Shares) shall be automatically converted into the right to receive an amount, net to the seller in cash, without interest, equal to $12.50 (the \u201cPer Share Merger Consideration\u201d), subject to any required withholding of Taxes. All Shares that have been converted pursuant to this Section 1.5(a)(iii) shall be cancelled automatically and shall be extinguished and cease to exist, and the holders of (1) Shares represented by Company Stock Certificates (as defined below) or (2) Book-Entry Shares shall cease to have any rights with respect to those Shares, other than the right to receive the Per Share Merger Consideration in accordance with Section 1.8.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    219651,
                    219906
                ],
                "answer": "Section 5.2               Additional Parent and Merger Sub Conditions. The obligations of Parent and Merger Sub to consummate the Merger shall be further subject to the satisfaction at or prior to the Effective Time of each of the following conditions:   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    222367,
                    222621
                ],
                "answer": "(b)                Compliance with Agreements and Covenants. The Company shall have performed in all material respects all obligations and agreements contained in this Agreement to be performed or complied with by it prior to or at the Effective Time.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    68790,
                    69122
                ],
                "answer": "Section 2.8               Absence of Certain Changes or Events.   (a)                Since December 31, 2019 through the Agreement Date, no event or events or development or developments have occurred or are occurring that would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    264896,
                    270204
                ],
                "answer": "\u201cCompany Material Adverse Effect\u201d means any Effect that, individually or in the aggregate with all other Effects, is or would reasonably be expected to (A) be materially adverse to the business, financial condition, assets, Liabilities or results of operations of the Company and its Subsidiaries, taken as a whole or (B) prevent or materially delay the consummation of the Transactions past the Outside Date; provided that, solely with respect to the foregoing clause (A), none of the following Effects (and no Effect that directly results from or arises in connection with the following) shall constitute or shall be taken into account in determining whether there is a Company Material Adverse Effect to the extent resulting from or arising out of: (a) changes in or affecting the economies or general business, economic, regulatory or legislative conditions or securities, financial, credit or capital market conditions (including changes generally in prevailing interest rates, currency exchange rates, credit markets or equity price levels, trading volumes or the imposition of new or increased tariffs) anywhere in the world in which the Company and its Subsidiaries operate, (b) changes in the trading volume or trading price of Shares (provided that the facts and circumstances giving rise to such changes in such volume or price may be deemed to constitute, and may be taken into account in determining whether there is, a Company Material Adverse Effect), (c) changes in the industry in which the Company and its Subsidiaries operate, (d) national or international political conditions, acts of war (whether or not declared), the threat, commencement, continuation or escalation of a war, acts of armed hostility, sabotage, terrorism or cyber intrusion, government shutdown or other international or national calamity or any material worsening of such conditions threatened, or existing as of the Agreement Date, (e) changes (or prospective changes) in Law or GAAP (or in the interpretation thereof), (f) any failure by the Company to meet its guidance or any published analyst projections, estimates or expectations of the Company\u2019s past or projected revenue, earnings or other financial performance or results of operations for any period, in and of itself, and any resulting analyst downgrade of the Company\u2019s securities, or any failure by the Company to meet its internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations, in and of itself (provided that the facts and circumstances giving rise to such failures may be deemed to constitute, and may be taken into account in determining whether there is a Company Material Adverse Effect if such facts and circumstances are not otherwise excluded under this definition), (g) any legal or related Proceedings made or brought by any of the current or former Company Stockholders (on their own behalf or on behalf of the Company) against the Company or the Company Board, relating to, in connection with, or arising out of the Merger or the other Transactions, including the Proxy Statement, (h) any Effects directly or indirectly attributable to the execution, announcement or pendency of this Agreement or the anticipated consummation of the Merger (including the identity of, or any facts or circumstances relating to, Parent as the acquirer of the Company), including the impact thereof on relationships, contractual or otherwise, with officers, employees, customers, suppliers, distributors, vendors, licensors, licensees, lenders, investors, Governmental Authorities, subcontractors or partners (including the exercise, or prospective exercise, by any party of rights that arise upon a change of control) (provided, that this clause (h) shall not apply to any representations and warranties set forth in Section 2.4 or the condition set forth in Section 5.2(a) to the extent related thereto), (i) fires, pandemics, epidemics, disease outbreaks, quarantine restrictions, earthquakes, hurricanes, tornadoes or other natural or man-made disaster or any other national or international calamity, crisis or disaster, or any escalation or worsening of any of the foregoing and including any COVID-19 Responses taken in compliance with Section 4.1 and (j) except for the obligations of the Company and its Subsidiaries set forth in the first sentence of Section 4.1, any Effects resulting from or arising out of (i) the failure by the Company or any of its Subsidiaries to take any action expressly prohibited by this Agreement or (ii) any actions taken by the Company or any of its Subsidiaries as expressly required by this Agreement or with the prior written consent, or at the prior written request, of Parent or Merger Sub after disclosure to Parent of all material facts and information; provided that, with respect to clauses (a), (c), (d), (e) and (i), only to the extent such Effect does not adversely affect the Company and its Subsidiaries, taken as a whole, in a disproportionate manner relative to other similarly situated participants in the industry in which the Company and its Subsidiaries operate (in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether there has been a Company Material Adverse Effect).   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    281377,
                    281702
                ],
                "answer": "\u201cknowledge\u201d means, with respect to the Company and with respect to any matter in question, the actual knowledge of the Persons set forth on Schedule A of the Company Disclosure Letter, after reasonable inquiry, and, with respect to Parent, the actual knowledge of any executive officer of Parent, after reasonable inquiry.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    162610,
                    162671
                ],
                "answer": "Section 4.4               No Solicitation of Transactions.   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    166992,
                    168956
                ],
                "answer": "(c)                Notwithstanding anything in this Agreement to the contrary, at any time following the Agreement Date and prior to obtaining the Company Stockholder Approval, in response to a written Acquisition Proposal that did not result from a breach of the terms of this Section 4.4 (a \u201cQualifying Acquisition Proposal\u201d) that the Company Board determines in good faith (after consultation with one or more of its financial advisors and with its outside legal counsel) that such Qualifying Acquisition Proposal constitutes, or could reasonably be expected to result in, a Superior Proposal and that the failure to take the action described in clause (i) or (ii) below would be inconsistent with its fiduciary duties to the Company\u2019s stockholders under applicable Law, the Company and the Company Representatives shall be permitted to (i) furnish to the Person that has made the Qualifying Acquisition Proposal (and such Person\u2019s representatives) information relating to the Company and its Subsidiaries and/or afford access to the business, properties, assets, books, records or other non-public information, or to any personnel, of the Company or any of its Subsidiaries, in each case pursuant to an Acceptable Confidentiality Agreement, provided that the Company shall substantially concurrently provide to Parent any non-public information concerning the Company that is provided to (or given access to) any Person which was not previously provided or made available to Parent and (ii) engage or participate in discussions or negotiations with the Person (or such Person\u2019s representatives) that has made the Qualifying Acquisition Proposal; provided that prior to or concurrently with the Company first taking such actions with respect to a Qualifying Acquisition Proposal as described in clauses (i) or (ii) above, the Company shall provide written notice to Parent of such determination of the Company Board as provided for in this Section 4.4(c).   \n\n\n"
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    289872,
                    290918
                ],
                "answer": "\u201cSuperior Proposal\u201d means any bona fide written Acquisition Proposal that did not result from a violation of Section 4.4, with all of the percentages included in the definition of Acquisition Proposal increased from 15% to 50%, that the Company Board determines in its good faith judgment (after consultation with the Company\u2019s financial advisors and outside legal counsel), and considering such factors as the Company Board considers to be relevant in good faith, to be (a) more favorable to the Company Stockholders from a financial point of view than the Merger and the other Transactions (including any changes to the terms of the Merger and this Agreement proposed by Parent in accordance with Section 4.4(f)) and (b) reasonably capable of being completed in a timely manner in accordance with its terms and for which financing, if a cash transaction (in whole or part), is determined by the Company Board in good faith to be available, in each case, taking into account all financial, regulatory, legal and other aspects of the proposal.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    280021,
                    281328
                ],
                "answer": "\u201cIntervening Event\u201d means any material event or development or material change in circumstances with respect to the Company and its Subsidiaries taken as a whole that, irrespective of when such event, development or change occurred, (a) was not known to the Company Board as of, or prior to, the Agreement Date, or if known or reasonably foreseeable, the magnitude or consequences of which were not known, understood or reasonably foreseeable by the Company Board as of the Agreement Date and (b) does not relate to any Acquisition Inquiry or Acquisition Proposal; provided that (i) in no event shall any action that is taken by Parent or Merger Sub to the extent required by the affirmative covenants set forth in Section 4.4, or the consequences of any such action, constitute an \u201cIntervening Event\u201d, and (ii) in no event shall (x) any change in the market price, trading volume or ratings of any securities or Indebtedness of the Company or any of its Subsidiaries or (y) the Company meeting or exceeding any internal or public financial projections, forecasts, estimates or predictions constitute an Intervening Event; provided, however, that, in each case of the foregoing clauses (x) and (y), the underlying causes thereof may be considered in determining whether an Intervening Event has occurred.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    225094,
                    225281
                ],
                "answer": "Section 6.1               Termination. This Agreement may be validly terminated and the Transactions may be abandoned by action taken or authorized by the terminating Party or Parties:   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    227063,
                    227582
                ],
                "answer": "(e)                By the Company, if prior to obtaining the Company Stockholder Approval, the Company Board (or a duly authorized committee thereof) determines to accept a Superior Proposal and enter into the Alternative Acquisition Agreement, subject to, and in accordance with, the terms and conditions of Section 4.4; provided that such termination shall not be effective unless the Company shall pay the Termination Fee to Parent prior to or concurrently with such termination in accordance with Section 6.2(b);   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    229972,
                    230041
                ],
                "answer": "Section 6.2               Effect of Termination; Termination Fees.   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    231198,
                    231238
                ],
                "answer": "(b)                In the event that:   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    231650,
                    231706
                ],
                "answer": "(ii)               this Agreement is validly terminated "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    232264,
                    232960
                ],
                "answer": "(B) within 12 months after such termination, the Company enters into a definitive Contract with respect to an Acquisition Proposal or consummates an Acquisition Proposal (which need not be the same Acquisition Proposal that was made, announced or publicly known prior to the termination of this Agreement) (provided that for all purposes of this Section 6.2(b)(ii), the term Acquisition Proposal shall have the meaning assigned to such term in Exhibit A, except that the references to \u201c15%\u201d shall be deemed to be references to 50%), then the Company shall pay to Parent the Termination Fee concurrently with entering into a definitive Contract or the consummation of such Acquisition Proposal.   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What happens during a Breach of No-Shop clause",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    162610,
                    162671
                ],
                "answer": "Section 4.4               No Solicitation of Transactions.   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    225094,
                    225281
                ],
                "answer": "Section 6.1               Termination. This Agreement may be validly terminated and the Transactions may be abandoned by action taken or authorized by the terminating Party or Parties:   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    226725,
                    226811
                ],
                "answer": "(d)                By Parent, if prior to obtaining the Company Stockholder Approval, "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    226934,
                    227052
                ],
                "answer": "(ii) the Company shall have committed a material Intentional Breach of any of its obligations under Section 4.4;   \n\n\n"
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    229972,
                    230041
                ],
                "answer": "Section 6.2               Effect of Termination; Termination Fees.   "
            },
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    231198,
                    231650
                ],
                "answer": "(b)                In the event that:   (i)                 this Agreement is validly terminated by Parent pursuant to Section 6.1(d) or by the Company pursuant to Section 6.1(e), then the Company shall pay to Parent prior to or concurrently with such termination, in the case of a termination by the Company, or within two Business Days thereafter, in the case of a termination by Parent, a termination fee of $78.9 million (the \u201cTermination Fee\u201d).   "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    127797,
                    128508
                ],
                "answer": "Section 4.1              Covenants of the Company. Except as expressly provided or permitted herein, set forth in Section 4.1 of the Company Disclosure Letter or consented to in writing by Parent (which consent shall not be unreasonably withheld, conditioned or delayed), during the period commencing on the Agreement Date and ending at the Effective Time or such earlier date as this Agreement may be terminated in accordance with its terms (the \u201cPre-Closing Period\u201d), the Company shall, and shall cause each of its Subsidiaries to (1) act and carry on its business in the ordinary course of business consistent with past practice, except with respect to actions or omissions that constitute COVID-19 Responses"
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    182585,
                    183364
                ],
                "answer": "Subject to Section 4.5(c) and the other terms and conditions of this Agreement, the Company and Parent agree, and Parent and the Company each agree to cause its Subsidiaries to use their reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable Law to consummate and make effective the Transactions and to use their respective reasonable best efforts to cause the conditions to each Party\u2019s obligation to consummate the Transactions as set forth in Section 5.1 to be satisfied as promptly as practicable (but in no event later than the Outside Date), including taking all actions necessary (i) to obtain all Governmental Authorizations required for the consummation of the Merger"
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    190050,
                    191359
                ],
                "answer": "provided that, in no event will Parent or its Subsidiaries be obligated to (i) propose, negotiate, offer or commit to or effect, by consent decree, hold separate order or otherwise, the sale, divestiture, license or disposition of any assets or businesses of Parent or its Subsidiaries or Affiliates, now owned or hereafter sought to be acquired, (ii) terminate or amend any existing relationships or contractual rights or obligations or (iii) offer or commit to take any action that would limit or modify Parent\u2019s rights of ownership in, or ability to conduct the business of, any of its operations, divisions, businesses, product lines, customers or assets, including, after the Closing, the business of the Company, if any such foregoing action, in each of (i)- (iii), (A) would reasonably be expected to, individually or in the aggregate, (1) materially reduce the reasonably anticipated benefits to Parent of the transactions contemplated by this Agreement, (2) adversely impact Parent or any of Parent\u2019s Subsidiaries other than, after the Closing, the Company and the Company\u2019s Subsidiaries or (3) impact the Company or any of the Company\u2019s Subsidiaries in a manner that is material to the Company and the Subsidiaries, taken as a whole or (B) is not contingent on the consummation of the Transactions. "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"Electronic Arts Inc.\" and Target \"Glu Mobile Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Glu Mobile Inc._Electronic Arts Inc..txt",
                "span": [
                    243115,
                    243908
                ],
                "answer": "Section 7.7               Specific Performance. The Parties agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached and that money damages or other legal remedies would not be an adequate remedy for any such damage. It is accordingly agreed that prior to any valid termination of this Agreement in accordance with Section 6.1, (a) each Party (on behalf of itself or any third-party beneficiary to this Agreement) shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which they are entitled at law or in equity "
            }
        ],
        "file_set": [
            "Glu Mobile Inc._Electronic Arts Inc..txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    66562,
                    67122
                ],
                "answer": "(a)          other than shares of Company Common Stock to be cancelled or converted pursuant to Section 2.03(b) (the \u201cExcluded Shares\u201d), each share of Company Common Stock outstanding immediately prior to the Effective Time shall be converted into, and shall thereafter represent only, the right to receive, 0.396 (the \u201cExchange Ratio\u201d) Parent ADSs (the \u201cMerger Consideration\u201d), subject to Section 2.08 with respect to fractional Parent ADSs, and immediately following such conversion, shall be automatically cancelled and cease to exist (the \u201cCancellation\u201d); "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    111642,
                    111766
                ],
                "answer": "Section 4.09          Absence of Certain Changes.  Since the Company Balance Sheet Date through the date of this Agreement: "
            },
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    112005,
                    112067
                ],
                "answer": "; (b) there has not been any Company Material Adverse Effect; "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Definition of \"Material Adverse Effect\"",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    32261,
                    36582
                ],
                "answer": "\u201cMaterial Adverse Effect\u201d with respect to a Party means any event, change, effect, circumstance, fact, development or occurrence, individually or in the aggregate, that (a) has had or would reasonably be expected to have a material adverse effect on the business, operations, condition (financial or otherwise), assets or liabilities of such Party and its Subsidiaries, taken as a whole, or (b) materially impairs the ability of such Party to consummate the transactions contemplated by this Agreement or would reasonably be expected to do so; provided, that in the case of clause (a) only, no event, change, effect, circumstance, fact, development or occurrence to the extent resulting from, arising out of, or relating to any of the following shall be deemed to constitute a Material Adverse Effect with respect to such Party or shall be taken into account in determining whether there has been or would reasonably be expected to be a Material Adverse Effect with respect to such Party:  (i) any changes in general U.S. or global economic, capital markets or regulatory conditions or other general business, financial or market conditions, (ii) any changes in conditions generally affecting the industries in which such Party or any of its Subsidiaries operates, (iii) any decline, in and of itself, in the market price or trading volume of such Party\u2019s securities or in such Party\u2019s credit ratings (provided, that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such decline that are not otherwise excluded from the definition of Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect with respect to such Party), (iv) any failure, in and of itself, by such Party or any of its Subsidiaries to meet any internal or published projections, forecasts, estimates or predictions in respect of revenues, earnings or other financial or operating metrics for any period (provided, that any events, changes, effects, circumstances, facts, developments or occurrences giving rise to or contributing to such failure that are not otherwise excluded from the definition of Material Adverse Effect may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect with respect to such Party), (v) the public announcement of this Agreement or the transactions contemplated hereby, including the impact thereof on the relationships of a Party with their respective customers, suppliers, distributors, partners or other material third-party business relations or with their respective employees directly arising out of or related to the foregoing, (vi) any changes in Applicable Law or GAAP or IFRS, as applicable, first announced or proposed after the date of this Agreement, (vii) geopolitical conditions, the outbreak or escalation of hostilities, civil or political unrest, any acts of war or terrorism or any worsening thereof, (viii) any epidemic or pandemic (including COVID-19), hurricane, earthquake, flood, calamity or other natural disasters or acts of God or any worsening thereof or any declaration of martial law, quarantine or similar directive, policy or guidance or Law or other action by any Governmental Authority in connection therewith or in response thereto, (ix) any COVID-19 Measures, (x) the taking of any action required to be taken pursuant to this Agreement, or which the other Party has requested in writing, (xi) any Transaction Litigation or (xii) any matters expressly set forth in the Company Disclosure Schedule or Parent Disclosure Schedule; provided, that the matters referred to in clauses (i), (ii), (vi), (vii), (viii) or (ix) may be taken into account to the extent that the impact of any such event, change, effect, circumstance, fact, development or occurrence on such Party and its Subsidiaries, taken as a whole, is disproportionately adverse relative to its impact on the other participants in the industries in which such Party and its Subsidiaries operate (in which case only the incremental disproportionate impact or impacts may be taken into account in determining whether there has been, or would reasonably be expected to be, a Material Adverse Effect). "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    31295,
                    31471
                ],
                "answer": "\u201cknowledge\u201d means (i) with respect to the Company, the knowledge of those individuals set forth in Section 1.01 of the Company Disclosure Schedule after reasonable inquiry and "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    271923,
                    271980
                ],
                "answer": "Section 6.03          No Solicitation by the Company. \n\n\n"
            },
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    275126,
                    276546
                ],
                "answer": "(c)          Notwithstanding the foregoing, if at any time prior to the receipt of the Company Stockholder Approval (the \u201cCompany Approval Time\u201d), the Board of Directors of the Company receives a bona fide written Company Acquisition Proposal made after the date of this Agreement that has not resulted from a violation of this Section 6.03 and the Board of Directors of the Company determines in good faith, after consultation with its financial advisor and outside legal counsel, that such Company Acquisition Proposal is or is reasonably likely to lead to a Company Superior Proposal and, after consultation with its outside legal counsel, that failure to take the actions referred to in clause (A) and (B) below would be inconsistent with the directors\u2019 fiduciary duties under Applicable Law, then the Company may (A) subject to compliance with this Section 6.03, engage in negotiations or discussions with such Third Party and (B) furnish to such Third Party and its Representatives non-public information relating to the Company or any of its Subsidiaries pursuant to an Acceptable Confidentiality Agreement; provided, that all such non-public information (to the extent that such information has not been previously provided or made available to Parent) is provided or made available to Parent, as the case may be, substantially concurrently with the time it is provided or made available to such Third Party. \n\n\n"
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    52208,
                    53401
                ],
                "answer": "\u201cSuperior Proposal\u201d means, with respect to a Party, any bona fide, written Acquisition Proposal made after the date of this Agreement that is fully financed or has fully committed financing that the Board of Directors of such Party determines in good faith, after consultation with its financial advisor and outside legal counsel, and taking into account all legal, financial, regulatory and other terms and conditions of the Acquisition Proposal (including any governmental or other approval requirements, the availability and terms of any necessary financing, and other aspects of the Acquisition Proposal and the Third Party making the Acquisition Proposal), (i) would result in a transaction that is more favorable to such Party\u2019s stockholders from a financial point of view than the Merger (including any adjustment to the terms and conditions proposed by the other Party hereto in response to such Acquisition Proposal) and (ii) is reasonably likely of being completed on the terms proposed on a timely basis; provided that for purposes of this definition, references in the term \u201cAcquisition Proposal\u201d to twenty percent (20%) shall be deemed to be references to fifty percent (50%). \n\n\n"
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    19726,
                    20587
                ],
                "answer": "\u201cCompany Intervening Event\u201d means any material event, change, effect, circumstance, fact, development or occurrence that (i) was not known or reasonably foreseeable to the Board of Directors of the Company as of or prior to the date of this Agreement and (ii) does not relate to or involve (A) any Company Acquisition Proposal or Company Inquiry, (B) any change in the market price or trading volume of the Company Common Stock (but the underlying facts or events contributing to the change in the market price or trading volume can be taken into account in determining whether a Company Intervening Event has occurred unless otherwise expressly excluded hereby), (C) any event or circumstance relating to Parent or any of its Subsidiaries, (D) any breach of this Agreement by the Company or any of its Subsidiaries or (E) the lapsing of any COVID\u201119 Measures. "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    363080,
                    363369
                ],
                "answer": "Section 9.01          Termination.  This Agreement may be terminated and the Merger and the other transactions contemplated hereby may be abandoned at any time prior to the Effective Time (notwithstanding receipt of the Company Stockholder Approval or the Parent Shareholder Approval): \n\n\n"
            },
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    368946,
                    368978
                ],
                "answer": "(d)          by the Company: \n\n\n"
            },
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    371797,
                    372421
                ],
                "answer": "(iii)          prior to obtaining the Company Stockholder Approval, in order to enter into a definitive agreement providing for a Company Superior Proposal promptly following such termination, provided that the Company (i) shall have complied with all of the terms and conditions set forth in Section 6.03 (No Solicitation), (ii) shall have paid the Company Termination Payment substantially concurrently with or prior to (and as a condition to) such termination in accordance with Section 9.03(a) and (iii) substantially concurrently enters into such definitive agreement with respect to such Company Superior Proposal. \n\n\n"
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    249460,
                    250786
                ],
                "answer": "Section 6.01          Conduct of the Company. \n\n\n(a)          From the date of this Agreement until the earlier of the Effective Time and the termination of this Agreement, except (i) as prohibited or required by Applicable Law, (ii) as a result of COVID-19 Measures, (iii) as set forth in Section 6.01 of the Company Disclosure Schedule, or (iv) as otherwise required or expressly contemplated by this Agreement, unless Parent shall have given its prior written consent (which consent shall not be unreasonably withheld, conditioned or delayed), the Company shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to conduct its business in all material respects in the ordinary course of business consistent with past practice and to preserve intact its business organization, keep available the services of its employees who are integral to the operation of the business as presently conducted and maintain its existing relations and goodwill with material customers, members, suppliers, licensors, licensees and other Third Parties with whom it has material business relations; provided, that no action by the Company or any of its Subsidiaries to the extent expressly permitted by an exception to any of Section 6.01(b)(i) through Section 6.01(b)(xxii) shall be a breach of this sentence. "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    297056,
                    298282
                ],
                "answer": "Section 7.01          Reasonable Best Efforts; Filings. \n\n\n(a)          Subject to the terms and conditions of this Agreement, each of the Company and Parent shall, and each shall cause its Subsidiaries to, use their respective reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under Applicable Law to consummate the Merger and other transactions contemplated hereby as promptly as reasonably practicable, including (i) (A) preparing and filing as promptly as practicable with any Governmental Authority all documentation to effect all Filings as are necessary, proper or advisable to consummate the Merger and the other transactions contemplated hereby, (B) obtaining, as promptly as practicable, and thereafter maintaining, all Consents from any Governmental Authority that are necessary, proper or advisable to consummate the Merger or other transactions contemplated hereby, and complying with the terms and conditions of each Consent (including by supplying as promptly as reasonably practicable any additional information or documentary material that may be requested pursuant to the HSR Act or other applicable Antitrust Laws), "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    304439,
                    305784
                ],
                "answer": "(e)          Notwithstanding any other provision of this Agreement to the contrary, in no event shall Parent or any of its Subsidiaries be required to (i) agree or proffer to divest or hold separate (in a trust or otherwise), or take any other action with respect to, any of the assets or businesses of Parent, the Company, the Surviving Corporation (assuming the consummation of the Merger) or any of their respective Subsidiaries, (ii) agree or proffer to limit in any manner whatsoever or not to exercise any rights of ownership of any securities (including the shares of Company Common Stock) or (iii) enter into any agreement that in any way limits the ownership or operation of any business of Parent, the Company, the Surviving Corporation (assuming the consummation of the Merger) or any of their respective Subsidiaries, in each case that is not conditioned upon, or that becomes effective prior to, the Closing or that is material to the business, financial condition or results of operations of Parent, the Company, the Surviving Corporation or any of their respective Subsidiaries, taken as a whole.  Neither the Company nor any of its Subsidiaries shall agree to any of the actions or other matters contemplated by the first sentence in this Section 7.01(e) as applicable to the Company without the prior written consent of Parent. "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Merger Agreement between \"Amryt Pharma plc\" and \"Chiasma, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Chiasma, Inc._Amryt Pharma plc.txt",
                "span": [
                    396746,
                    397569
                ],
                "answer": "Section 10.13          Specific Performance.  The Parties\u2019 rights in this Section 10.13 are an integral part of the transactions contemplated by this Agreement.  The Parties acknowledge and agree that irreparable harm would occur and that the Parties would not have any adequate remedy at law (a) for any breach of any of the provisions of this Agreement or (b) in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms.  It is accordingly agreed that (except where this Agreement is validly terminated in accordance with Section 9.01) the Parties shall be entitled to an injunction or injunctions to prevent breaches or threatened breaches of this Agreement and to specifically enforce the terms and provisions of this Agreement, without proof of actual damages, "
            }
        ],
        "file_set": [
            "Chiasma, Inc._Amryt Pharma plc.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    49699,
                    50120
                ],
                "answer": "(a) At the Effective Time, each share of Common Stock issued and outstanding immediately prior to the Effective Time (other than (i) Cancelled Shares, and (ii) Dissenting Shares) shall, by virtue of the Merger and without any action on the part of the holder thereof or the Company or the Purchaser Parties, be converted into the right to receive $4.80 in cash, without any interest thereon (the \u201cMerger Consideration\u201d). "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    231232,
                    231476
                ],
                "answer": "Section 7.2. Conditions to the Purchaser Parties\u2019 Obligations to Effect the Merger. The obligations of the Purchaser Parties to effect the Merger are subject to the satisfaction (or waiver by the Purchaser Parties) of the following conditions: "
            },
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    233262,
                    233485
                ],
                "answer": "(b) The Company shall have performed all obligations and complied with all covenants, in each case in all material respects, required by this Agreement to be performed or complied with by it at or prior to the Closing; and "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; What is the Definition of \"Knowledge\"",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    32900,
                    33055
                ],
                "answer": "\u201cknowledge\u201d means, with respect to any Acquired Company, the actual knowledge of the individuals listed in Section 1.01(a) of the Company Disclosure Letter"
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    40325,
                    41596
                ],
                "answer": "\u201cSuperior Proposal\u201d means a bona fide written Acquisition Proposal which did not arise from a material breach of Section 6.3(b) (with all references to \u201c15%\u201d in the definition of Acquisition Proposal increased to \u201c50%\u201d) that the Board or any Independent Committee determines in good faith, after consultation with its financial advisor and outside legal counsel, to be more favorable from a financial point of view to the holders of Unaffiliated Shares than the transactions contemplated hereby (including the Merger), in each case taking into account all financial considerations, the identity of the third party making such Superior Proposal, all legal and regulatory (including antitrust and CFIUS) considerations, the anticipated likelihood, timing and conditions thereof (including any financing condition or the reliability of any debt or equity funding commitments, any break-up fee, expense reimbursement provisions and conditions to consummation) and after taking into account any changes to this Agreement proposed by Parent in connection with the exercise of its rights in response to such Superior Proposal pursuant to Section 6.3(d); and all other factors and matters that the Board or any Independent Committee determines in good faith to be relevant. \n\n\n\n\n"
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    31404,
                    32900
                ],
                "answer": "\u201cIntervening Event\u201d means any material Effect with respect to the Acquired Companies taken as a whole that (A) was not, as of the date of this Agreement, known to or reasonably foreseeable to the Board or the Special Committee or if known to, or reasonably foreseeable to the Board or the Special Committee as of the date hereof, the material consequences of which were not known and reasonably foreseeable to the Board or the Special Committee as of the date hereof and (B) becomes known to or by the Board or the Special Committee prior to the receipt of the later of the Company Stockholder Approval and the Majority of the Minority Approval; provided, however, that in no event shall the following alone constitute an Intervening Event: (i) the receipt, existence or terms of any Acquisition Proposal or any matter relating thereto; or (ii) any change in the price, or change in trading volume, of the Common Stock or the fact that the Company meets or exceeds internal or published projections, budgets, forecasts or estimates of revenues, earnings or other financial results for any period (provided, however, that the underlying causes giving rise to or contributing to such change or fact may be taken into account in determining whether an Intervening Event has occurred) or (iii) any matters generally affecting the industry in which the Company operates as a whole that have not had or would not reasonably be expected to have a disproportionate effect on the Acquired Companies. \n\n\n\n\n"
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    235727,
                    236087
                ],
                "answer": "Section 8.1. Termination. This Agreement may be terminated, and the Merger may be abandoned at any time prior to the Effective Time (notwithstanding the adoption of this Agreement by the stockholders of the Company or Merger Sub), only as follows (it being understood and agreed that this Agreement may not be terminated for any reason or on any other basis): "
            },
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    239671,
                    239723
                ],
                "answer": "(c) by the Company (in accordance with Section 9.14)"
            },
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    240550,
                    241028
                ],
                "answer": "(ii) at any time prior to the receipt of the Company Stockholder Approval and the Majority of the Minority Approval, if the Board authorized the Company to enter into a definitive agreement with respect to a Superior Proposal, to the extent permitted by and in accordance with the terms of Section 6.3; provided, however, that the Company shall concurrently with, and as a condition of, such termination, pay the Company Termination Fee to Parent pursuant to Section 8.2(b)(i); "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    242994,
                    243030
                ],
                "answer": "Section 8.2. Effect of Termination. "
            },
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    246109,
                    246149
                ],
                "answer": "(d) If (A) this Agreement is terminated "
            },
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    246465,
                    247121
                ],
                "answer": "(C) within twelve months following such termination of this Agreement, either a transaction contemplated by such Acquisition Proposal is consummated or the Company enters into a definitive agreement providing for the consummation of a transaction contemplated by such Acquisition Proposal and such transaction is subsequently consummated, then the Company shall promptly (and in any event within three Business Days after such consummation) pay, or cause to be paid, to Parent the Company Termination Fee by wire transfer of immediately available funds to an account or accounts designated in writing by Parent, which shall be promptly provided by Parent. "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    151740,
                    152865
                ],
                "answer": "Section 6.1. Interim Operations of the Company. During the period from the date of this Agreement through the Closing or the date, if any, on which this Agreement is earlier terminated pursuant to Section 8.1 (the \u201cPre-Closing Period\u201d), except (u) for any actions required to comply with any COVID-19 Measure, (v) as may be required by Law, (w) with the prior written consent of Parent (which consent shall not be unreasonably conditioned, withheld or delayed), (x) as required or specifically contemplated by this Agreement, (y) as set forth in Section 6.1 of the Company Disclosure Letter or (z) with respect to actions or omissions taken by or at the direction of any member of the Purchaser Group (including in such Person\u2019s capacity as a director, officer or employee of any of the Acquired Companies), the Company shall, subject to the restrictions and exceptions set forth in Section 6.1 or elsewhere in this Agreement, ensure that the business and operations of the Acquired Companies are conducted in the ordinary course of business in accordance with past practices and in compliance with all then- applicable Law. "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; Where is the Closing Conditions: Regulatory Approvals clause",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    199972,
                    200756
                ],
                "answer": "(a) Upon the terms and subject to the conditions set forth in this Agreement, the Company and Parent shall each use their reasonable best efforts to promptly (i) take, or to cause to be taken, all actions, and to do, or to cause to be done, and to assist and cooperate with the other parties to this Agreement in doing all things necessary, proper or advisable under applicable Law or otherwise to consummate and make effective the Merger; (ii) obtain from any Governmental Entities any actions, non-actions, clearances, waivers, consents, approvals, permits or Orders required to be obtained by the Company, Parent or any of their respective Subsidiaries in connection with the authorization, execution, delivery and performance of this Agreement and the consummation of the Merger; "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; I want information about the Limitations on Antitrust Efforts",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    205271,
                    206312
                ],
                "answer": "(d) Parent\u2019s obligations under this Section 6.7 to use reasonable best efforts shall include, solely to the extent that any of the following actions are not material to the business, financial condition, results of operations of assets of the Acquired Companies, taken as a whole, (i) proposing, negotiating, committing to or effecting, by consent decree, hold separate order, or otherwise, the sale, transfer, license, divestiture or other disposition of, or any prohibition or limitation on the ownership (including conduct or behavioral remedies or covenants), operation, effective control or exercise of full rights of ownership of, any of the businesses, product lines or assets of Parent or any of its Affiliates or of the Company, and (ii) defending any judicial or administrative action or similar proceeding instituted (or threatened to be instituted) by any Governmental Entity or seeking to have any stay, restraining order, injunction or similar order entered by any Governmental Entity vacated, lifted, reversed, or overturned. "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"V99, Inc.\" and Target \"Telenav, Inc.\"; Where is the Specific Performance clause",
        "snippets": [
            {
                "file_path": "maud/Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt",
                "span": [
                    266215,
                    267239
                ],
                "answer": "Section 9.9. Specific Performance. The Parties agree that irreparable damage, for which monetary damages would not be an adequate remedy, would occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached by the Parties (including a Party\u2019s failure to take such actions as are required of it hereunder in order to consummate the transactions contemplated by this Agreement). Prior to the termination of this Agreement pursuant to Section 8.1, it is accordingly agreed that the Parties shall be entitled to an injunction or injunctions, or any other appropriate form of specific performance or equitable relief, to prevent breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement in any court of competent jurisdiction, in each case in accordance with this Section 9.9, this being in addition to any other remedy to which they are entitled under the terms of this Agreement at law or in equity. "
            }
        ],
        "file_set": [
            "Telenav, Inc._Management Led Buyout.pdf||Telenav, Inc._Management Led Buyout Amendment No. 1.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What is the Type of Consideration",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    5659,
                    6908
                ],
                "answer": "WHEREAS, the boards of directors of Parent, Purchaser and the Company each have approved the acquisition of the Company on the terms and subject to the conditions set forth in this Agreement and, accordingly, Purchaser has agreed to commence a tender offer (as it may be amended from time to time as permitted by this Agreement, the \u201cOffer\u201d) to purchase any (subject to the Minimum Tender Condition) and all of the issued and outstanding shares (each, a \u201cShare\u201d and, collectively, \u201cShares\u201d) of Common Stock, par value $0.0001 per share, of the Company (\u201cCompany Common Stock\u201d), for $22.50 per Share, net to the seller in cash, without interest (the \u201cClosing Amount\u201d), plus one contingent value right per share (a \u201cCVR\u201d) which shall represent the right to receive the Milestone Payment (as such term is used in the Contingent Value Rights Agreement in the form attached hereto as Annex IV (the \u201cCVR Agreement\u201d) to be entered into between Parent and a trustee mutually agreeable to Parent and the Company (the \u201cTrustee\u201d), if any, at the time provided for in the CVR Agreement, net to the seller in cash, without interest (the Closing Amount plus one CVR, collectively, or any higher amount per share paid pursuant to the Offer, the \u201cOffer Price\u201d); \n\n\n"
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    26502,
                    27364
                ],
                "answer": "Section 3.1. Conversion of Securities. At the Effective Time, by virtue of the Merger and without any further action on the part of Parent, Purchaser, the Company or the holders of any of the following securities, the following will occur: \n\n\n(a) each Share issued and outstanding immediately prior to the Effective Time (other than any Shares described in Section 3.1(b), Company Restricted Stock and any Dissenting Shares) will be converted into the right to receive the Offer Price, without interest (the \u201cMerger Consideration\u201d), less any applicable tax withholding. As of the Effective Time, all such Shares shall no longer be outstanding and shall cease to exist, and each holder of any such Shares shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration in accordance with Section 3.4, without interest;   "
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; Information about the Closing Condition: Compliance with Covenants",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    253667,
                    253694
                ],
                "answer": "CONDITIONS TO THE OFFER \n\n\n"
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    254938,
                    255442
                ],
                "answer": "2. Additionally, Purchaser is not required to accept for payment or, subject to any applicable rules and regulations of the SEC, including Rule 14e-l(c) under the Exchange Act (relating to Purchaser\u2019s obligation to pay for or return tendered Shares promptly after the termination or withdrawal of the Offer), to pay for any Shares validly tendered and not validly withdrawn in connection with the Offer if, immediately prior to the then applicable Expiration Date, any of the following conditions exist: "
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    255648,
                    256012
                ],
                "answer": "(b) (i) the Company has breached or failed to comply in any material respect with any of its agreements or covenants to be performed or complied with by it under the Agreement on or before the Acceptance Time and has not thereafter cured such breach or failure to comply, and such breach or failure to comply has not been waived in writing by Parent or Purchaser, "
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What is the Target's Representation & Warranty of No Material Adverse Effect, with regards to some specified date",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    58896,
                    59076
                ],
                "answer": "Section 4.8. Absence of Certain Developments. From the Company Balance Sheet Date to the date of this Agreement, the Company has not experienced a Company Material Adverse Effect. "
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; Where is the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    145957,
                    147928
                ],
                "answer": "Section 6.3. Acquisition Proposals. \n\n\n(a) The Company shall not, and shall instruct its Representatives not to: (i) directly or indirectly initiate, solicit, or knowingly encourage or knowingly facilitate (including by way of providing information) any inquiries, proposals or offers, or the making of any submission or announcement of any inquiry, proposal or offer that constitutes or would reasonably be expected to lead to any Acquisition Proposal, (ii) directly or indirectly engage in, enter into or participate in any discussions or negotiations with any Person with respect to any Acquisition Proposal or (iii) provide any non-public information to, or afford access to the business, properties, assets, books or records of the Company to, any Person (other than Parent, Purchaser, or any designees of Parent or Purchaser) in connection with any Acquisition Proposal. The Company shall, and shall cause its directors and officers to, and shall direct its other Representatives to, (x) immediately cease any solicitation, discussions, or negotiations with any Person (other than Parent, Purchaser, or any designees of Parent or Purchaser) with respect to any Acquisition Proposal, (y) request the return or destruction of all confidential information provided by or on behalf of the Company to any such Person and (z) terminate access to any physical or electronic data rooms relating to a possible Acquisition Proposal. Notwithstanding the foregoing, the Company and its Representatives may, solely in response to an inquiry or proposal that did not result from a material breach of this Section 6.3(a), (A) seek to clarify and understand the terms and conditions of any inquiry or proposal made by any Person solely to determine whether such inquiry or proposal constitutes an Acquisition Proposal and (B) inform a Person that has made or, to the Knowledge of the Company, is considering making an Acquisition Proposal of the provisions of this Section 6.3. \n\n\n"
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What about the Fiduciary exception to the No-Shop Clause",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    145957,
                    145996
                ],
                "answer": "Section 6.3. Acquisition Proposals. \n\n\n"
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    147928,
                    149068
                ],
                "answer": "(b) Notwithstanding Section 6.3(a) or any other provision of this Agreement, if at any time following the date of this Agreement and prior to the Acceptance Time, (i) the Company has received a written Acquisition Proposal that did not result from a material breach of Section 6.3(a) and (ii) the Company Board or a committee thereof determines in good faith, after consultation with outside counsel and a financial advisor, that such Acquisition Proposal constitutes or is reasonably likely to lead to or result in a Superior Proposal, then the Company may (A) furnish information with respect to the Company to the Person making such Acquisition Proposal and its Representatives and (B) participate in discussions or negotiations with such Person and its Representatives regarding such Acquisition Proposal; provided, that the Company may only take the actions described in clauses (A) or (B) above if the Company Board determines in good faith, after consultation with outside counsel, that the failure to take any such action would be, or would reasonably be expected to be, inconsistent with its fiduciary duties under applicable Law; "
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What is the Definition of \"Superior Proposal\"",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    238244,
                    239147
                ],
                "answer": "\u201cSuperior Proposal\u201d means any written bona fide (as reasonably determined by the Company Board in good faith) Acquisition Proposal received after the date of this Agreement that did not result from a material breach of Section 6.3(a) (except the references in the definition thereof to \u201ctwenty percent (20%)\u201d will be replaced by \u201cfifty percent (50%)\u201d) that the Company Board or a committee thereof has determined in good faith, after consultation with outside counsel and its independent financial advisor, is superior to the Acquisition Proposal reflected in this Agreement, taking into account all of the terms and conditions (including all of the financial, regulatory, financing, conditionality, legal and other terms, as well as the likelihood of consummation thereof) and all other aspects of such Acquisition Proposal (including any changes to the terms of this Agreement proposed by Parent). \n\n\n"
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What is the Definition of \"Interveining Event\"",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    221842,
                    223117
                ],
                "answer": "\u201cIntervening Event\u201d means a change, effect, event, circumstance, occurrence, or other matter material to the Company that was not known to the Company Board or any committee thereof on the date of this Agreement (or if known, the consequences of which were not known to the Company Board or any committee thereof as of the date of this Agreement), which change, effect, event, circumstance, occurrence, or other matter, or any consequence thereof, becomes known to the Company Board or any committee thereof prior to the Acceptance Time; provided, however, that in no event will any Acquisition Proposal or any inquiry, offer, or proposal that constitutes or would reasonably be expected to lead to an Acquisition Proposal constitute an Intervening Event; provided, further, that in no event shall any of the following constitute or contribute to an Intervening Event: (i) changes in the financial or securities markets or general economic or political conditions in the United States, (ii) changes (including changes of applicable Law) or conditions generally affecting the industry in which the Company operates or (iii) the Company\u2019s meeting or exceeding any internal or published budgets, projections, forecasts or predictions of financial performance for any period. \n\n\n"
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; Information about the Fiduciary Termination Right Triggers for termination",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    188121,
                    188306
                ],
                "answer": "Section 8.3. Termination by the Company. This Agreement may be terminated, and the Offer and the Merger may be abandoned, at any time prior to the Acceptance Time, by the Company if:   "
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    189452,
                    189849
                ],
                "answer": "(b) The Company Board or any committee thereof effects a Change of Board Recommendation in respect of a Superior Proposal in accordance with Section 6.3(e)(i) or Section 6.3(e)(ii); provided, that, promptly following such termination, the Company enters into an Alternative Acquisition Agreement in respect of such Superior Proposal and pays the termination fee due pursuant to Section 8.5(b). \n\n\n"
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; Is there a Tail provision for acquisition proposals",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    191028,
                    191067
                ],
                "answer": "Section 8.5. Effect of Termination. \n\n\n"
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    192134,
                    192160
                ],
                "answer": "(b) In the event that: \n\n\n"
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    192317,
                    192356
                ],
                "answer": "(iii) (A) this Agreement is terminated "
            },
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    192839,
                    193391
                ],
                "answer": "(C) within twelve (12) months after such termination, the Company enters into an Alternative Acquisition Agreement with respect to an Acquisition Proposal (and the transactions contemplated by such Acquisition Proposal are subsequently consummated) or the Acquisition Proposal is consummated (provided, that, for purposes of clause (C) of this Section 8.5(b)(iii), references to \u201c20%\u201d in the definition of Acquisition Proposal will be substituted for \u201c50%\u201d); \n\n\nThen, in any such case, the Company shall pay Parent a termination fee of $30,000,000.00, "
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    },
    {
        "query": "Consider the Acquisition Agreement between Parent \"ELI LILLY AND COMPANY\" and Target \"PREVAIL THERAPEUTICS INC.\"; What are the Ordinary course of business covenants",
        "snippets": [
            {
                "file_path": "maud/Prevail Therapeutics Inc._Eli Lilly and Company.txt",
                "span": [
                    133569,
                    134391
                ],
                "answer": "Section 6.1. Covenants of the Company. \n\n\n(a) Except (i) as set forth in Section 6.1(a) of the Company Disclosure Letter, (ii) as required by applicable Law, (iii) as expressly permitted by this Agreement, (iv) any action taken, or omitted to be taken, in each case, that is reasonably necessary to comply with any directives, guidelines or recommendations promulgated by any Governmental Body in connection with or in response to COVID-19 or (v) with the prior written consent of Parent (which consent will not be unreasonably delayed, withheld or conditioned), from the date of this Agreement until the earlier of the Acceptance Time or the date this Agreement is terminated (the \u201cPre-Closing Period\u201d), the Company shall use commercially reasonable efforts (A) to carry on its business in the ordinary course of business"
            }
        ],
        "file_set": [
            "Prevail Therapeutics Inc._Eli Lilly and Company.txt"
        ]
    }
]
